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RISK REDUCING BEHAVIORS IN A COMMUNITY SAMPLE OF WOMEN WITH A 
FAMILY HISTORY OF BREAST CANCER 
 
Tamara J. Somers, Ph.D. 
 
University of Pittsburgh, 2006 
 
 
 
This study was designed to examine and explain the use of risk-reducing behaviors in a group of 
women recruited from the community who had a family history of breast cancer. An empirically 
derived model was developed that included variables hypothesized to influence adherence 
intentions, early detection behaviors, and high-risk clinic contact intentions. The model included 
the background variables of age, objective risk, education, income, and healthcare 
communication and the proximal variables of perceived risk, cancer specific distress, and 
attitude. This study also prospectively examined the use of high-risk services. Participants 
included women (N = 187) with a family history of breast cancer who had no prior contact with a 
high-risk or familial breast cancer clinic or program. Study hypotheses were tested with 
correlational analyses, structural equation modeling (SEM), and logistic regression. Results of 
SEM found that the proposed variables accounted for 42% of the variance in adherence 
intentions, and 23% of the variance in both early detection behaviors and clinic contact 
intentions. Approximately 24% of the women who participated in this study contacted the high-
risk clinic to receive additional information about their risk. Predictors of clinic contact included 
higher objective risk, higher clinic contact intentions, lower perceived risk, and higher cancer 
distress. Implications of these findings are discussed.   
 
 
 
 iii
 
 
TABLE OF CONTENTS 
 
 
 
I. INTRODUCTION................................................................................................... 1 
II. STUDY PURPOSE................................................................................................ 3 
III. BACKGROUND.................................................................................................. 7 
 A. RISK FACTORS AND RISK REDUCING BEHAVIORS…………….. 7 
  1. Risk Assessment............................................................................... 8 
  2. Early Detection................................................................................ 9 
   a. Mammography Screening.................................................... 9 
   b. Clinical and Breast Self Exam............................................. 10 
  3. Prevention........................................................................................ 11 
   a. Chemoprevention................................................................. 11 
   b. Risk Reducing Surgery......................................................... 12 
 B. FACTORS AFFECTING RISK REDUCING BEHAVIORS…………… 14 
  1. Age................................................................................................... 15 
  2. Objective Risk.................................................................................. 18 
  3. Socioeconomic Factors.................................................................... 19 
  4. Healthcare Use and Communication............................................... 20 
  5. Perceived Risk.................................................................................. 21 
   a. Perceived Risk and Behavior....................................……... 24 
 iv
   b. Perceived Risk and Risk Reducing Behavior....................... 24 
  6. Cancer Specific Distress.................................................................. 25 
  7. Attitudes Toward Risk-Reducing Behavior...................................... 28 
 C. OTHER MODEL RELATIONSHIPS…………………………………… 29 
  1. Perceived Risk.................................................................................. 30 
  2. Attitudes Toward Risk Reducing Behaviors..................................... 31 
  3. Cancer Specific Distress.................................................................. 32 
IV. STUDY AIMS AND HYPOTHESIS................................................................... 34 
V. METHODS............................................................................................................ 46 
 A. PARTICIPANTS….................................................................................... 46 
 B. RECRUITMENT PROCEDURES ............................................................ 46 
 C. STUDY PROCEDURES .......................................................................... 49 
 D. MEASURES…........................................................................................... 50 
  1. Background Variables..................................................................... 50 
   a. Demographic Variables....................................................... 50 
   b. Objective Breast Cancer Risk.............................................. 50 
  2. Predictor Variables.......................................................................... 51 
   a. Demographic and Background Variables............................ 51 
   b. Healthcare Communication................................................. 51 
   c. Perceived Risk...................................................................... 56 
   d. Attitudes Toward Risk-Reducing Behaviors......................... 62 
   e. Cancer Specific Distress....................................................... 66 
  3. Outcome Variables........................................................................... 69 
 v
   a. Early Detection Behavior..................................................... 69 
   b. Clinic Contact Behavior....................................................... 70 
   c. Clinic Contact Intentions...................................................... 71 
   d. Adherence Intentions............................................................ 71 
 E. STATISTICAL ANALYSES .................................................................... 71 
  1. Structural Equation Modeling......................................................... 73 
  2. Logistic Regression.......................................................................... 74 
VI. RESULTS............................................................................................................. 75 
 A. PARTICIPANT CHARACTERISTICS..................................................... 75 
 B. PREDICTOR VARIABLES ..................................................................... 81 
  1. Healthcare Communication............................................................. 81 
  2. Perceived Risk.................................................................................. 85 
  3. Attitudes Toward Risk-Reducing Behavior...................................... 88 
  4. Cancer Specific Distress.................................................................. 92 
   a. Cancer Worry....................................................................... 92 
   b. Cancer Distress.................................................................... 92 
 C. OUTCOME VARIABLES........................................................................ 92 
  1. Early Detection Behaviors............................................................... 92 
   a. Composite Score for Early Detection Behaviors................. 95 
  2. Clinic Contact Intentions................................................................ 99 
  3. Clinic Contact Behavior.................................................................. 99 
  4. Adherence Intentions....................................................................... 99 
 D. PRELIMINARY ANALYSES .......................................………………….. 100 
 vi
 E. TESTING THE HYPOTHESES ........….................................................... 107 
  1. Primary Aim 1.................................................................................. 107 
  2. Primary Aim 2.................................................................................. 110 
  3. Primary Aim 3.................................................................................. 113 
  4. Primary Aim 4.................................................................................. 116 
  5. Primary Aim 5.................................................................................. 119 
   a. Aim 1 Within SEM................................................................ 144 
   b. Aim 2 Within SEM................................................................ 145 
   c. Aim 3 Within SEM................................................................ 146 
   d. Aim 4 Within SEM................................................................ 147 
   e. Indirect Effects...................................................................... 148 
   f. Other Model Pathways.......................................................... 149 
   g. Model Summary.................................................................... 150 
  6. Secondary Aim................................................................................. 150 
VII. DISCUSSION...................................................................................................... 153 
 A. BACKGROUND VARIABLES AND OUTCOMES................................ 154 
  1. Socioeconomic Variables................................................................. 154 
  2. Healthcare Communication............................................................. 156 
  3. Age................................................................................................... 158 
  4. Objective Risk.................................................................................. 160 
 B. PROXIMAL VARIABLES……................................................................ 161 
  1. Perceived Risk…………………………………………………………… 162 
 vii
 
   a. Perceived Risk, Background Variables, and Cancer Specific 
Distress...................................................................................... 
164 
  2. Cancer Specific Distress................................................................. 166 
  3. Attitude............................................................................................. 168 
   a. Attitude and Other Study Variables..................................... 171 
  4. Race.................................................................................................. 172 
 C. SUMMARY AND FUTURE DIRECTIONS............................................ 175 
 D. LIMITATIONS…...……………………………………………………... 177 
 E. BIBLIOGRAPHY 179 
 
 viii
 
 
LIST OF TABLES 
 
Table 1 Descriptive statistics for the healthcare communication items……………. 53 
Table 2 Descriptive statistics for perceived risk items…………………………….. 58 
Table 3 Descriptive statistics for attitude items……………………………………. 63 
Table 4 Descriptive statistics for cancer worry items……………………………… 68 
Table 5 Summary of demographic and breast cancer history information………… 78 
Table 6 Final principal component analysis of healthcare communication………... 83 
Table 7 Final principal component analysis of perceived risk items………………. 86 
Table 8 Principal component analysis of attitude items…………………………… 89 
Table 9 Rates of early detection behaviors by age………………………………… 94 
Table 10 ANOVAs (F score reported) for individual behaviors and study variables 
and correlation (r’s reported) for the early detection behavior combined 
variable and study variables………………………………………………. 
 
 
97 
Table 11 Pearson correlations between background variables……………………… 101 
Table 12 Pearson correlations between background and predictor variables……….. 102 
Table 13 Pearson correlations between outcome measures and background and 
other predictor variables…………………………………………………... 
103 
Table 14 Pearson correlations predictor variables………………………………….. 104 
Table 15 Significant relationships between race and other study variables………… 105 
Table 16 Significant relationships between partner status and other study variables.. 106 
 ix
Table 17 Goodness of fit difference tests summary for model with latent factor…… 131 
Table 18 Goodness of fit summary for model with no latent factor………………… 139 
Table 19 Summary of comparison of non-nested models…………………………… 141 
Table 20 Standardized parameters for the final structural equation model predicting 
risk reducing behaviors……………………………………………………. 
 
142 
 
 x
 
 
LIST OF FIGURES 
 
Figure 1 Full hypothesized model………………………………………………… 5 
Figure 2 Representation of Aim 1 ………………………………………………... 37 
Figure 3 Representation of Aim 2 ……………………………………………… 39 
Figure 4 Representation of Aim 3 ………………………………………………... 41 
Figure 5 Representation of Aim 4 ………………………………………………... 43 
Figure 6 Recruitment flow chart………………………………………………….. 48 
Figure 7 Results for Aim 1………………………………………………………... 109 
Figure 8 Results for Aim 2………………………………………………………... 112 
Figure 9 Results for Aim 3………………………………………………………... 114 
Figure 10 Results for Aim 4………………………………………………………... 117 
Figure 11 Full hypothesized model with structural equation modeling……………. 121 
Figure 12 Respecified model……………………………………………………… 122 
Figure 13 Respecified model 2……………………………………………………... 125 
Figure 14 Respecified model 3……………………………………………………... 126 
Figure 15 Respecified model 4…………………………………………………… 127 
Figure 16 Respecified model 5……………………………………………………... 128 
Figure 17 Respecified model 6…………………………………………………….. 129 
Figure 18 Respecified model 7……………………………………………………... 130 
Figure 19 Respecified model 8……………………………………………………... 132 
 xi
Figure 20 Observed variables only model 1………………………………………... 134 
Figure 21 Observed variables only model 2………………………………………... 135 
Figure 22 Observed variables only model 3……………………………………….. 136 
Figure 23 Observed variables only model 4………………………………………... 137 
Figure 24 Observed variables only model 5………………………………………... 138 
 
 
 
 xii
  
INTRODUCTION 
 
 
Motivating people to engage in cancer risk-reducing behaviors has proven challenging, but 
remains critically important. Cancer risk-reduction has been difficult to pursue, in part because 
many of the risk factors associated with cancer were not thought to be modifiable. Behavioral 
factors such as tobacco use and energy balance have been increasingly featured in etiological 
models and can clearly be changed. Family history, genetic predisposition, and most 
reproductive factors are not easily altered. However, with increased understanding of cancer 
etiology, increased methods and utilization of cancer screening, and the development of 
chemoprevention agents, risk-reduction has become gradually more promising. During the last 
two decades, advances in science and technology have refined risk-reducing cancer strategies, 
thus providing the potential to dramatically decrease cancer morbidity and mortality. 
The use of risk-reducing behaviors for breast cancer is important for women with a 
family history of breast cancer. With the exception of age, family history is the strongest known 
risk factor for development of disease. Family history and age, together with reproductive 
history, risk can be readily assessed and risk reduction is possible. However, there is evidence 
that a significant minority of women at increased risk for breast cancer do not use risk reduction 
strategies as recommended (Botkin et al., 2003; Lerman et al., 2000). Although there are obvious 
advantages to using risk-reducing behaviors such as assessment (e.g., calculated risk estimates 
and genetic testing), early detection (e.g., mammography, clinical breast exam, and self breast 
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exam), and in some cases prevention strategies (e.g., chemoprevention and risk-reducing 
surgeries), several barriers have been identified that prevent women from taking full advantage 
of these strategies. These barriers include demographic variables, healthcare communication and 
knowledge, and physiological and psychological distress that might result from the use of risk-
reducing strategies. To facilitate optimal use of risk-reducing strategies, clinics with programs 
that specialize in familial or high-risk breast cancer assessment and intervention have been 
developed. Such programs can provide women with comprehensive information about their risk 
and recommend strategies to decrease their risk. In short, it is important that women with a 
family history of breast cancer are aware of risk-reducing strategies and engage in risk 
assessment and reduction programs if the full benefits of scientific and technological advances 
are to impact morbidity and mortality due to this disease. To facilitate optimal use it will be 
important that models of these key health behaviors are developed. This research proposed such 
a model to examine some of the barriers to use of risk-reducing behaviors, with the ultimate goal 
of enhancing acceptability and use of risk-reducing options. 
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STUDY PURPOSE 
 
 
This study aimed to provide a better understanding of variables that predict the use of risk-
reducing behaviors in all women at increased risk for breast cancer and this aim is reflected in 
the recruitment strategy. A key aim was to broaden the diversity of the sample of women studied. 
As others have noted (e.g., DiLorenzo et al., 2006), what is known about variables that are 
associated with engagement has been gleaned primarily from samples recruited in settings that 
specialize in high risk treatment. With few exceptions, samples have consisted of women who 
were recruited based on participation in other research (e.g., research isolating the BRCA1/2 
gene), through a family member with cancer, or who have self-referred to a high risk clinic. 
These sample characteristics may provide biased information about predictors of behavior and 
may not generalize to women at high risk from the community at large. Little is known about the 
use of risk-reducing behaviors in women from the general community. Greater diversity of the 
samples must be achieved if we are to move beyond this and develop ways of enhancing risk 
reduction in all women. In this research, the sample was made up of women recruited from the 
community with a family history of breast cancer in a first degree relative. 
This study aimed to explain and model pathways between variables that have been 
associated with risk reducing behaviors. Although several demographic, health, cognitive, and 
affective variables have been associated with the use of risk-reducing behaviors, what we know 
about the relationships of these variables to each other and their subsequent relationships with 
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risk-reducing behaviors is limited. This study aimed to provide better understanding about distal 
and proximal pathways to behavior. Background variables such as age, objective risk, income, 
and education can be conceptualized as distal background variables, whereas variables such as 
perceived risk, attitudes toward behaviors, and cancer specific distress can be considered more 
proximal predictors of behavior that are based on one’s high risk status and may mediate the 
impact of distal variables on outcomes. A critical question in this study was: are background 
variables (e.g., distal) or cognitive and affective variables (e.g., proximal) better at predicting the 
use of risk-reducing strategies? If both are independently predicting behavior, do background 
variables also affect more proximal cognitive or affective variables, and if so, what proximal 
processes are associated with these relationships? The proposed study tested an empirically 
derived model that included background and dispositional variables known to be associated with 
risk-reducing behavior using structural equation modeling (SEM) techniques to identify 
pathways to risk-reducing behaviors (see Figure 1).  
 4
  
Figure 1. Full hypothesized model.  
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      In summary, for risk-reducing behaviors to affect disease occurrence as intended, it is critical 
to understand what factors influence use so that compliance can be altered. Perhaps most 
importantly, it is necessary to study these factors in a more “general population” of women with 
a family history of breast cancer  than has been studied in the past so that promotion of risk-
reducing behaviors can be widely employed to impact breast cancer incidence and severity.  
To orient the reader before introducing the study’s aims, hypotheses, and methods, this 
dissertation will 1) briefly review risk factors for breast cancer and strategies for risk reduction, 
and 2) provide a review of variables included in the proposed model that are known to be 
associated with risk-reducing behaviors in women at high risk for breast cancer and present 
pathways of possible mediation in the model. 
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BACKGROUND 
 
 
RISK FACTORS AND RISK REDUCING BEHAVIORS 
 
Lifetime risk of breast cancer among American women is approximately 13%, with a 3% risk of 
dying from the disease. The strongest known risk factors for or correlates of breast cancer 
include heritable genes, older age, family history, and history of atypical breast biopsy. Other 
risk factors include race or ethnicity, earlier age at menarche, and nulliparity or older age at first 
birth (United States Preventative Services Task Force [USPSTF], 2002). Dietary factors and 
smoking may also be related to breast cancer risk, but the evidence supporting these factors is 
less conclusive (i.e., Nkondjock & Ghardirian, 2004). Due to the relatively high incidence of 
breast cancer, there are general guidelines for all women to engage in early detection procedures. 
For women with known risk factors for disease, use of behaviors that can reduce their risk of 
life-threatening illness is particularly important. Presently, clinics that specialize in high risk 
assessment and counseling are the “gatekeepers” to recommendation and availability of these 
services. This suggests that one of the first steps toward increased optimal use of risk-reducing 
behavior is increasing women’s attendance at high risk clinics.  
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 Risk Assessment 
 
For more than a decade, programs and trials have used equations combining weighted risk 
factors to produce risk estimates. These formulations have traditionally accounted for age, family 
history of breast cancer, reproductive history, and a combination of other risk factors. One such 
formulation, the Gail model, is the most commonly used tool to estimate a woman’s overall risk 
of developing breast cancer “over the next five years” (Euhus, Leitch, Huth, & Peters, 2002). In 
this model, risk estimates are based on current age, age at menarche, age at first live birth, family 
history of breast cancer in first degree relatives, and history of breast biopsy (Gail et al., 1989). 
Other formulations are also used and for women who are thought to be at high risk by such 
models, traditional recommendations have been aimed at early detection procedures. More 
recently, risk assessment models have been used to identify candidates for genetic testing or 
prevention strategies. 
About 10 years ago investigators identified two penetrant breast and ovarian cancer 
susceptibility genes, BRCA1 and BRCA2 (Miki et al., 1994; Wooster et al., 1995). The 
prevalence of inherited BRCA1/2 mutations in the general population is small (.01-.02 percent; 
Haber, 2002), accounting for 5-10% of breast cancer cases (Easton, Bishop, Ford, & Crockford, 
1993; Newman, Austin, Lee, & King, 1988). However, women who carry mutations in one of 
these genes have a 50-80% life time risk of developing breast cancer and up to two thirds are 
likely to develop ovarian cancer by age 70 (Ford et al., 1998). Mutations in these genes are 
associated with early onset breast cancer (Claus, Schildkraut, Thompson, & Risch, 1996), with 
risk beginning to increase near the age of 25 (Meijers-Heijboer et al., 2001). Management 
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options for women with mutations include early detection procedures such as mammography, 
clinical and self-breast exam, and prevention strategies including chemoprevention and risk-
reducing surgeries.  
 
Early Detection 
 
During the last two decades decreased breast cancer mortality rates have been attributed to better 
early detection strategies (Peto, Boreham, Clarke, Davies, & Beral, 2000). In 1987, only 30% of 
women over 40 reported mammography use within the previous two years. Strikingly, in 1998, 
68% of women over 40 reported having a mammogram in the last two years (Breen, Wagener, 
Brown, Davis, & Ballard-Barbash, 2001). Other recommended early detection strategies include 
clinical breast exams and self breast exams. Standard recommendations for early detection 
behaviors are routinely suggested for all women (American Cancer Society [ACS], 2004). There 
is some thought that women with a family history should engage in early detection starting at 
younger ages and with more frequency than women at average risk, but no general consensus has 
been made regarding appropriate age and frequency for these women (i.e., Helzlsouer, 1999). 
 
Mammography Screening. Screening mammography may decrease mortality caused by breast 
cancer and can identify disease in its early stages in asymptomatic women (Sabatino et al., 
2004). There are well-established guidelines suggesting yearly mammograms for all women over 
the age of 40 (ACS, 2004; USPSTF, 2002). These suggestions include women at increased risk, 
although it has been suggested that these women should start screening at younger ages (Burke et 
al., 1997) and screen more frequently (Komenaka et al., 2004). However, there is currently no 
 9
consensus regarding age or frequency of mammograms for women who are at high risk by virtue 
of family history alone or by family history and BRCA1/2 mutation status. Although the benefits 
of annual mammography screening are widely known, many women, including many at high 
risk, do not perform mammography screening behaviors as recommended (Bastani, Marcus & 
Hollatz-Brown, 1991; Hyman, Baker, Ephraim, Moadel, & Phillip, 1994; McCaul, Branstetter, 
Schroeder, & Glasglow, 1996).  
 
Clinical and Breast Self Exam. Along with regular mammography screening, most 
recommending organizations suggest periodic clinical breast exams (CBE) as the most effective 
screening method, recommending CBE for all women (Morrison, 1994). CBE has the potential 
to detect up to 5% of early-stage breast cancers that are not detected by other methods (Sabatino 
et al., 2004; Stefanek, Hartmann, & Nelson, 2001). In randomized clinical trials, the percent of 
breast cancers detected by CBE alone has ranged from 3%-45% (i.e., Stefanek et al.). The ACS 
(2004) suggests that women over 40 years old should have an annual CBE and that younger 
women (20-39) should have a CBE every 3 years. Some studies investigating surveillance among 
women with BRCA1/2 mutations have recommended that these women undergo CBE two to 
four times a year (Scheuer et al., 2002). Although mammography use greatly increased during 
the 1990s, the use of CBE remained largely unchanged during this same time period despite 
widespread recommendations (Adams, Florence, Thorpe, Becker, & Joski, 2003). Unchanging 
rates have been attributed to ambiguity regarding the benefits of CBE. Several other clinical and 
patient barriers have also been cited as barriers; these include embarrassment, patient refusal, 
lack of confidence in performing exam, lack of time, and primary reliance on mammography 
(i.e., Meissner, Breen, & Yabroff, 2003).  
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Breast self exam (BSE) reflects an attempt to have women examine their own breasts in 
addition to having regular CBE. The accuracy, efficacy, and compliance of BSE is unknown 
(i.e., Stefanek et al., 2001). Although only retrospective studies have shown that BSE are 
efficacious in detecting disease (Foster & Costanza, 1984), BSE has been recommended as a 
good health behavior. The ACS (2004) recommends that all women over the age of 20 engage in 
monthly self-exams. For women at high genetic risk, the Cancer Genetics Studies Consortium 
recommended monthly breast self-examination beginning between 18-21 years of age.  
 
Prevention 
 
The goal of primary prevention is to prevent the development of disease. For women at average 
risk for breast cancer there are no recommendations for prevention. For women at high risk, 
however, there are a limited number of options for primary prevention (chemoprevention, risk-
reducing surgeries). The medical efficacy and long-term outcomes of these prevention strategies 
are still being explored and there is an iatrogenic risk inherent in available strategies (i.e., 
Helzlsouer, 1999).  
 
Chemoprevention. Hormone-based interventions are often used in breast cancer therapy due to 
its association with endogenous and exogenous estrogens (Clemons & Goss, 2001). In women at 
high risk for breast cancer, it has been recommended that physicians discuss chemoprevention as 
an option and inform their patients of the benefits and possible dangers of various therapies 
(USPSTF, 2002). The use of tamoxifen, a selective estrogen receptor modulator (SERM) with 
both estrogen agonist and antagonist properties, has been approved for use as a preventive agent 
 11
in women ages 35 years and older with a 5-year risk of breast cancer of at least 1.67% based on 
Gail model calculations (Food and Drug Administration [FDA], 1998). A recent meta-analysis 
using all available data concluded that a reduction rate of 30-40% in breast cancer was achieved 
with tamoxifen (Cuzick et al., 2003). Several significant side effects from tamoxifen treatment 
have been noted, including symptomatic side effects (hot flashes), increased risk for 
thromboembolic events, and increased risk for endometrial cancer. Additionally, it is not known 
whether or not chemoprevention reduces risk in women with a genetic mutation. Raloxifen, a 
different SERM, is currently being investigated as better chemoprevention agent. Raloxifen has 
been shown to reduce breast cancer and does not appear to be associated with increased 
endometrial cancer (Cauley et al., 2001).  
 
Risk-Reducing Surgery. Traditionally, women undergoing risk-reducing surgery for breast cancer 
have been limited to high risk by virtue of family history of cancer. The discovery of BRCA1/2 
genes allows for a more distinct assessment of risk, and genetic testing information is important 
for women considering these prevention surgeries. For women at high risk, risk-reducing 
mastectomy (RRM) and risk-reducing oophorectomy (RRO) for ovarian cancer with some 
suggested influence on breast cancer, are options for prevention to reduce their risk of cancer in 
the future (Garofalo & Baum, 2003).   
Most studies of RRM have been retrospective. In women with a family history of cancer, 
studies have suggested that RRM may provide risk reductions rates of up to 90% (Hartmann et 
al., 1999; Hartmann et al., 2001; Rebbeck et al. 2004). Follow-up time in these studies has 
ranged from 6-13.4 years. One prospective study investigated the differences in rates of breast 
cancer diagnosis in BRCA1/2 mutation carriers who elected RRM (n = 76) or increased 
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surveillance (n = 63). This study found that after approximately three years of follow up, none of 
the women who had surgery developed breast cancer while eight (12%) of the women who used 
increased surveillance developed breast cancer (Meijers-Heijboer et al., 2001). Although the 
majority of studies on RRM efficacy have had short follow-ups and none involved 
randomization, available research suggests that RRM does appear to significantly reduce the risk 
of breast cancer. More prospective studies, longer follow up, larger samples, and controls for 
bias associated with self assignment to condition are needed to establish the protective effect and 
optimal timing for surgery as well as to identify any long-term physiological or psychological 
complications of RRM (Eisen, Rebbeck, Wood, & Webber, 2000; Garofalo & Baum, 2003; 
Rebbeck et al.).  
RRO is a surgical option available to women at increased risk for ovarian cancer. Several 
studies have shown that bilateral oophorectomy is beneficial in reducing the risk of ovarian 
cancer and a limited number of studies have also documented reduction of risk of breast cancer 
attributable to oophorectomy. Among women with BRCA1/2 mutations, RRO has been shown to 
reduce the risk of breast cancer by 50-70% and to virtually eliminate risk of ovarian cancer 
(Rebbeck et al., 1999; Rebbeck et al., 2002). Although the suggestion has been made that women 
with BRCA1/2 mutations should undergo RRO once childbearing is complete (Rebbeck, 2000; 
Eisen et al., 2000), more information is needed to thoroughly assess the risk and benefits 
involved (Burke et al., 1997). Women who undergo RRO experience immediate surgical 
menopause (Rebbeck, 2000), and premature menopause has been associated with an increased 
risk of osteoporosis and cardiovascular disease (i.e., Rebbeck et al.). In addition to the relative 
dearth of reports on the medical efficacy of this procedure, reports of psychosocial implications 
of RRO are limited; some studies of surgically induced menopause have reported lower libido 
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and lower sexual satisfaction after surgery (Dennerstein, Wood, & Burrows, 1977; Nathorst-
Boos, von Schoultz, & Carlstorm, 1993).  
Compared to twenty years ago, there are several viable options for risk reduction in 
women at high risk for breast cancer. As medical science continues to advance and refine these 
options, it will be important for behavioral scientists to work toward understanding how to 
promote the use of risk-reducing behaviors. To do this, it will be necessary to identify variables 
that influence engagement and to understand how these variables interact to influence 
engagement. Although perhaps more important, it is necessary that women at increased risk 
based on a family history of breast cancer are informed that there are available options for risk 
reduction and that these strategies can be explored through clinics and centers that specialize in 
cancer prevention for high risk populations.  
 
 
FACTORS AFFECTING RISK REDUCING BEHAVIORS 
 
Theory and empirical investigation suggest several factors that are associated with health 
behaviors. Many factors have been studied in a broad spectrum of behavior including smoking 
cessation (Norman, Conner, & Bell, 1999), condom use (Smith & Stasson, 2000), and exercise 
(Lowe, Bennett, Walker, Milne, & Bozionelos, 2003). Despite recent advances in options for risk 
reduction, there is limited information about factors that affect risk-reducing behaviors for 
women at increased risk for breast cancer (i.e., Stefanek et al., 2001). Investigators have 
identified variables that predict early detection behaviors (mammography, clinical and self breast 
exams) in general populations of women, although less work has been done exclusively with 
 14
high risk women, and information about risk assessment and prevention is incomplete. Factors 
that have received at least mild empirical support for associations with risk-reducing behaviors 
for breast cancer include age, objective risk, socioeconomic status variables such as income and 
education, healthcare use and communication, perceived risk, cancer specific distress, and 
attitudes toward behaviors. Age, objective risk, socioeconomic, and healthcare use and 
communication variables can be conceptualized as more distal background variables, whereas 
perceived risk, cancer specific distress, and attitudes toward behavior can be considered more 
proximal predictors of behavior that are based on one’s high risk status and that may impact the 
effects of background variables on risk-reducing behavior. These factors are included in the 
proposed model of pathways to risk-reducing behaviors (Figure 1). Current work offers little 
explanation about interactions between these variables and the unique variance each holds when 
predicting risk-reducing behaviors. The proposed model hypothesizes some direct and indirect 
pathways to behavior.  
 
Age 
 
Age is included as a predictor variable in the proposed model because although the direction of 
the relationship varies across behaviors, age has consistently been associated with risk-reducing 
behaviors. The consistency with which age influences these behaviors points to the importance 
of understanding the relationship between age and behavior, and identifying variables that may 
mediate this relationship. Most current work suggests that genetic testing is most widely used by 
women under the age of 50 (Lerman et al., 1997; Meijers-Heijboer et al., 2000), although some 
work has found no association between age and genetic testing (Kelly et al., 2004; Lee et al., 
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2002; Lerman et al., 1996; Lodder et al., 2003). It is generally believed that the earlier increased 
risk status is identified, the more benefit the use of risk-reducing behaviors can provide. It is 
important to understand why younger women are more likely to engage in genetic testing as a 
risk assessment method and the specific factors that influence this relationship.  
One of the primary values of genetic testing or any risk assessment method is 
identification of who will benefit most from intensive or early surveillance. Studies evaluating 
mammography use in women at high risk generally suggest that adherence is highest among 
women in their late 30s, 40s, and 50s (Diefenbach, Miller, & Daly, 1999; Schwartz et al., 2003). 
In some cases, it may be beneficial that women who reach a certain degree of increased risk 
employ mammography screening earlier than their late 30s. However, even among younger 
women found to carry a mutation in BRCA1/2 (i.e., lifetime risk of 50-80%), there is evidence 
that adherence to mammography screening may be poor. In one prospective study, Lerman et al. 
(2000) found that women age 25-39 years old were less likely to engage in mammography after 
testing than women who were over 40. In this sample, among the younger age group a significant 
minority (36%) of carriers of a genetic mutation did not use mammography in the year following 
testing. Peshkin et al. (2002) found that only 39% of women age 25-39 identified to have a 
genetic mutation had a mammogram in the year following testing compared to 74% of women 
over 40. These findings among women at the highest risk may suggest that younger women (< 
40) are at risk for poor adherence to screening practices. Although age can not be modified, it is 
important to understand what modifiable (i.e., proximal) variables may mediate the relationship 
between age and behavior to influence change in screening practices among younger women at 
increased risk.  
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Research investigating predictors of chemoprevention and risk-reducing surgery use is 
limited. However, available research suggests that age appears to be related to these behaviors. 
In two retrospective studies, older age was associated with the use of chemoprevention 
(Lovegrove, Rumsey, Harcourt, & Cawthorn, 2000; Tchou, Hou, Rademaker, Jordan, & 
Morrow, 2004). Although there are benefits of chemoprevention in women over 50, its value is 
optimized when it is used at younger ages because the greatest risk/benefit ratio for 
chemoprevention is in premenopausal women. Like chemoprevention, RRO has consistently 
been related to older age (Botkin et al., 2003; Meijers-Heijboer et al., 2000; Scheuer et al., 2002; 
Schwartz et al., 2003). However, RRM may be associated with younger age. Only one 
prospective study (Scheuer et al.) and one cross-sectional study (Meijers-Heijboer et al., 2000) 
have evaluated the impact of age on the use of RRM, but both reported that the use of RRM was 
associated with younger age.   
 Among women at high risk for breast cancer, there are specific ages when the use of risk-
reducing behaviors may provide the most benefit. The importance of age in the utility of risk-
reducing behaviors as well as the suspected influence of age on these behaviors should 
encourage investigators to begin considering age as a primary variable instead of a control 
variable in models predicting these behaviors. Further, as age is not a modifiable variable, it will 
be important to understand the relationship between age and other variables that may be 
modifiable.  
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 Objective Risk 
 
In general population samples, there is often a positive relationship between the objective risk 
markers of family history and early detection behaviors (Aiken, West, Woodward, & Reno, 
1994; McCaul, Branstetter, et al., 1996). However, it is less clear how degree of risk among 
women with a family history of disease affects the use of risk-reducing behaviors. Further, it is 
not well understood whether objective risk accounts for unique variance when predicting risk-
reducing behavior or if objective risk has its effect through some other more proximal variable 
such as perceived risk. Among women at higher objective risk, some studies have not found a 
relationship between objective risk markers and risk-reducing behavior (i.e., Botkin et al., 2003; 
Kelly et al., 2004; Meiser et al., 2003), although other studies have found that risk is positively 
related to behavior. Calculated objective risk has been related to the use of genetic testing (Lee et 
al., 2002; Lerman et al., 1997; Meijers-Heijboer et al., 2000); and after testing, having a genetic 
mutation in BRCA1/2 has predicted the use of RRM and RRO (Hatcher, Fallowfield, & Ahern., 
2001; Lerman et al., 1996; Schwartz et al., 2003). History of abnormal biopsy, another objective 
risk factor for disease, has also been associated with RRM and with chemoprevention use 
(Bober, Hoke, Duda, Regan, & Tung, 2004; Hatcher et al.; Tchou et al., 2004). When 
considering these findings, it is important to note that women in these studies are often self-
referred to high-risk clinics and the results may not represent women at large with a family 
history of breast cancer (i.e., women who do not voluntarily present for high risk consultation). It 
could be that women in these studies actually are at greater increased risk or believe themselves 
to be at a high degree at increase risk; therefore noted relationships may not generalize to more 
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diverse samples of women with a family history of disease. Ideally, women at the highest risk 
would engage more fully in risk-reducing behaviors, although this relationship is not clear from 
in the current literature. The relationship between degree of risk and risk-reducing behavior is 
important to explore. Understanding this relationship will become particularly necessary as risk-
reducing options become more refined and availability of these options becomes more 
widespread.  
 
Socioeconomic Factors 
 
Other than age, there are few demographic variables exhibiting consistent relationships with risk-
reducing behaviors. Demographic variables such as education level, income, and having health 
insurance appear to have little influence on risk-reducing behaviors for breast cancer except for 
use of mammography. However, the absence of relationships must be couched in the limited 
range of socioeconomic variation studied. To date, samples in studies investigating risk-reducing 
behaviors (with the exception of mammography) have been recruited almost exclusively from 
major academic centers and/or specialty cancer clinics where the demographic profile of the 
samples is homogeneous.  There is limited information about more diverse populations and about 
women who do not initiate care or seek information from high risk cancer settings.  
Studies of mammography have been conducted in large community samples and 
consequently, the results are less limited by these factors. In these studies, socioeconomic 
variables, particularly education, insurance, and income, have been implicated as being 
important in predicting mammography (Lerman et al., 1991; Lerman, Daly, Masny, & Balshem, 
1994; Rimer et al., 1996), suggesting that other risk-reducing behaviors may also be influenced 
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by these factors. Studies that have considered these factors in risk-reducing behaviors also point 
toward a significant relationship. For example, Lerman et al. (1997) found that insurance status 
was related to the uptake of genetic testing, and another study found dramatically different rates 
of use of genetic testing when testing was offered free of charge compared to when individuals 
were required to pay (Lee et al., 2002). Despite limited evidence of the impact of socioeconomic 
variables on risk-reducing behaviors outside of mammography, education level is hypothesized 
to be a main predictor in the proposed model. Education level, as well as other indicators of 
socioeconomic status, will be important to consider as research on risk-reducing behaviors 
begins to focus on more diverse population samples.  
 
Healthcare Use and Communication 
 
Recruitment strategies in past work (e.g., high risk settings) allow for the assumption that all of 
the women in these studies regularly use health care services and have communicated with a 
healthcare professional about their risk of breast cancer. Women captured by this type of 
research may not represent women in the general population. The present study observed risk 
reduction in a group of women at increased risk who were drawn from the community, thus it 
will be important to understand how their past healthcare utilization as well as their 
communication and familiarity with risk reduction affects behavior. For example, it is 
conceivable that women are not participating in risk-reducing behaviors because they are 1) not 
active in healthcare systems and/or 2) because they have limited information and awareness of 
the importance of risk-reducing behaviors.  
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Although limited data are available, there is some research that implicates physicians’ 
recommendation as an important predictor of risk-reducing behaviors. In a group of women at 
average risk for breast cancer, when several variables were measured, physicians’ 
recommendation was found to be the variable that accounted for the most variance in 
mammography use (Aiken et al., 1994). Bober et al. (2004) found that among high-risk women, 
those that reported that their physician had recommended the use of chemoprevention were more 
likely to choose chemoprevention as a risk-reducing behavior than those that did not report such 
a recommendation. Kinney, Richards, Vernon, and Vogel (1998) found similar results, reporting 
that compared to women who said their physician advised against chemoprevention, women who 
reported that their physician recommended chemoprevention were 13 times more likely to use 
this risk-reducing behavior. In a recent study looking at the impact of physicians’ 
recommendation on the use of prostate screening, it was found that recommendation had a strong 
effect on the use of screening (OR = 236.3, 70.5-791.4; Rutten, Meissner, Breen, Vernon, & 
Rimer, 2005). 
Similarly, being aware of risk-reducing strategies and having more information about 
these strategies is also likely to be related to use of risk-reducing behaviors. Again, largely 
because most of this work has been done in populations that are already participating in some 
sort of risk-reducing arena, it is not well understood how communication and information might 
impact the use of screening and prevention. Lerman et al. (1996) reported that individuals who 
understood more about genetic tests were more likely to use testing than those that were not. 
While some studies have found similar results (Thompson et al., 2002), others have suggested 
that knowing about risk or risk-reducing behaviors is negatively related to behavior outcomes or 
intentions (Kinney et al., 2001; Lodder et al., 2003). Reasons for these differences are not easy to 
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explain, and studying a more diverse population to look at this relationship may lend more 
informative results about the impact of healthcare use and communication on risk-reducing 
behaviors.  
 
Perceived Risk 
 
Perceived risk can be defined in a variety of ways, but it is generally considered to reflect 
people’s beliefs about their vulnerability to a specific disease. Although some research has 
shown that individuals may be overly optimistic and underestimate their personal risk of health 
problems and disease (Green, Grant, Hill, Brizzolara, & Belmont, 2003; Weinstein, 1982; 
Weinstein & Klein, 1995), other research has suggested that individuals may overestimate their 
risk of disease (i.e., Croyle & Lerman, 1999). Women’s perceptions of their risk of breast cancer 
tend to be significantly overestimated or exaggerated (Bowen et al., 2003; Croyle & Lerman, 
1999). Importantly, findings also suggest that an individual’s estimation of their risk, 
independent of their objective risk, may influence whether they engage in risk-reducing 
behaviors (Croyle & Lerman; Rimer & Real, 2003). Perceived risk is included as a predictor of 
behavior in the proposed model.  
 
Perceived Risk and Behavior. Models predicting health behaviors have proposed that perceived 
risk is a motivator of precautionary health behavior (Ajzen, 1991; Rogers, 1983; Rosenstock, 
1990; Weinstein, 1988), and empirical research has often assessed this variable. Research has 
found that perceived risk is both positively and negatively related to health behaviors, and some 
research has suggested that there is a curvilinear relationship between perceived risk and health 
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behaviors. Most intuitive of these findings is the positive relationship between perceived risk and 
risk-reducing behavior; if people feel that they are at risk, they are likely to view risk-reducing 
behaviors as decreasing their risk of morbidity and mortality due to disease. A common 
explanation for a negative relationship between perceived risk and health behaviors is that high 
perceived risk inhibits behavior due to excessive levels of fear or distress leading to avoidance 
(Chaffee & Roser, 1986; Kash, Holland, Halper, & Miller, 1992). A curvilinear relationship 
suggests that individuals with the lowest and highest perceived risk (or levels of anxiety) are 
least likely to engage in risk-reducing behaviors and that people with moderate perceived risk are 
most likely to engage in these behaviors (e.g., Hailey, 1991). 
 Results of two meta-analyses that considered the relationship between perceived risk and 
breast cancer screening behavior supported studies finding a positive relationship between these 
two variables. Studies included in these meta-analyses included women at average risk and at 
increased risk. McCaul et al. (1996) analyzed the results of 19 studies and found that in 18 of 
these studies, perceived risk was positively associated with mammography (r = .16). They 
concluded that high perceived risk did not interfere with mammography screening and that there 
was no empirical support for a curvilinear relationship between perceived risk and 
mammography. However, the size of this effect is small, suggesting a rather weak positive 
association. In 2004, Katapodi, Lee, Facione, and Dodd examined 13 additional studies and 
found that the relationship between perceived risk and mammography was still positive in the 
majority of these studies. McCaul, Branstetter et al.’s findings also provided evidence that the 
highest levels of perceived risk were associated with excessive breast self-examination and 
increased frequency of screening behavior. 
 
 23
Perceived Risk and Risk-Reducing Behaviors. Although for certain behaviors the evidence is 
limited, studies investigating the relationship between perceived risk and risk-reducing behaviors 
in women at high risk for breast cancer have generally reported a positive relationship between 
perceived risk and risk-reducing behaviors. Some studies have failed to find this relationship, but 
no study has reported a negative relationship between perceived risk and risk-reducing 
behaviors. A limited number of studies have examined the relationship between perceived risk 
and genetic testing behavior (Kelly et al., 2004; Lee, Bernhardt, & Helzlsouer, 2002). These 
studies did not find a relationship between these two variables, but positive relationships between 
perceived risk and genetic testing intentions have been documented (Bowen et al., 2003; 
Jacobsen et al., 1997). Several cross-sectional studies have reported a positive relationship 
between mammography use and perceived risk samples limited to high risk women (Bowen et 
al.; Burnett et al., 1999, Schwartz et al., 1999), although two prospective studies have failed to 
find a relationship between perceived risk and screening (Diefenbach et al., 1999; Schwartz, 
Taylor, & Willard, 2003). Prospective data suggest that increased perceived risk is related to the 
use of chemoprevention (Bober, Hoke, Duba, Regan, & Tung, 2004) and studies of intentions for 
chemoprevention concur with these findings (Julian-Reynier et al., 2001; Meiser et al., 2003). 
The one study that investigated the relationship between perceived risk and RRM use in high risk 
women reported a positive relationship between these variables (Hatcher et al., 2001), and 
intentions for RRM studies have reported positive (Meiser et al., 2000) and no relationships 
(Meiser et al., 2003). One prospective study found that perceived risk was related to the use of 
RRO in high risk women (Schwartz et al., 2003), and two intention studies found a positive 
relationship between perceived risk and RRO intentions (Julian-Reynier et al.; Meiser et al.).  
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As stated above, most women in these studies have a relatively high perceived risk, thus 
the assessment of risk in many studies is limited to differing degrees of high perceived risk, with 
infrequent measurement of underestimation or accurate estimation of risk. This leaves the 
implications of high perceived risk unclear and suggests the importance of understanding its 
relationship to other predictor variables. The ability to determine how perceived risk alone 
predicts behavior in high risk populations may be limited. Psychological variables, such as fear 
or worry, may mediate cognitive variables like perceived risk (i.e., Weinstein, 1988). Research 
has shown that educational efforts aimed at changing a woman’s perceived risk of breast cancer 
often have minimal effect. Resistance to changes in cognitions may reflect the interaction of 
affective variables with perceived risk; it is possible that a focus on psychological variables 
might change perceived risk. Studies investigating the relationship between perceived risk, 
psychological factors, and behavior are limited. McCaul and Mullens (2003) recently suggested 
that our knowledge about the relative contributions of cognition and affect is limited by the lack 
of investigation of the interaction of these constructs.  
 
Cancer Specific Distress 
 
General psychological distress does not appear to be elevated in women with a high risk for 
cancer (Butow et al., 2005; Coyne, Benazon, Gaba, Calzone, & Weber, 2000); however, these 
women may experience significant distress specific to their high risk status. In one study, about 
one third of women with first degree relatives who had breast cancer reported that they worried 
so much about being diagnosed with breast cancer that it interfered with their daily life (Lerman 
et al., 1993). Other research has also found increased levels of worry in women with a family 
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history of breast or ovarian cancer (Andersen et al., 2002; McCaul, Branstetter, O’Donnell, 
Jacobson, & Quinlan, 1998). Women at high risk may have intrusive thoughts about their cancer 
risk (Erblich, Bovbjerg, & Valdimarsdottir, 2000; McCaul et al.; Valdimarsdottir et al., 1995), 
with some women having levels of intrusive thoughts comparable to women with a diagnosis of 
breast cancer (Lerman et al.). Further, women at high risk can experience significant levels of 
cancer specific distress when undergoing early detection screening procedures (e.g., 
mammography; Gurevich et al., 2004; Valdimarsdottir et al., 2002). 
 Most work investigating the relationship between cancer specific distress and behaviors 
has examined the influence of distress on early detection behaviors. In general population 
samples and high risk samples, cancer specific distress has been associated with both increases 
and decreases in early detection procedures for breast cancer. For example, Lerman et al. (1991) 
reported that although half of women receiving an abnormal mammography result reported 
anxiety about the result, anxiety did not interfere with subsequent screening. In fact, in this 
study, women with the least concerns about their results were least likely to obtain repeat 
mammography. Other studies have also shown that breast and ovarian cancer worry predict 
screening behaviors (Bowen et al., 2003; McCaul et al., 1998), with levels of worry 
incrementally associated with screening behavior (Andersen et al., 2002). McCaul, Schroeder, 
and Reid (1996) found that women with the highest levels of worry were most likely to 
participate in screening for breast cancer, while women with the lowest levels of worry were 
least likely to participate in screening. Still, some work has reported that cancer anxiety is related 
to a decrease in early detection behaviors among women at high risk (i.e., Kash, Holland, 
Osborne, & Miller, 1995; Kash et al., 1992), 
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 Although less work has been done, there is some research looking at the relationship 
between genetic testing, chemoprevention, and RRO and cancer specific distress. Two studies 
have investigated the relationship between cancer distress and mastectomy intentions, but to our 
knowledge there are no studies that have reported investigating the relationship between cancer 
specific distress and RRM behavior. Cancer specific distress has predicted interest in genetic 
testing (Bowen et al., 2003; Kinney et al., 2001), although the picture is less clear for actual 
behavior. Three prospective studies have assessed distress specific to disease and genetic testing 
use. Kelly et al. (2004) assessed distress specific to disease status by tailoring six items from the 
Profile of Mood States (POMS; Lebo & Nesselroade, 1978) and found no association with 
genetic testing use. Two other studies used the intrusions scale of the Impact of Event Scale 
(IES; Horowitz, Wilner, & Alvarez, 1979), with one study reporting a positive relationship 
(Lerman et al., 1997) and the other reporting no association (Thompson et al., 2002). It is 
possible that variations in sample sizes may account for these differences (N = 149 and N = 76; 
respectively), with the latter having insufficient power to detect an effect.  
 Only one study was identified that considered cancer specific distress and 
chemoprevention use. In a prospective study, Bober et al. (2004) assessed both cancer specific 
distress (measured by the IES) and cancer worry. Results of this study found that both cancer 
specific distress and cancer worry were increased among women who accepted chemoprevention 
compared with women who declined. Although no studies have investigated the relationship 
between cancer specific distress and RRM use, two intention studies using the same assessment 
method (IES) have reported inconsistent results. Meiser et al. (2000) found that cancer distress 
was related to RRM intentions while another study by the same group (Meiser et al., 2003) found 
no relationship. One possible explanation for inconsistent findings may be that in the study that 
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found a relationship, women were recruited from a familial cancer clinic. In the study that found 
no association, the sample was drawn from the general population. It will be important in future 
work to understand if this relationship is a product of recruitment strategies, and if so, it will be 
necessary to better define the relationship between distress and behavior in more general 
populations of women. Only one study has evaluated the relationship between cancer specific 
distress and RRO (Schwartz et al., 2003). This relatively large (N = 289) prospective study found 
that cancer worry was associated with RRO use, while cancer distress (IES) was not. In future 
work, it will be important to clarify the nature of the relationship between these two cancer 
specific distress measures and their relative impact on risk-reducing behaviors.  
 
Attitudes Toward Risk Reducing Behaviors 
 
With the exception of basic demographic and health information, perceived risk, and distress, 
few variables have consistently been examined when investigating risk-reducing behaviors. 
However, when attitudes toward risk reducing behavior are assessed in relation to behavior, 
significant relationships are often found. Further, attitudes toward behavior have been included 
as important in many theoretical models of health behavior. Attitudes refer to peoples’ overall 
evaluation or opinion about behavior or person (Ajzen, 1991). The more favorable an 
individual’s attitude toward a behavior, the more likely the individual will intend to engage in the 
behavior. Attitude is measured in relation to the specific behavior under investigation, and has 
been conceptualized as the level of enjoyment expected and belief in efficacy and importance of 
a behavior. McCaul, Sandgren, O’Neill, & Hinsz (1993) found that general attitudes toward self-
exams predicted a significant portion of the variance in intentions to adhere to a regimen of 
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breast and testicular self-exams. Similarly, in a community sample general attitudes about 
genetic testing for colon and breast cancer predicted intentions to undergo genetic testing 
(Braithwaite, Sutton, & Steggles, 2002). Components of attitudes toward behavior have also 
predicted use of health behaviors. One study found that women who felt that they would benefit 
from the mammography were more likely to complete annual mammography (Pakenham, Pruss, 
& Clutton, 2000).  
When attitudes toward risk reducing behaviors are assessed, the relationship is often 
significant, thus warranting the continued investigation of this relationship. Lerman et al. (1996) 
reported the perceived importance of genetic testing was related to test use in a high risk sample. 
Positive genetic testing intentions have been related to increased perception of benefits and 
decreased perceived costs of testing (Capelli et al., 2001). Other work has reported that genetic 
testing use was significantly associated with women’s attitudes toward risk-reducing surgeries 
(Lodder et al., 2003), and belief in the efficacy of chemoprevention was significantly related to 
its uptake (Bober et al., 2004). 
 
OTHER MODEL RELATIONSHIPS 
 
It is important to understand the relationship between the background variables in this model and 
the more proximal variables. Although all of the model variables have been related to behavior, 
it is likely that their relationships with each other impact their relationship with risk-reducing 
behaviors. The model in this study suggests that perceived risk, attitudes toward risk reducing 
behavior, and cancer distress may indirectly impact the outcomes through their relationships with 
the background variables.  
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 Perceived Risk  
 
As others have noted, there are a limited number of studies that highlight the influence of 
demographic characteristics on perceived risk for breast cancer (e.g., Katapodi et al., 2004). This 
may partially be because perceived risk predicts more variance on behavioral outcomes than 
demographic (background) variables. Perceived risk may mediate the relationships between age, 
objective risk, and education and risk-reducing behaviors.  
Although women of all ages have a high perceived risk of cancer (Lerman, Kash, & 
Stefanek, 1994), younger women may experience the highest levels of perceived risk (Katapodi 
et al.; Meiser et al., 2002). Relationships between age and risk-reducing behaviors are not 
consistent, for some behaviors older age is more predictive and for others younger age is more 
predictive. However, the relationship between high perceived risk and behavior is consistent; 
thus, perceived risk might act as an indirect path or mediator of the impact of age on outcomes.  
Objective risk is related also related to perceived risk, but again perceived risk appears to 
be more predictive of behavior than objective risk. There is evidence that engagement in health 
behaviors is not always logical, nor is one’s perceived risk. Meiser et al. (2001) found that 
women with the lowest levels of objective risk actually had the highest levels of perceived risk.  
The cognitive component of perceived risk is not captured by measures of objective risk; thus, 
the impact of objective risk on behaviors might be accounted for in perceived risk. It may be the 
component of risk that causes women to overestimate their risk best predicts behavior rather than 
objective risk, thus suggesting that perceived risk may at least partially mediate the relationships 
between objective risk and behaviors.  
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Results investigating the impact of socioeconomic variables on perceived risk are 
inconsistent. In one community based sample, Bosompra et al. (2000) found that socioeconomic 
status was negatively related to perceived risk, while other studies have found no relationships 
(Bunn, Bosompra, Ashikaga, Flynn, & Worden, 2002). However, work investigating risk-
reducing behaviors has largely been done in women with high levels of resources and this work 
has consistently found high levels of perceived risk and perceived risk has consistently related to 
behavior. This might suggest that socioeconomic status in the case of breast cancer is related to 
increased perceived risk. Additionally, given the inconsistent relationships seen between 
socioeconomic variables and risk-reducing behaviors, it can be hypothesized that perceived risk 
is mediating any effect that socioeconomic variables have on outcome variables. 
The amount of healthcare communication that women receive may increase their 
perceived risk for breast cancer. Women that receive more cancer information are more likely to 
think about their risk. Audrain-McGovern et al. (2004) suggested that a lack of access or 
attention to healthcare may cause women to be unaware of their objective risk, which in turn 
would not increase their perceived risk. The hypothesized model did not expect healthcare 
communication to be related to perceived risk.  
 
Attitudes Toward Risk Reducing Behavior 
 
The availability of literature examining the relationship between risk-reducing behavior attitudes 
and education, objective risk, and health use and communication is sparse; further, attitudes 
toward risk reducing behaviors are not often assessed with common measures. Some work has 
found a positive association between attitudes toward the benefits of risk reducing behaviors and 
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age (Cameron & Reeve, 2006). Based on past work in risk-reducing behaviors where most 
women have many socioeconomic resources, there are implications that these women are more 
interested in risk-reduction, and it may be that these women also have better attitudes toward 
risk-reduction. Like perceived risk, attitudes toward behavior are largely considered a cognitive 
variable. The incongruent relationship between perceived risk and objective risk suggests that 
objective risk may have even less effect on cognitive factors that are not directly related to risk, 
in this case attitudes. Objective risk in a sample of women at similar risk is not likely to be 
related to the formation of attitudes about risk-reduction. Attitudes toward risk reducing 
behavior, like perceived risk, might account for some of the variance seen between age and 
socioeconomic variables and risk-reducing behaviors. 
 
Cancer Specific Distress 
 
Similar to relationships between age and perceived risk, there is evidence that younger women 
experience more cancer specific distress than do older women. This is a fairly consistent finding 
in risk-reducing behavior literature. In a recent study done in a large community sample, Simon, 
Steptoe, and Wardle (2005) found that before and after screening for colon cancer, 
socioeconomic status was negatively related to bowel cancer worry. However, like relationships 
found with perceived risk, cancer worry appears to be relatively high in studied samples of 
women at increased risk for breast cancer, which may suggests that women with more resources 
have more worry about breast cancer. In studies with samples of women at a similar risk for 
breast cancer, it is unlikely that objective risk will impact distress. It is more likely that perceived 
risk will impact distress.  
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 Individuals who report higher levels of perceived risk for cancer live with the expectation 
that they may develop and experience a life threatening disease. Understandably, this perception 
may lead to increased levels of psychological distress. Some research has shown that individuals 
with increased perceptions of risk have increased levels of general worry (Gerend, Aiken, & 
West, 2004; McGregor et al., 2004) and anxiety (Rothemund, Paepke, & Flor, 2001). Other 
studies have reported that high perceived risk was related to high levels of cancer specific worry 
(Collins, Halliday, Warren, & Williamson, 2000). Results of a meta-analysis found a positive 
relationship between emotional distress and perceived risk across seven studies (Katapodi et al., 
2004). However, there is little work that addresses the relationships among perceived risk, 
distress, and behavior. 
 When an individual is faced with a personal health threat, emotional factors may alter the 
cognitive processing of risk-related information (Croyle & Lerman, 1999) and dictate the use of 
risk-reducing behaviors. Increasing attention has been paid to the direct and indirect influences 
that emotion may have on health behaviors (McCaul & Mullens, 2003). A recent study found 
that when assessing the relative impact of perceived risk and cancer worry on genetic testing 
interest, although both worry and perceived risk were related to these outcomes, when worry was 
controlled, perceived risk was not associated with testing interest (Cameron & Reeve, 2006). 
Other research suggests that worry can predict health behaviors independent of the contribution 
of perceived risk (McCaul, Reid, Rathge, & Martinson, 1996; Schwartz, Lerman, Miller, Daly, & 
Masny, 1995). Similarly, the impacts of the cognitive variable of attitudes toward risk-reducing 
behaviors on risk-reducing behaviors might be mediated by cancer distress.  
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STUDY AIMS AND HYPOTHESES 
 
 
The goal of this research was to evaluate predictors of risk-reducing behavior in a community 
sample of women with a family history of breast cancer. This study assessed several factors 
known to affect risk-reducing behaviors and estimated the variance associated with background 
variables (age, objective risk, education, income, Healthcare Communication) and proximal 
variables (perceived risk, cancer distress, attitudes toward risk-reducing behaviors) in predicting 
the outcomes of risk-reducing behaviors and intentions (adherence intentions, early detection 
behavior, clinic contact intentions, clinic contact). This study had five primary aims and one 
secondary aim. 
The first aim was to examine the relationship between background variables and risk-
reducing behaviors and intentions. The second aim was to examine the relationship between the 
predictor variable of perceived risk and the outcome variables, examine the relationship between 
perceived risk and the background variables, and to examine perceived risk as a mediator 
between the background variables and the outcomes variables. The third aim was to examine the 
relationship between the predictor variable of attitudes toward risk-reducing behaviors and the 
outcome variables, examine the relationship between attitudes toward risk-reducing behaviors 
and the background variables, and to examine attitudes toward risk-reducing behavior as a 
mediator between the background variables and the outcome variables. The fourth aim was to 
examine the relationship between cancer specific distress and the outcome variables, examine the 
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relationship between perceived risk and the background variables, and to examine cancer distress 
as a mediator between the background variables and the outcome variables. The final aim was to 
test a model (see Figure 1) of these variables to look at the relative influence of each variable on 
risk-reducing behaviors.  
A secondary aim was to examine how these variables affect whether women contacted a 
high-risk breast cancer clinic. For Aims 1-4, correlational analyses were used to test study 
hypotheses. For Aim 5, SEM was used to test the hypotheses within the proposed model and to 
explain unique variance among the predictor and outcome variables. To test the secondary aim, 
logistic regression analysis was used. The statistical plan for this project is further explained 
below in the data analysis section.  
PRIMARY AIM 1: This aim is represented in Figure 2. The first aim of this study 
was to examine the relationships between the outcome variables and the 
background variables, namely age, objective risk, education, income, and healthcare 
communication.  
  
Hypotheses for Aim 1 
  Age was expected to be positively related to early detection behaviors, and negatively 
associated with adherence intentions and clinic contact intentions. 
 
  Objective risk was expected to be positively related to early detection behaviors, 
adherence intentions, and clinic contact intentions.  
 
  Education was expected to be positively related to early detection behaviors, 
adherence intentions, and clinic contact intentions.  
 
  Income was expected to be positively related to early detection behaviors, adherence 
intentions, and clinic contact intentions.  
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  Healthcare communication variables were expected to be positively related to early 
detection behaviors, adherence intentions, and clinic contact intentions.  
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Figure 2. Representation of Aim 1. 
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PRIMARY AIM 2: Aim 2 is represented in Figure 3. There were three objectives for Aim 2. The 
first was to examine the relationship between perceived risk and each outcome variable. The 
second objective was to investigate the relationships between the background variables and 
perceived risk. The third objective was to investigate perceived risk as a mediator of the 
relationship between age and outcomes, objective risk and outcomes, education and outcomes, 
and income and the outcomes. 
 
Hypotheses for Aim 2 
  Perceived risk was expected to be positively related to early detection behaviors, 
adherence intentions, and clinic contact intentions.  
 
  Age was expected to be negatively related to perceived risk.  
  Objective risk was expected to be positively related to perceived risk. 
  Education was expected to be positively related to perceived risk. 
  Income was expected to be positively related to perceived risk.  
  Healthcare communication was expected to be positively related to perceived risk. 
 
  Perceived risk was expected to at least partially mediate the relationship between age 
and outcomes, the relationship between objective risk and outcomes, and the 
relationship between education and outcomes, and between income and the outcomes.  
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Figure 3. Representation of Aim 2. 
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PRIMARY AIM 3: Aim 3 is represented in Figure 4. Like Aim 2, there were three objectives for 
Aim 3. The first was to examine the relationship between attitudes toward risk-reducing 
behaviors and the outcome variables. The second objective was to investigate the relationships 
between the background variables and attitudes toward risk-reducing behaviors. Finally, 
attitudes toward risk-reducing behaviors were investigated as a mediator between age and 
outcomes, education and outcomes, and income and the outcomes. 
 
Hypotheses for Aim 3 
  Attitudes toward risk-reducing behaviors were expected to be positively related to 
early detection behaviors, adherence intentions, and clinic contact intentions.  
 
  Age was expected to be positively related to attitudes toward risk-reducing behaviors. 
  Education was expected to be positively related to attitudes toward risk-reducing 
behaviors. 
  Income was expected to be positively related to attitudes toward risk-reducing 
behaviors. 
  Objective risk was not expected to be related to attitudes toward risk-reducing 
behavior. 
  Healthcare communication was not expected to be related to attitudes toward risk-
reducing behavior.  
 
  Attitudes toward risk-reducing behavior were expected to at least partially mediate 
the relationship between age and outcomes, between education and outcomes, and 
between income and outcomes.  
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Figure 4. Representation of Aim 3.  
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PRIMARY AIM 4: Aim 4 is summarized in Figure 5. There were several objectives 
for Aim 4. First, the relationship between cancer specific distress and each outcome 
behavior was investigated. Next, the relationship between perceived risk and cancer 
specific distress, and attitudes toward risk-reducing behavior and cancer specific 
distress were examined. As well, the relationship between cancer specific distress 
and the background variables was examined. Finally, cancer specific distress was 
examined as a mediator of the relationships between the outcomes and perceived 
risk, attitudes toward risk-reducing behavior, age, education, and income. 
 
Hypotheses for Aim 4 
  Cancer specific distress was expected to be positively related to early detection 
behaviors, adherence intentions, and clinic contact intentions.  
 
  Perceived risk was expected to be positively related to cancer specific distress. 
  Attitudes toward risk-reducing behavior were expected to be positively related to 
cancer specific distress.  
  Age was expected to be negatively related to cancer specific distress. 
  Education and income were expected to be positively related to cancer specific 
distress. 
  Objective risk and healthcare communication were not expected to be related to 
cancer specific distress. 
 
  Cancer specific distress was expected to at least partially mediate the relationship 
between perceived risk and outcome variables, the relationship between attitudes 
toward risk-reducing behaviors and outcome variables, the relationship between age 
and outcome variables, the relationship between education and outcome variables, 
and the relationship between income and outcome variables.     
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Figure 5. Representation of Aim 4.
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PRIMARY AIM 5: This aim included testing these hypotheses in the complete proposed model 
using SEM to account for unique variance in relationships among the predictors and outcome 
variables (see Figure 1). The overall objective of this aim was to explain and model the 
pathways between variables that predict risk-reducing behaviors in women at high risk for 
breast cancer.  
 
  It was expected that background variables (age, objective risk, education, income, 
healthcare communication) would predict outcome variables (adherence intentions, 
early detection behavior, and clinic contact intentions) within the SEM model. 
  It was also expected that the proximal variables (perceived risk, cancer specific 
distress, cancer worry, attitudes toward risk-reducing behavior) would predict the 
outcome variables in this study within the SEM model. 
  Background variables were predicted to be related to the proximal variables in this 
model. 
  It was expected that when unique variance between the model variables is accounted 
for by this analysis technique, that some of the relationships found in Aims 1-4 would 
not be found. 
 
Secondary Aim 1: To explore whether or not the variables included in the proposed 
model were associated with actual clinic contact after women had been given risk 
information and a brochure to contact the high risk clinic. Further, the outcome variables 
of adherence and clinic contact intentions was explored as predictors of clinic contact in 
this sample. 
  
Hypotheses for Secondary Aim 1 
  Age was expected to be negatively related to clinic contact. 
  Objective risk was expected to be positively related to clinic contact. 
  Education level was expected to be positively related to clinic contact.  
  Healthcare communication was expected to be positively related to clinic contact.  
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  Perceived risk was expected to be positively related to clinic contact. 
  Cancer specific distress was expected to be positively related to clinic contact. 
  Attitudes toward risk-reducing behavior were expected to be positively related to 
clinic contact. 
  Clinic contact intention was expected to be positively related to actual clinic 
contact.  
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METHODS 
 
 
PARTICIPANTS 
 
A total of 203 individuals who contacted study coordinators were eligible and scheduled for a 
study session. Of scheduled participants, 187 (92%) signed consent and completed the study 
session. All participants received and completed an initial follow-up phone call, and 143 of 149 
possible participants completed the second follow-up phone call.  
 
 
RECRUITMENT PROCEDURES 
 
Two methods of recruitment were used for this study. First, print and online advertisements were 
posted throughout Pittsburgh in community settings such as retail stores, restaurants, and 
university buildings. Potential subjects were asked to contact the study coordinators by phone 
and were screened using a phone screening script. Second, women were recruited through the 
Quality of Life Registry at the University of Pittsburgh, Division of General Internal Medicine 
(DGIMR; IRB #0302087; Primary Investigator: Rachel Hess, M.D., MSc). The DGIMR research 
project includes prospective evaluation of subjects for eligibility in future research studies. All 
patients seen in the division’s practices are screened for participation in this registry of potential 
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research participants. Eligible patients who consent become part of the Prospective Subject List 
(PSL). By doing this, patients are consenting to be contacted for studies for which they might 
meet eligibility criteria. All women who were added to the PSL from January 2005 through 
October 2005 were contacted by mail and asked if they would consider participating in the 
current study. Figure 6 outlines the process of participant recruitment for this study. All 
participants were enrolled in this study between October 24, 2005 and May 2, 2006.  
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Figure 6. Recruitment flow chart. 
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STUDY PROCEDURES 
 
When potential participants contacted the study by phone, eligibility was assessed. Eligible 
participants a) were female in gender, b) were 22-69 years old, c) had a first degree relative with 
a history of breast cancer, d) had no prior contact with a high risk breast clinic or program, d) 
were able to read and write English, and e) were able to give informed consent. If the participant 
met eligibility criteria for this study, an appointment was made to complete study procedures and 
information was gathered to generate breast cancer risk information for the participant. All study 
appointments took place at the University of Pittsburgh Cancer Institute Department of 
Behavioral Medicine and Oncology, Montefiore Hospital, or the Hillman Cancer Center. At the 
appointment informed consent was obtained after a discussion of the purpose and nature of the 
study. Then, participants completed all study measurements. Upon completion of study 
measurements, all participants were given a tailored standardized form with information about 
her breast cancer risk. This form was generated from a website created and maintained by the 
Harvard Center for Cancer Prevention within the Harvard School of Public Health 
(www.yourdiseaserisk.com). This information did not include a Gail Score for the participant. 
The participant was also given a standard brochure about a high risk breast cancer clinic located 
at Hillman Cancer Center. The participant was instructed to read through her standardized 
objective risk and the clinic brochure and then completed a question asking about her intentions 
for contacting the high risk clinic. Participants were told they would be contacted by phone in 
two weeks.  
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Two weeks after the study appointment, the investigator called the participant and asked 
if she had contacted a high risk clinic. If the participant indicated that she had contacted the 
clinic by leaving a message for a follow-up call, talking with someone to receive additional 
information, and/or making an appointment at the clinic, this was the last contact the investigator 
had with the participant. If she indicated that she had not contacted the clinic, the participant was 
asked if she intended to contact the clinic. If she indicated that she did not intend to contact the 
clinic, this was the final contact between the investigator and the participant. However, if the 
participant indicated that she had not contacted the clinic, but intended to call the clinic, she was 
contacted again four weeks later. At this final call, both behavior and intentions about contacting 
the clinic were assessed again. Participants received $35.00 by postal mail approximately four 
weeks after completing the study session.  
 
 
MEASURES 
 
 
Background Variables 
 
Demographic variables. Information on age, race, marital status, education level, employment 
status, and household income were collected.  
 
Objective Breast Cancer Risk. To determine objective breast cancer risk, information needed to 
calculate a lifetime and 5-year Gail score (Gail et al., 1989) was collected. Risk factors included 
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in the Gail calculation are: age, age at menarche, age at first live birth, number of benign breast 
biopsies, and number of first-degree relatives with breast cancer. A woman’s Gail Score is 
expressed as the percentage risk she has of developing breast cancer in her lifetime and in the 
next five years. Additionally, to better describe the sample, participants were asked whether or 
not their sister or mother had died as a result of breast cancer.  
 
Predictor Variables 
 
Demographic and Background Variables. Age, objective risk, education, and income were used 
as predictor variables. Objective risk measurement was calculated using the Gail model (Gail et 
al., 1989). Four additional constructs were used as predictor variables including: 1) Healthcare 
Communication, 2) Perceived Risk, 3) Attitudes Toward Risk Reducing Behavior, and 4) Cancer 
Specific Distress. 
 
1. Healthcare Communication. Fifteen questions were asked about participants’ familiarity with 
risk-reducing options and their communication about risk reduction for breast cancer with health 
care professionals. Communication has been assessed many ways in past research and is often 
assessed with only one item addressing communication about a specific health behavior (e.g., 
“Has you physician recommended that you have a mammogram?). To our knowledge, there are 
no standardized assessment tools to assess communication about breast cancer risk. For this 
reason, several questions inquiring about healthcare communication were included in this study 
and subsequent principal component analyses were done to extract factors of common items. 
Table 1 provides each question as assessed, the range of possible response, the range of response, 
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the study mean of each response, and the standard deviation for each item.1 Results of principal 
component analyses are presented in the results section.   
 
1 Table 2 does not include the Healthcare Service Utilization item. This item response is included in the text below. 
Table 1. Descriptive statistics for the healthcare communication items. 
 
 Possible  
Range 
Study 
Range 
X SD 
1. How often have you talked with your healthcare provider about your increased risk of 
breast cancer based on your family history of the disease? 
1-5 1-5 2.8 1.2 
2. How often have you asked your healthcare provider if there are things you can do to lower 
your risk of getting breast cancer? 
1-5 1-5 2.1 1.2 
3. How familiar are you with the genetic test for breast cancer risk? 0-4 0-4 1.1 1.2 
4. To what extent have you heard about genetic testing for breast cancer in the news or media? 0-4 0-4 1.2 1.2 
5. How familiar are you with chemoprevention (medication) that can lower your risk of 
developing breast cancer? 
0-4 0-4 .76 1.1 
6. To what extent have you heard about chemoprevention (medication) for breast cancer in the 
news or media? 
0-4 0-4 .70 1.1 
How often or strongly has a healthcare provider recommended that you do any of the following:     
7. Have yearly mammograms done. 1-4 1-4 2.9 1.3 
8. Have clinical breast exams done (when a healthcare provider checks your breast for lumps). 1-4 1-4 3.4 .93 
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9. Do self breast exams (when you check your breasts for lumps). 1-4 1-4 3.4 .85 
10. Go to a specialty high-risk clinic or cancer genetic program. 1-4 1-4 1.1 .48 
11. Get genetic testing done. 1-4 1-4 1.1 .40 
12. Consider taking medication (chemoprevention like tamoxifen or raloxifen) to lower your 
risk of breast cancer. 
1-4 1-4 1.1 .32 
13. Consider having surgery to remove your breasts or ovaries to lower your risk of breast 
cancer. 
1-4 1-4 1.1 .30 
14. Made any recommendations for prevention regarding your increased risk of breast cancer 
based on family history. 
1-4 1-4 1.7 .95 
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a. Healthcare Service Utilization. Because much of the work to date on healthcare 
communication has been done in samples recruited through medical settings, it 
was important to assess whether or not a community recruited sample was 
using healthcare services. To assess use of healthcare services in this 
community sample, participants were asked about the last time they had an 
appointment with a health care provider. Participants provided answers on this 
scale: 1) 1-3 months since last visit, 2) 4-6 months since last visit, 3) 7-12 
months since last visit, 4) More than 1 year since last visit, 5) More than 2 years 
since last visit, and 6) More than 5 years since last visit. 
b. Communication about Risk. Participants were asked two questions about their 
communication with healthcare professionals about their breast cancer risk. 
They were asked if they had talked with a health care professional about their 
increased risk of breast cancer based on family history, and if they had inquired 
about options to reduce their risk. These two questions were answered on a 1 = 
“Never” to 5 = “A lot” Likert-type scale. 
c. Prevention Familiarity. Based on questions asked by Cameron & Reeve (2006), 
four questions about familiarity and informational media exposure to risk-
reducing options were asked. Participants were asked about their familiarity 
with genetic testing and chemoprevention and whether or not they had heard 
about these options in the news or media. These four questions were answered 
on a 0 = “Not at all” to 4 = “A great deal” Likert-type scale.  
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d. Healthcare Provider Recommendation. Healthcare communication is often 
assessed with one or two questions that inquire whether an individual’s 
physician has recommended certain health behaviors (e.g., Bober et al., 2004; 
Rutten et al., 2005). In this study, participants were asked to report if a 
healthcare professional had recommended the use of eight risk-reducing 
behaviors including mammograms, clinical breast exams, breast self exams, 
high-risk clinic consultation, genetic testing, chemoprevention, prophylactic 
oophorectomy, and prophylactic mastectomy. These eight questions were all 
answered on a 1 = “Never” to 4 = “Strongly recommended” Likert-type scale.   
 
2. Perceived Risk. There is no general agreement about how to measure perceived risk and 
perceived risk has been measured in several ways in the literature. This is largely because it is 
not clear how people think about and rate risk. Recent work has suggested the importance of 
measuring absolute and comparative perceptions of risk, as well as affective perceptions of risk 
(e.g., Zajac et al., 2006). Conviction of perceived risk has also been noted as important in 
understanding how individuals assess their health risks.  
A total of 12 items assessing perceived risk, including questions that assessed absolute, 
comparative, affective perceptions, and convictions of perceptions, were included in this study 
and dispersed throughout the questionnaire packet including four items that make up a 
standardized scale of perceived risk. After study materials were completed, principal component 
analyses were done to extract factors of common items. Principal component analyses were done 
to ascertain if the disparate measurements of perceived risk in past work are in fact capturing 
similar constructs or if there are differences in these items. Table 2 provides each question as 
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assessed, the range of possible response, the range of response, the study mean of each response, 
and the standard deviation for each item. Results of principal component analyses are reported in 
the results section. 
  
Table 2. Descriptive statistics for perceived risk items.  
 
 Possible 
Range 
Study 
Range 
X SD 
1. What do you think is the average woman’s percentage risk of developing breast cancer in 
the future? 
0-100% 1-90 26.0 19.0 
2. What do you think is your percentage risk of developing breast cancer in the future? 0-100% 1-96 41.3 23.5 
3. Compared to other women your age what do you believe is the likelihood that you will 
develop breast cancer in the future? 
-3 to 3 -3 to 3 1.4 1.1 
4. I feel at risk for breast cancer. 1 to 12 1-12 8.1 2.8 
5. What do you think is the average women’s risk of developing breast cancer? 1 to 12 1-10 5.2 2.1 
6.  What do you think is your risk for developing breast cancer in the future? 1 to 12 1-12 7.1 2.4 
7. My body will fight off breast cancer in the future.* 1-5 1-5 3.3 .96 
8. The chances that I might develop breast cancer are pretty high.* 1-5 1-5 3.7 .98 
9. No matter what I do, there’s a good chance of developing breast cancer.* 1-5 1-5 3.2 1.1 
10. I expect to be free of breast cancer in the future.* 1-5 1-5 2.8 .97 
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Think about how you have answered the questions about your risk of breast cancer throughout all 
these questions today: 
    
11.     How confident are you in your estimates of your risk for breast cancer? 1 to 12 1-12 7.13 3.0 
12.    How much do you believe in how you rated your risk for breast cancer? 1 to 12 1-12 8.35 2.8 
Note. * = question from the ADQ. 
 
  
 
a. Absolute Perceived Risk. Two items were included that measured absolute perceived 
risk. Women were asked to rate other women’s and their own risk of getting breast 
cancer on a 0% to 100% scale by marking an “X” on a line with graduated risk 
marked (e.g., 0%, 0.5%, 1-10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 
100%).2 An additional question based on work by Weinstein and Klein (2005) asked 
women to rate their other women’s risk and their own risk after reading this sentence: 
“Some factors that may suggest increased risk for breast cancer including getting 
older, having a family history of breast cancer, starting your period at an earlier age, 
having no children or having children after turning 30.” This question was answered 
on a 1 = “No Chance” to 12 = “Certain to happen” Likert-type scale.  
b. Comparative Perceived Risk. To measure comparative risk, women were asked to this 
question: “Compared to other women your age what do you believe is the likelihood 
that you will develop breast cancer in the future?” (i.e., Weinstein & Klein, 1995). 
This question was answered on a -3 = “Much below average” to 3 = “Much above 
average” Likert- type scale.  
c. Affective Perceived Risk. Affective perceived risk was measured with one item based 
on work by Weinstein et al. (in press). The question was: “I feel at risk for breast 
cancer”. This question was answered on a 1 = “Strongly Disagree” to 12 = “Strongly 
Agree” Likert-type scale.  
d. Conviction of Perceived Risk. Participants were additionally asked two questions 
about their confidence and belief in their ratings of risk. The first question asked: 
                                                 
2 It should be noted for the reader that these two questions were placed early in the assessment packet and were 
grouped following questions that asked readers about their objective risk factors (e.g., number of relatives with 
breast cancer, age at first menses, number of biopsies).  
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“Think about how you have answered questions about your risk of breast cancer 
throughout all these questions today. How confident are you in your estimates of 
your risk for breast cancer?”. This question was answered on a 1 = “Not Confident at 
All” to 12 = “Very Confident” Likert-type scale. The second question asked: “Think 
about how you have answered questions about your risk of breast cancer throughout 
all these questions today. How much do you believe in how you rated your risk for 
breast cancer?”. This question was answered on a 1 = “Not at all” to 12 = “A great 
deal” Likert-type scale.  
e. Perceived Susceptibility. To understand how individual items commonly used in the 
literature to assess perceived risk would factor in with a standardized scale of risk, 
perceived risk was also assessed with the perceived susceptibility scale from the 
Adherence Determinants Questionnaire (ADQ; DiMatteo et al., 1993). The ADQ 
assesses 7 elements of patients’ adherence to medical treatment and prevention. 
Several of these scales were used in this study. On the form used in this study the 
questions were worded to specifically refer to breast cancer. Several of the questions 
inquired about “prevention and surveillance”. Included in the instructions was this 
sentence: Prevention and surveillance recommendations refer to things you have been 
told to do to lessen your risk of breast cancer or to increase the likelihood of 
detecting breast cancer early. The four items that make up the perceived 
susceptibility scale of the ADQ were included in this study to understand how items 
that were part of a validated instrument would factor in with items of risk (e.g., 
Comparative, Absolute, Affect, Conviction) used in the literature.  
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3. Attitudes Toward Risk-Reducing Behavior. There are few standardized assessment instruments 
for attitudes toward health prevention behavior in general, and to our knowledge, none for 
attitudes about prevention or risk reducing behaviors for breast cancer. There is little consistency 
of items used across studies and the literature on attitudes related to risk-reducing behaviors 
often relies on limited number of items to assess these concepts (e.g., Cameron and Reeve, 2006, 
Lodder et al., 2003). For these reasons, this study included 17 items to assess attitudes toward 
risk reducing behavior including a standardized scale from the ADQ. After study materials were 
completed, principal component analyses were done to extract factors of common items. Table 3 
provides each question as assessed, the range of possible response, the range of response, the 
study mean of each response, and the standard deviation for each item. Results of principal 
component analyses are reported in the results section. 
  
Table 3. Descriptive statistics for attitudes toward risk-reducing behavior items.  
 
 Possible 
Range 
Study 
Range 
 
X 
 
SD 
1.  Getting advice and counseling from a high risk clinic can help reduce a woman’s chances of 
dying from breast cancer. 
1-6 1-6 4.5 1.4 
2. Getting advice and counseling from a high-risk clinic would help a woman in making 
decisions about whether and when to have children. 
1-6 1-6 4.1 1.4 
3. A woman should do all she can to find out about her risk of developing breast cancer for the 
sake of her family and loved ones. 
1-6 1-6 4.8 1.3 
4. The medical community will provide treatment for women at high-risk for breast cancer that 
will prolong their health and well-being. 
1-6 1-6 4.27 1.2 
5. A woman at increased risk for breast cancer should seek out information at a high-risk clinic 
to find out what she can do to lower her risk of disease. 
1-6 2-6 4.7 1.1 
6. A woman at increased risk should have genetic testing in order to find out her exact genetic 
risk. 
1-6 1-6 3.8 1.4 
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7. A woman with a positive genetic test result (i.e., a genetic mutation that increases risk of 
breast cancer) should take chemoprevention (medication) to lower her risk of developing 
breast cancer. 
1-6 1-6 3.7 1.3 
8. A woman with a positive genetic test result (i.e., a genetic mutation that increases risk of 
breast cancer) should have prophylactic mastectomy (surgical removal of the breasts) in 
order to reduce her cancer risk. 
1-6 1-6 2.4 1.2 
9. A woman with a positive genetic test result (i.e., genetic mutation that increases risk of 
breast cancer) should have a prophylactic oophorectomy (surgical removal of the ovaries) to 
reduce her risk of breast cancer. 
1-6 1-6 2.4 1.2 
10. I’ll be just as healthy if I avoid the prevention surveillance recommendations.* 1-5 1-5 1.9 .92 
11. Following prevention and surveillance recommendations will help me to be healthy.* 1-5 1-5 4.2 .71 
12. Following prevention and surveillance recommendations is better for me than not following 
them.* 
1-5 1-5 4.3 .71 
13. The benefits of prevention and surveillance recommendations outweigh any difficulty I 
might have in following them.* 
1-5 2-5 4.1 .70 
14. Prevention and surveillance recommendations are too much trouble for what I get out of it.* 1-5 1-5 1.8 .90 
64 
65 
 
15. Because prevention and surveillance recommendations are too difficult, they are not worth 
following.* 
1-5 1-5 1.6 .71 
16. I believe that prevention and surveillance recommendations will help to prevent my getting 
breast cancer.* 
1-5 1-5 3.7 .89 
17. It’s hard to believe that prevention and surveillance recommendations will help me.* 1-5 1-5 2.0 .83 
Note. * = question from the ADQ.
 
  
 
a. Attitudes Toward Risk Reducing Behaviors. Attitudes Toward Risk Reducing 
Behavior was measured with nine items that were modeled after questions used by 
Cameron and Reeves (2006). These nine questions are numbered 1-9 in Table 4. 
These questions were important to include in this study because the attitudes of 
women with a family history of breast cancer about high-risk clinic use and its 
benefits, and in turn these attitudes relationship with behavior, have not been well 
studied. All nine questions were answered on a 1 = “Strongly disagree” to 6 = 
“Strongly agree” Likert-type scale. 
b. Attitudes Toward Prevention and Surveillance.  To understand how a standardized 
scale used in past literature to assess attitudes about the benefits and costs of 
prevention and surveillance would factor with the above mentioned attitude 
questions, attitudes toward prevention and surveillance were also assessed with the 
benefits and costs scale from the ADQ (ADQ; DiMatteo et al., 1993). Attitudes about 
the benefits and costs of prevention and surveillance were measured with eight 
questions (items 10-17 in Table 4) that make up the perceived utility of adhering scale 
on the ADQ.  
 
4. Cancer Specific Distress 
a. Cancer Worry. Four items assessing cancer specific worry were modified from the 
Lerman Cancer Worry Scale (CWS; Lerman et al., 1991). This scale is widely used in 
cancer research and has shown good internal consistency (alpha = .73; McGregor et 
al., 2004). An additional question about cancer worry was included that has been used 
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in past research (e.g., Andersen et al., 2004). These five questions demonstrated good 
reliability in this study (Cronbach’s alpha = .87).  Table 4 provides each question as 
assessed, the range of possible response, the range of response, the study mean of 
each response, and the standard deviation for each item. The final worry variable used 
in this study was created from converting each item to a z-score and by finding the 
mean of the five converted scores. 
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 Possible 
Range 
Study 
Range 
 
X 
 
SD 
1. Please rate the extent to which you think about getting breast cancer. 1-7 1-7 3.64 1.6 
2. How often do you worry about breast cancer? 1-7 1-7 3.2 1.6 
3.  How many days out of the last 7 did you worry about breast cancer? 0-7 0-7 1.1 1.5 
4. How much do you worries about breast cancer affect your mood?  1-7 1-7 1.7 1.2 
5.  How much do your worries about breast cancer affect your ability to perform daily 
activities? 
1-7 1-7 1.3 .94 
Table 4. Descriptive statistics for cancer worry items.   
 
 
 b. Cancer Distress. The intrusion and avoidance scales from Impact of Event Scale-
Revised (IES-R; Weiss & Marmar, 1997) were used to assess the experience of 
intrusive and avoidant thinking related to “being at higher risk for the occurrence of 
breast cancer”. One item on from the IES-R was modified to fit the present study 
population. The original item was: “I found myself acting or feeling like I was back at 
that time”. The question was modified to read: “I found myself acting or feeling as 
though I did when I first realized my risk”.  Both scales had 8 items, for a total of 16 
items. Each question was rated on a 5-point scale: 0 = not at all, 1 = a little bit, 2 = 
moderately, 3 = quite a bit and 4 = extremely. The IES-R is a well validated 
instrument, has been widely used in cancer research, and has consistently 
demonstrated good internal consistency (Cronbach’s alpha = .83-.89; Cella et al., 
2002), as it did in the present study (Cronbach’s alpha = .91). The final cancer 
distress score in this study was calculated by averaging the sample scores (X = 7.10; 
SD = 8.6).  
 
Outcome Variables 
 
Four different outcomes were measured. These included 1) Early Detection Behaviors, 2) Clinic 
Contact Behavior, 3) Clinic Contact Intentions, and 4) Adherence Intentions.  
 
1. Early Detection Behaviors. The use of early detection behaviors, including mammography, 
clinical breast exam, and self-breast exam, was assessed. As noted earlier, the American Cancer 
Society (ACS; 2004) recommends that women 40 and over undergo yearly mammography. 
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 Women in their 20s are advised to begin clinical breast exams every 3 years, and to perform 
breast self exam regularly. For women with a family history of breast cancer, the ACS suggests 
that women discuss with their health care provider the possibility of starting these behaviors at 
earlier ages and/or performing these behaviors more frequently. Although there is no clear 
consensus about the exact age to begin mammography in women with a family history, some 
expert opinion suggests that 30 years of age is an appropriate time to initiate mammography if a 
woman is not considering pregnancy (V.Vogel, personal communication, August 14, 2005).  
Women were asked if they had ever had a mammogram, clinical breast exam, or breast 
self exam. Then women were asked how many mammograms they had in the last two years, if 
they had a clinical breast exam within the last two years, and if they had performed a breast self 
exam in the last six months. Last, due to general age stipulations of mammography, women 
under the age of 40 were asked if they had talked with a health care professional about the 
possibility of beginning mammography at an early age because of their family history of disease. 
Responses to this item were used to measure adherence for mammography in women under 40.  
Past research has indicated that self-reports of early detection behavior use (e.g., mammography) 
are reliable (King, Rimer, Trock, Balshem, & Engstrom, 1990). The results of these assessments 
are presented below in the results section. 
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 2. Clinic Contact Behavior. Clinic contact behavior was measured at two time points. As 
described in detail above, participants received a telephone call 2 weeks after completing the 
study session and 6 weeks after the study session to inquire about whether they had contacted the 
high risk clinic. Clinic contact was a binary outcome of either Yes or No. Results are presented 
below. 
 
3. Clinic Contact Intentions. After women had completed all study questionnaires, they were 
given an estimate of their objective risk (e.g., Harvard Risk Index), told about the high-risk 
breast cancer clinic, and given a brochure about the clinic. Clinic contact intentions were 
assessed with one paper pencil question: Do you intend to contact the high-risk clinic? This 
question was assessed with a Likert-type scale with 1 = “Definitely no” and 5 = “Definitely yes”. 
This same question was asked verbally at a two and six week follow-up phone call. Results are 
presented below.  
4. Adherence Intentions. To assess adherence intentions, the four questions that make up the 
adherence intentions subscale of the ADQ (described above) were used. Insert questions. All 
questions are answered on a 5-point Likert-type scale ranging from 1 = “Strongly disagree to 5 = 
“Strongly agree”. This subscale has demonstrated fair to good internal consistency (DiMatteo et 
al., 1993; alpha = .73 to .94) across three different health adherence domains. The Cronbach 
alpha score for this scale in the present study was .72.  
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STATISTICAL ANALYSES 
 
Because this study was designed to evaluate and validate concepts that have been studied in 
several different ways and with several diverse items and scales, several items were included as 
measures related to healthcare communication, perceived risk, and attitudes toward risk reducing 
behaviors. To reduce these items to a small number of factors and to concisely describe the 
constructs, principal component analyses were used. A scree plot with eigenvalues greater than 
1.0 with oblimin rotation was used to extract components of these constructs. The results of 
principal component analyses are documented. Next, to examine the data and test the hypotheses 
in Aim 1-4, correlational analyses assessed relationships among continuous variables, analyses 
of variance (ANOVA) were used to assess relationships between one continuous and one 
categorical variable, and χ2 analyses were used to look at the relationship between two 
categorical variables.  
Mediation was tested as outlined by Baron and Kenny (1986). For mediation to occur, first, 
an independent variable (IV) must be related to a dependent variable (DV) and a third variable 
(mediator) must be related to both the IV and the DV. Next, if these criteria are met, it is possible 
to test for mediation by examining the relationship between the IV and the DV controlling for the 
mediator. If the magnitude of the relationship between the IV and DV is decreased, according to 
Baron and Kenny, mediation has occurred. In this study, possible mediation was determined 
based on the results of the bivariate relationships. Once possible mediation was determined by 
the results of the bivariate relationships, partial correlations were run to test for mediation.  
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 When mediation according to Baron and Kenny (1986) was detected, the Sobel test was used 
to determine if the indirect effect of the independent variable on the dependent variable via the 
mediator was significant (Sobel, 1982). The following formula was used to do this:  
z  =  a  x  b / (b2 x Sa2 + a x Sb2) 
where a = path coefficient from the independent variable to the mediator, Sa2 = the standard 
error of a, b = path coefficient form the mediator to the dependent variable, and Sb2 = standard 
error of b. The Sobel’s z value must be sufficiently large, yielding a p-value of .05 for significant 
mediation to be identified. If the association between the IV and DV has been reduced to a non-
significant level, full mediation has occurred. If the association between the IV and the DV is 
still significant, partial mediation has occurred. Investigators have recently highlighted the 
importance of evaluating the statistical significance of mediation (Preacher & Hayes, 2004). 
Sobel tests were run as outlined by Jose (2004). 
 
Structural Equation Modeling  
 
The hypothesized model was tested with SEM. The model was estimated using EQS modeling 
software. To account for any non-normal data in the model, robust methods with Satorra-Bentler 
χ2 statistics were used to test the overall model fit (Satorra & Bentler, 1994) in all analyses and 
robust statistics were used to interpret parameter estimates. These methods have been found to 
outperform the standard estimator when using non-normal data (i.e., Curran, West, & Finch, 
1996). The primary task in the model testing procedure is to determine the “goodness of fit” 
between the hypothesized model (structural model) and the sample data. The structure of the 
hypothesized model is imposed on the data to examine the observed data fit (e.g., goodness of 
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 fit). The null hypothesis for model fit is that the estimated model fits the data well. Overall 
goodness of fit was evaluated using the Satorra-Bentler χ2  test , the robust comparative fit index 
(CFI; Bentler, 1990), and the robust root mean square error of approximation (RMSEA; Steiger 
& Lind, 1980). Good model fit was defined as a non-significant χ2 value (> .05), comparative fit 
index of greater than .05, and/or a RMSEA value less than or equal to .06 (Hu & Bentler, 1998). 
To create the best model fit changes suggested by SEM modification indexes were used. The 
Lagrange Multiplier test was used in determining parameters that were appropriate to add and the 
Wald W statistic was used to determine which parameters were appropriate to delete (Chou & 
Bentler, 1990). The Satorra-Bentler scaled χ2 difference test was used for both nested models 
(Satorra & Bentler, 2001). To compare these two non-nested models, the Akaike Information 
Criterion (AIC) and Consistent AIC (CAIC) differences were examined (Akaike, 1987; 
Bozdogan, 1987). Once the best model was identified, to estimate the path coefficients 
(parameter estimates), maximum likelihood estimations (MLE) were used. Further, indirect 
effects were estimated statistically as the product of direct effects that comprised them. 
 
Logistic Regression  
 
The secondary aim of this study was to prospectively follow the participants after they were 
given risk information and information about the high risk clinic to understand how the proposed 
factors might be related to behavior to seek out this resource. The outcome variable of clinic 
contact was a binary outcome variable (yes/no), thus logistic regression was used to examine 
what predictors were associated with clinic contact. Predictor variables included age, objective 
risk, education, income, Healthcare Communication, Perceived Risk, Cancer Distress, attitudes 
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 toward information seeking and attitudes toward the worth of prevention and surveillance. 
Further, the previous outcome variables of adherence intentions and clinic contact intention were 
examined as predictors of clinic contact. First, the predictor variables were analyzed using 
ANOVA and two-sided Pearson χ2  tests for univariate analyses. Chi-Square tests were used to 
examine the relationship between the outcome and race. Factors that were significant were 
included in simultaneous multiple logistic regression analysis if they were associated with clinic 
contact with a P value of 0.05 or less. Other research has had smaller sample sizes (e.g., N =  
149) than the current sample size using six predictors in a logistic regression model to look at a 
related outcome (e.g., genetic testing; Lerman et al., 1997).  
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RESULTS 
 
 
First, participant characteristics will be described. Next, results of the principal component 
analyses and descriptive results for healthcare communication, perceived risk, and attitudes 
toward risk –reducing behavior will be presented; this will be followed by the descriptive results 
of other model variables. Then preliminary correlational and univariate data for all study 
variables will be presented briefly with the use of text and tables. This will be followed by the 
results of the hypotheses for Aims 1-5. Aims 1-4 were tested with correlational analyses and Aim 
5 tested the full hypothesized model using SEM. Finally, the results of the logistic regression 
equation for secondary Aim 1 will be described. 
 
 
PARTICIPANT CHARACTERISTICS 
  
Participants (N =  187) who completed the study session had a mean age of 42.0 (SD =12.0; 
range =  22-69). The majority of participants were Caucasian (n =  145; 77.5%), 38 (20.3%) 
were African American/Black, 2 (1.1%) were Hispanic, 1 (0.5%) was Native American/Alaskan 
Native, and 1 (0.5%) selected “other” race. Ninety-four (50.3%) participants were married or 
living with a partner, 25 (13.4%) were divorced, 59 (31.6%) were never married, and 9 (4.8%) 
were widowed.  In this sample, 15 (8.0%) participants had less than a high school or a high 
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 school education, 47 (25.1%) had some college education or vocational training beyond high 
school, 74 (25.1%) earned a college degree, and 77 (41.4%) reported some graduate work or 
having a graduate degree. Most participants (n =  146; 78.1%) were employed. Nineteen 
participants (10.2%) reported an income of less than $10,000, 58 (31.0%) reported an income of 
$10,001-$30,000, 33 (17.6%) reported an income of $30,001-$50,000, 29 (15.5%) reported an 
income of $50,001-$70,000, 44 (24.0%) reported an income over $70,000, and 4 (2.1%) 
participants did not report this information. 
 Most of the participants reported a family history of breast cancer in their biological 
mother only (n =  149; 79.6%), 26 (13.9%) reported a history only in a sister, and 12 (6.5%) 
reported that their mother and at least one sister had a history breast cancer. Forty-two (22.5%) 
women reported that their mother died as a result of breast cancer and 6 (3.2%) women reported 
the death of a sister due to breast cancer. The average 5-year Gail Score risk for this sample was 
1.40% (range =  0 - 5.70; SD =1.18) and the average lifetime Gail Score was 17.31% (range =  
6.4 - 34.7; SD = 4.2). A 5-year Gail Score equal to or greater than 1.67% is considered 
“increased risk”; 41.2% (n =  77) of this sample were at increased risk according to this 
assessment tool.  
Because Gail Scores are most valid for women ages 35 or older, scores for this age group 
were considered separately. For women over the age of 35 (n =  129), the average Gail Score 5-
year risk was 1.93% (range =  .08-5.7; SD = 1.0) and lifetime risk was 16.8% (range =  6.0-
34.7; SD =4.6). Seventy-seven (59.7%) of these women were considered at “increased risk” 
according to this assessment tool.  
Thirty-five women (18.7%) reported a history of breast biopsy with benign results. The 
objective risk information that was provided to the women (e.g., tailored risk information from 
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 yourdiseaserisk.com) gave women a categorical rating of their risk. Based on this assessment 
tool, participant’s risk was classified as below average (n =  3; 1.6%), average (n =  9; 4.8%), 
above average (n =  99; 52.9%), much above average (n =  74; 39.6%), and very much above 
average (n =  2; 1.1%).3 Demographic and breast cancer information is summarized in Table 5.  
                                                 
3 Information on biopsy history and www.yourdisesaserisk.com statistics is reported for descriptive purposes only.  
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 Table 5. Summary of demographic and breast cancer history information.  
 
  N = 187 
  n % 
Race    
  Caucasian  145 77.5% 
  African-American/Black  38 20.3% 
  Other  4 2.1% 
Marital Status    
  Married or Living with a partner  94 50.3% 
  Divorced  25 13.4% 
  Never married  59 31.6% 
  Widowed  9 4.8% 
Education    
  Less than high school/high school degree  15 8.0% 
  Some college/vocational training  47 25.1% 
  College graduate  47 25.1% 
  Postgraduate work degree  77 41.4% 
Employment Status    
  Currently Employed  146 78.1% 
  Homemaker  6 3.2% 
  Currently Unemployed  4 2.1% 
  Retired  5 2.7% 
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   Disability  18 9.9% 
  Other  8 4.3% 
Household income    
  Less than $10,000  19 10.2% 
  $10,001 - $30,000  58 31.0% 
  $30,001 - $50,000  33 17.6% 
  $50,001 - $70,000  29 15.5% 
  More than $70,000  44 24.0% 
  Refused  4 2.1% 
Family History of Breast Cancer    
  Mother only with breast cancer history  149 85.1% 
  Sister only with breast cancer history  26 14.9% 
  Mother & sister with breast cancer history  12 6.4% 
  Mother death due to breast cancer  42 22.5% 
  Sister death due to breast cancer  6 3.2% 
5-year Gail score risk (full sample)    
  < 1.67  110 58.8% 
  > 1.67  77 41.2% 
5-year Gail score risk (age > 35)    
  < 1.67  52 40.3% 
  > 1.67  77 59.7% 
History of breast biopsy    
  Yes   152 81.3% 
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    No  35 18.7% 
Harvard Risk Index    
  Below Average  3 1.6% 
  Average  9 4.8% 
  Above Average  99 52.9% 
  Much Above Average  74 39.6% 
  Very Much Above Average  2 1.1% 
Note. Participant’s average age = 42.0 (SD = 12.0, range = 22-69). 
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Analyses were done to examine differences between women recruited through 
community advertisements and the PSL. Women recruited through community advertisements 
were younger than were women recruited through the PSL, F (1, 185) = 15.9, p < .001 (M =  
40.7; SD =11.9 vs. M =  50.6; SD =8.3), and had a lower 5-year Gail Score than did women 
recruited from the PSL, F (1, 185) = 16.4, p < .001(M =  1.26; SD =1.14 vs. M =  2.25; SD 
=1.07). There were no differences in life-time Gail Score, race, marital status, education, 
employment, income, family history of breast cancer, family death, or biopsy history. 
 
  
PREDICTOR VARIABLES 
 
 
Healthcare Communication 
 
In this sample, 62.6% of participants reported seeing a healthcare professional in the last three 
months, 20.3% reported a visit in the last 4-6 months, 10.4% reported 7-12 months since their 
last visit, 3.8% reported a month since last visit, and 1.1% reported more than 2 years since last 
visit. The individual items possible range or responses, and descriptive results for healthcare 
communication are summarized in Table 1. The principal component analysis for healthcare 
communication variables was run with all 15 items.  Four components were extracted and were 
labeled healthcare communication, provider recommend prevention, familiarity with prevention, 
and provider recommend early detection. Table 6 summarizes the results of the principal 
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component analysis. The eigenvalues for the four factors were, 3.99, 2.44, 2.16, and 1.40, 
respectively. The four components accounted for 66.3% of the total variance among the items. 
Based on the strength of the factor and theoretical implications, the factor of health care 
communication was selected to test the hypotheses. 
 Table 6. Final principal component analysis of healthcare communication.  
 
  Model 
  Factor 
Loading 
Proportion of 
Variance 
Explained 
1. Healthcare Communication  .266 
 How often have you talked with your healthcare provider about your increased risk of breast 
cancer based on your family history?  
 
.846 
 
 How often have you asked your healthcare provider if there are things you can do to lower your 
risk of getting breast cancer? 
 
.858 
 
 How strongly has a health care provider made any recommendations for prevention regarding 
your increased risk of breast cancer based on family history? 
 
.725 
 
2. Provider Recommends Prevention  .162 
 How often has your provider recommended going to a specialty high risk clinic or cancer genetic 
program?  
 
-.805 
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 How often has your provider recommended that you get genetic testing done? -.808  
 How often has your provider recommended that you consider taking medication to lower your risk 
of breast cancer? 
 
-.831 
 
 How often has your provider recommended surgery to remove your breast or ovaries to lower 
your risk of breast cancer?  
 
-.893 
 
3. Familiarity with Risk Reduction  .144 
 How familiar are you with the genetic test for breast cancer risk? .702  
 To what extent have you heard about genetic testing in the news or media? .740  
 How familiar are you with chemoprevention (medication) that can lower your risk of developing 
breast cancer? 
.892 
 
 
 To what extent have you heard about chemoprevention (medication in the news or media)? .879  
4.  Provider Recommends Early Detection  .090 
 How long since you have had an appointment with your health care provider? .616  
 How often has your health care provider recommended yearly mammograms? -.718  
 How often has your health care provider recommended clinical breast exams? -.710  
 How often has your health care provider recommended self breast exams? -.652  
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Perceived Risk 
 
All perceived risk items, possible range of response, and descriptive statistics from this sample 
are summarized in Table 2. All items that assessed a woman’s own perceived risk (8 items) were 
included in the principal component analysis (see Table 7). In the initial analysis, one item had a 
factor loading of 0.43, so the principal component analysis was rerun excluding this item. In the 
final analysis, the two components that were extracted were labeled perceived risk and 
conviction of perceived risk. The eigenvalues for the two factors were 4.31 and 1.43, 
respectively. The two components accounted for 63.7% of the total variance among these 9 
items. The items analyzed and the results of the principal component analysis are summarized in 
Table 5. The first perceived risk factor was used to test the hypotheses. 
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Table 7. Final principal component analysis of perceived risk items.  
 
  Model 
  Factor 
Loading 
Proportion of 
Variance 
Explained 
1. Perceived Risk  .478 
 What do you think is your percentage risk of developing breast cancer in the future? .680  
 What do you think is your risk for developing breast cancer in the future? .843  
 I feel at risk for breast cancer.  .855  
 The chances that I might develop breast cancer are pretty high. .784  
 No matter what I do, there’s a good chance of developing breast cancer. .627  
 I expect to be free of breast cancer in the future.  .612  
 Compared to other women your age what do you believe is the likelihood you will develop breast 
cancer in the future?  
.846  
2.  Conviction of Perceived Risk  .159 
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Note. The item “My body will fight off breast cancer in the future” was removed from the final analysis due to an initial factor loading 
of 0.424.
 How confident are you in your estimates of your risk for breast cancer?  .926  
 How much do you believe in how you rated our risk for breast cancer?  .862  
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Attitudes Toward Risk -Reducing Behavior 
 
All attitudes toward risk reducing behavior items, the range of possible responses, and the 
descriptive statistics from this study are summarized in Table 3. The initial principal component 
analysis was run with the 17 attitudes toward risk reducing behavior items assessed. Three of the 
items from the ADQ utility scale had low factor loadings (.32, .34, and .41), thus these three 
items were removed and the principal component analysis was rerun with a four factor solution 
imposed The final four factors had eigenvalues of 3.55, 2.21, 1.61, and 1.24, respectively. These 
items were labeled 1) attitudes toward information seeking, 2) attitudes toward the utility of 
prevention and surveillance, 3) attitudes toward prevention strategies, and 4) attitudes toward 
worth of prevention and surveillance. The four components accounted for 61.5% of the total 
variance among the final 14 items. The removed items and final principal component analysis 
are summarized in Table 8. The first factor, attitudes toward information seeking, was used to 
test the hypotheses. Attitudes toward worth of prevention and surveillance was also examined in 
relation to the hypotheses because the individual items (see Table 7) represent a broad concept of 
perceived benefits of following prevention and surveillance, and perceived benefits has been 
proposed as important in predicting health behaviors (i.e., Rosenstock, 1974).  
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Table 8. Principal component analysis of attitudes toward risk-reducing behavior items.  
 
  Model 
  Factor 
Loading 
Proportion of 
Variance 
Explained 
1. Attitudes Toward Information Seeking  .254 
 Getting advice and counseling at a high risk clinic can help reduce a woman’s chances of dying from 
breast cancer. 
.862  
 Getting advice and counseling from a high risk clinic would help women in making decisions about 
whether and when to have children. 
.717  
 A woman should do all she can to find out about her risk of developing breast cancer for the sake of 
her family and loved ones.  
.520 
 
 
 The medical community will provide treatment for women at high risk for breast cancer. .659  
 A woman at increased risk should seek out information at a high risk clinic to find out what she can 
do to lower her risk of disease. 
.475  
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2.  Attitudes Toward the Utility of Prevention and Surveillance  .158 
 I’ll be just as healthy if I avoid the prevention and surveillance recommendations. .821  
 Prevention and surveillance recommendations are too much trouble for what I get out of it. .588  
 It’s hard to believe that prevention and surveillance recommendations will help me.  .644  
3. Attitudes Toward Prevention Strategies  .115 
 A woman at increased risk should have genetic testing in order to find out her exact genetic risk. -.489  
 A woman with a positive genetic test result should take chemoprevention to lower her risk of 
developing breast cancer.  
-.597  
 A woman with a positive genetic test results should have prophylactic mastectomy in order to reduce 
her own cancer risk.  
-.840  
 A woman with a positive genetic test result should have a prophylactic oophorectomy to reduce her 
risk of breast cancer.  
-.934  
4. Attitudes Toward the Worth of Prevention and Surveillance  .088 
 Following prevention and surveillance recommendations is better for me than not following them. .745  
 The benefits of prevention and surveillance recommendations outweigh any difficulty I might have 
in following them. 
.854  
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Note. The items “Following prevention and surveillance recommendations will help me to be healthy”, “Because prevention and 
surveillance recommendations are too difficult, they are not worth following”, and “I believe that prevention and surveillance 
recommendations will help to prevent my getting breast cancer” were included in the initial principal component analysis, but were 
removed due to low factor loadings (.319, .408 and .339, respectively).  
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Cancer Specific Distress 
 
Cancer Worry. Individual items and descriptive statistics are summarized in Table 4. One item 
had a different range of possible scores than the others, so all items were converted to z-scores 
and the mean of z-scores created the final worry variable used in this study.  
 
Cancer Distress.  The sample mean of the IES avoidance and intrusion scale was 7.10 (SD =8.6; 
range =  0-49). 
 
 
OUTCOME VARAIBLES 
 
 
Early Detection Behaviors 
 
Early detection behaviors were considered separately for women 40 and over (n =  110) and 
women under 40 (n =  77). Among the older women, 94.5% reported a history of mammography 
with 79.1% having two or more mammograms in the last two years, 12.7% reported one 
mammogram in the last two years, and 8.2% reported no mammogram in the last two years. In 
the older group, 98.2% reported a history of clinical breast exam ever, 92.7% reported a history 
in the last two years, 89.1% reported a history of breast self exam, and 75.5% reported doing a 
breast self exam in the last six months. In women under 40, 32.9% reported a history of 
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mammography, while 77.6% reported talking with a health care provider about beginning 
mammography before the age of 40 due to their family history. In the younger group, 97.4% 
reported a history of clinical breast exam, 90.8% had a clinical breast exam in the last two years, 
90.8% reported breast self exam ever, and 68.4% reported doing a breast self exam in the last six 
months.  
When considering all women in this sample, 69.8% reported ever having a mammogram,  
97.3% reported a history of clinical breast exam with 91.4% having a clinical breast exam in the 
last 2 years, and 89.3% reported a history of breast self exam with 72.2% reporting self exam in 
the last six months. Others have also reported finding similar levels of adherence in community 
samples (e.g., 91% of community recruited sample of women 40 years and older reported history 
of mammography; Lipkus, Biradavolu, Fenn, Keller, & Rimer, 2001). This information is 
summarized in Table 9, which includes the χ2 statistics for differences between the age groups 
for shared behaviors. The only significant difference between age groups, as expected, was the 
use of mammography, χ2 (df =1, N = 186) = 80.4; p < .001.  
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Table 9. Rates of early detection behaviors by age. 
 
  
Age Category
 
Total
χ2(df = 1, n 
=186)
 > 40 < 40   
 n = 110 n = 77 N = 187 p value 
     
History of Mammography 94.5% 32.9% 69.8% <.001 
Mammography in last 2 years 91.8% - - - 
Talk with provider about early mammography - 77.6% - - 
History of Clinical Breast Exam 98.2% 97.4% 97.3% .54 
Clinical Breast Exam in last 2 years 92.7% 90.8% 91.4% .41 
History of Breast Self Exam 88.9% 90.8% 89.3% .45 
Breast Self Exam in last 6 months 75.5% 68.4% 72.2% .19 
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Composite Score for Early Detection Behaviors. Early detection behaviors are often considered 
separately in the literature although their collective and individual importance, particularly for 
women with a family history of disease, warranted examination of a composite score of these 
behaviors. Composite scores for women 40 and over (n = 110) were created from the item 
measuring adherence to mammograms over the last two years,4 history of clinical breast exam, 
clinical exam in the last two years, history of breast self exam, and breast self exam in the last six 
months. Each yes answer to these questions was given a score of 1 and each no question was 
given a score of 0. The possible range of scores for this composite was 0-5. The mean score for 
women 40 or over in this sample was 4.3 (range 1-5; SD =1.0).5
The composite score for women under 40 (n =  77) was created from the items assessing 
whether or not the women talked with a healthcare provider about early mammography, history 
of clinical breast exam, clinical exam in the last two years, history of breast self exam, and breast 
self exam in the last six months. Each yes answer to these questions was given a score of 1 and 
each no question was given a score of 0. The possible range of scores for this composite was 0-5. 
The mean score of women under 40 in this sample was 4.3 (range 1-5; SD =1.0). Finally, the 
composite scores for both age groups combined into one variable to create a composite score for 
the group. Other researchers have also used different adherence criteria across age groups to 
construct an adherence score (e.g., mammography; Bowen, Alfano, McGregor, & Andersen, 
2004). The combined mean was 4.3 (range 1-5; SD =1.0).  
                                                 
4 The importance of repeat adherence, referring to regularly completed mammography, has been suggested in recent 
literature because the greatest benefit of mammography is achieved with regular screening (i.e., Clark, Rakowski, & 
Bonacore, 2003; Rakowski et al., 2003), thus adherence in this study was described as two mammograms in the last 
two years.  
 
5 There was one 40 year old participant who had only had one mammogram in the last two years, because she was 
adherent on all other measures, due to her age, she was also coded as adherent on the mammogram item. 
Additionally, there were two 41 year olds who had only had one mammogram, but also due to their age and 
adherence on other measures, there mammography score was coded as adherent.  
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ANOVAs and bivariate correlations were used to explore the relationships between the 
individual early detection behaviors and the composite score of early detection behaviors and 
other study variables. As would be expected, the results generally suggest that the composite 
score shares similar relationships with other study variables as do the individual behaviors (see 
Table 10). In fact, other research has found that clinical breast exams are predictors of 
mammography (i.e., Wallace, MacKenzie, & Weeks, 2006). The combined composite score is 
used in all further analyses that include early detection behavior unless otherwise noted. 
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Table 10 . ANOVAs (F score reported) for individual behaviors and study variables and correlation (r’s reported) for the early 
detection behavior combined variable and study variables.  
 
 Mammo 
Adhere 
 
Talk with 
Provider 
 
Overall  
Mammo 
Adhere 
CBE 
History 
  
CBE 
Frequency
BSE 
History 
BSE 
Frequency 
Early 
Detection 
Combined 
degrees of freedom (1, 108) (1, 74) (1, 184) (1, 184) (1, 184) (1, 184) (1, 184) (1, 184) 
Age 4.1* 3.1 2.4 .66 .62 .27 .89 .09 
5-year risk 8.4** 4.0* 5.0* .002 1.8 .20 .97 .12 
Lifetime risk 6.5** 2.9 9.6** 1.17 2.8 2.3 .25 .16* 
Harvard Risk Index 3.5 .24 2.7 .26 .66 .24 .55 .05 
Education 1.8 .83 2.5 2.3 6.0* 12.1** 1.2 .22** 
Income 5.5* 7.9** 14.0** 2.7 5.4* 11.4** 6.4* .33** 
Communication 5.0* 28.3** 28.9** .17 3.3 7.0** 10.9** .35** 
Recommend Prevention .63 3.8* 2.9 .95 .05 .02 .04 .05 
Familiarity with Prevention .32 4.7* 4.2* .69 5.7* .92 .53 .16* 
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Recommend Early Detection 17.5** 28.1** 38.5** 9.0** 30.0** 2.6 4.9* .41** 
Perceived Risk 6.4* .66 7.3** 1.4 3.7* .009 .62 .15* 
Conviction Perceived Risk .21 .54 .84 3.4 .16 1.7 1.4 .12 
Cancer Worry 1.1 1.6 2.9 .52 .32 .41 .41 .04 
Cancer Distress .13 1.5 1.5 .001 1.2 1.6 2.1 -.07 
Attitude Information  4.0* .06 3.0 1.4 3.5 .50 .84 .09 
Attitude Utility 4.4 3.8* 6.3* 2.2 6.1* .04 .04 .15* 
Attitude Prevent Surgery .05 1.6 .45 1.6 1.0 .48 .02 .02 
Attitude Worth 1.2 .82 1.2 13.5** 10.6** .18 2.4 .21** 
Adherence Intentions 9.1** 18.69** 23.3** 10.3** 22.3** 1.9 3.2 .36** 
Clinic Contact Intentions .31 .001 .05 .55 1.6 .25 .05 .02 
Note. Mammo Adhere includes only women 40 years old or over (n = 110). Talk with provider includes only women under the age of 
40. *p < .05. **p < .01.
 
  
Clinic Contact Intentions 
 
At baseline, the mean score for this question was 3.4 (SD =1.2; Definitely no = 5.9%, 2 = 16.6%, 
3 = 31.6%, 4 = 19.3%, and Definitely yes = 26.7%). At the two week call, the mean score was 
3.2 (SD =1.2; Definitely no = 10.8%, 2 =16.8%, 3 = 30.5%, 4 = 23.4%, Definitely yes = 18.6%); 
at six weeks (n =  120), the mean score was 3.5 (SD =1.1; Definitely no = 4.2%, 2 = 14.2%, 3 = 
30.0%, 4 = 26.6%, Definitely yes = 25.0%). 
 
Clinic Contact Behavior 
 
All participants completed the first follow-up call and 143 of a possible 149 completed the last 
follow-up call. At the two week call, 20 participants had contacted the clinic; at the six week call, 
23 additional participants had contacted the clinic. In total, 43 (23.4) participants reported 
contacting the clinic and 138 (76.2) reported not contacting the clinic. 
 
Adherence Intentions 
 
In this study, the sample mean for the ADQ adherence intentions scale was 17.3 (SD =2.1; range 
=  11-20).  
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PRELIMINARY ANALYSES 
 
Correlational coffecients were used to describe the relationships between each continuous 
predictor and outcome variable described above. Table 11 shows all relationships among 
background variables (age, 5-year risk, lifetime risk, Harvard Risk Index, education, and 
income), Table 12 shows the relationship among background variables and predictor variables 
(healthcare communication factors, perceived risk factors, cancer worry, cancer distress, attitude 
factors), Table 13 shows the relationship between the outcome variables (adherence intentions, 
early detection behavior, and clinic contact intentions) and background and predictor variables, 
and Table 14 shows the relationship between the predictor variables.  
ANOVAs were used to describe relationships between the continuous study variables and 
categorical study variables (e.g., race, martial status). Table 15 and Table 16 summarize the 
significant relationships between race and marital status, respectively, with other study variables.  
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 Table 11. Pearson correlations between background variables.  
 
 Age 5-year 
risk 
Lifetime 
risk 
Harvard 
Risk 
Index 
Education Income 
Age -      
5-year risk .86** -     
Lifetime risk -.20** .19* -    
Harvard Risk Index .09 .23** .25** -   
Education -.13 -.09 .27** .16* -  
Income .19* .17* .22** .01 .42** - 
Note. * = p < .05, ** = p < .01. 
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 Table 12. Pearson correlations between background and predictor variables.  
 
 Age 5-year 
risk 
Lifetime 
risk 
Harvard 
Risk 
Index 
Education Income 
Communication .04 .07 .11 .03 .08 .17* 
Rec Prevention .04 .11 .11 .11 -.13 -.06 
Familiarity with Prevention .12 .19* .18* .12 .17* .31** 
Rec Early Detection .38** .36** .01 .07 .04 .21** 
Perceived Risk -.10 .04 .23* .07 -.14 -.04 
Conviction Perceived Risk .11 .11 -.06 .01 -.13 -.10 
Cancer Worry -.14 -.12 -.07 -.04 -.27** -.15* 
Cancer Distress -.08 -.16* -.12 -.14 -.20** -.22** 
Attitude Information  .19** .20** -.04 -.03 -.12 -.15* 
Attitude Utility .07 .10 .14 -.02 .12 .20** 
Attitude Prevention .13 .05 -.11 -.06 -.36** -.03 
Attitude Worth .13 .16* .015 .02 .05 .12 
Note. Rec = Recommend. * = p < .05, ** = p < .01. 
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 Table 13. Pearson correlations between outcome measures and background and other predictor 
variables.  
 
  
Adherence 
Intentions 
Early 
Detection 
Behaviors
 
Contact 
Intentions 
Contact 
Intentions 
2-week 
Contact 
Intentions 
6-week 
Age .25** .09 .06 -.02 .07 
5-year risk .23** .12 .05 -.06 -.05 
Lifetime risk .01 .16* -.06 -.12 -.21* 
Harvard Risk Index -.05 .05 .03 -.13 .06 
Education .02 .22** -.30** -.23** -.24* 
Income .19* .33** -.28** -.16* -.27* 
Communication .36** .35** .06 -.08 -.14 
Recommend Prevention -.10 .05 .07 -.02 -.05 
Familiarity with Prevention .17* .16* -.14 -.06 -.15 
Recommend Early Detection .46** .41** .11 .04 .03 
Perceived Risk .06 .15* .09 .09 .17* 
Conviction Perceived Risk .14 .12 .10 .09 .19* 
Cancer Worry .01 .04 .17* .26** .25** 
Cancer Distress .01 -.07 .24** .23** .22* 
Attitude Information  .23** .09 .34** .26** -.05 
Attitude Utility .50** .15* .11 .02 .04 
Attitude Prevention .03 .02 .35** .35** .32** 
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Attitude Worth .57** .21** .18* .04 -.04 
Note. * = p < .05, ** = p < .01. 
 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
1. Communicat  ion -            
2. Recommend Prevention .15* -           
3. Familiarity with Prevention .24** .17* -          
4. Recommend Early Detection .35** .16* .17* -         
5. Perceived Risk .12 .21** -.03 .10 -        
6. Conviction Perceived Risk .22** .11 .02 .16* .30** -       
7. Cancer Worry .06 .18* .05 -.04 .42** .24** -      
8. Cancer Distress .07 .25** -.10 .01 .21** .18* .54** -     
9. Attitude Information  .19* .11 -.04 .28** .11 .06 .16* .10 -    
10.Attitude Utility .20** -.17* -.01 .31 .11 .10 -.15* -.11 .11 -   
11.Attitude Prevention -.03 .15* -.05 .16* .19* .09 .28** .16* .41** .04 -  
12.Attitude Worth .12 -.07 -.08 .25** .07 .12 .02 .02 .08 .29** -.04  
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Table 14. Pearson correlations predictor variables. 
Note. * = p < .05, ** = p < .01 
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Table 15. Significant relationships between race and other study variables.  
 
 
 
Caucasian 
M (SD) 
African 
American 
/Black 
M (SD) 
 
df 
 
F 
 
p 
Lifetime Risk 18.7(3.0) 11.8(3.8) 1, 181 143.2 <.001 
Education 3.3(.85) 2.0(.94) 1, 180 60.1 <.001 
Income 3.4(1.3) 2.0(.94) 1, 177 29.7 <.001 
Familiarity with Prevention .4.2(3.7) 2.6(3.6) 1,181 6.1 .014 
Cancer Worry -.10(.64) .40(1.2) 1,181 12.2 .001 
Cancer Distress 6.2(7.5) 10.5(11.7) 1, 181 7.4 .007 
Attitude Utility  12.6(1.7) 11.7(2.5) 1,176 5.3 .023 
Attitude Prevention Strategies 11.9(3.73) 13.5(4.6) 1, 178 4.4 .037 
Early Detection Behavior 4.4(0.9) 3.8(1.3) 1, 180 12.5 .001 
Clinic Contact Intentions 3.3(1.2) 3.9(1.3) 1, 181 7.4 .006 
2 week clinic contact intentions 3.0(1.2) 3.9(1.7) 1, 161 14.6 <.001 
6 week clinic contact intentions 3.4(1.1) 4.3(.91) 1,114 13.5 <.001 
Note. Variables examined with no significant relationships included age, 5-year risk, Harvard 
Risk Index, healthcare communication, provider recommend prevention, provider recommend 
early detection, perceived risk, conviction of perceived risk, attitude information, attitude worth 
prevention, and adherence intentions. 
  
Marriage-
like 
Relationship 
(n = 94) 
 
Never 
Married 
(n = 59) 
 
Divorced 
 
(n = 25) 
 
Widowed 
 
(n = 9) 
  
df 
 
F 
 
p 
Age 42.9(10.7) 36.0(11.0) 47.2(9.5) 58.6(5.9)  3, 183 15.6 <.001
5-year risk 1.4(1.0) .96(1.2) 1.92(1.26) 2.4(.97)  3,183 8.0 <.001
Education 3.2(.91) 3.0(1.1) 2.6(1.0) 2.2(.97)  3,182 4.32 .006 
Income 3.7(1.4) 2.4(1.0) 2.8(1.0) 2.6(1.4)  3, 179 16.29 <.001
Attitude Prevention Strategies 11.7(3.7) 12.1(4.1) 13.8(3.2) 14.4(5.4)  3, 180 2.76 .044 
Adherence Intentions 17.5(1.9) 16.6 17.7(1.9) 17.4(2.1)  3, 179 2.76 .043 
6 week clinic contact intentions 3.28(1.2) 3.6(.92) 4.3(1.0) 5.0(0.0)  3, 97 4.6 .005 
Note. Variables examined with no significant relationships included lifetime risk, yourdiseaserisk.com rating , cancer worry, cancer 
distress, healthcare communication, provider recommend prevention, familiarity with prevention, provider recommend early 
detection, perceived risk, perceived risk conviction, attitude information, attitude utility, attitude prevention, attitude worth, early 
detection behaviors, baseline clinic contact intentions, 2 week clinic contact intentions.
Table 16. Significant relationships between partner status and other study variables. 
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TESTING THE HYPOTHESES 
 
When testing the hypotheses, the variables of age, lifetime objective risk, education, income, 
Healthcare Communication (factor 1), Perceived Risk (factor 1), Attitudes Toward Information 
Seeking and Attitudes Toward Worth of Prevention and Surveillance (factor 1 and 4), Cancer 
Worry, Cancer Distress, adherence intentions, composite score of early detection behavior, and 
clinic contact intentions at baseline were used.  
 
Primary Aim 1 
 
The hypotheses and results for this aim are summarized in Figure 7. The first aim of this study 
was to examine the relationship between the outcome variables (adherence intentions, early 
detection behavior, and clinic contact) and age, objective risk, education, income, and healthcare 
communication (see Table 13). It was expected that age would be positively related to early 
detection behaviors and negatively related to adherence intentions and clinic contact intentions. 
In this sample, the only significant relationship was a positive association between age and 
adherence intentions (r =  .25, p = .001). Objective risk was expected to be positively associated 
with all the outcomes, but was only related to early detection behaviors (r =  .16; p = .03). 
Education was expected to be positively related to all outcomes; early detection behaviors 
supported this hypothesis (r =  .22; p = .002), while clinic contact intention was negatively 
related to education (r =  -.30; p < .001), and adherence intentions were not related. As expected, 
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 income was positively related to both early detection behaviors (r =  .33; p < .001) and 
adherence intentions (r =  .19; p = .01), however contrary to expectations, it was negatively 
related to clinic contact intentions (r =  -.28; p < .001). Consistent with predictions, healthcare 
communication was positively associated with early detection behaviors (r =  .35; p < .001) and 
adherence intentions (r =  .36; p < .001).  
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Figure 7. Results for Aim 1. 
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Primary Aim 2 
 
The hypotheses and results of this aim are presented in Figure 8. The first objective for Aim 2 
was to examine the relationship between perceived risk and each outcome variable (see Table 
13). The only relationship found was between perceived risk and early detection behaviors (r =  
.15; p = .04). Perceived risk was not related to adherence intentions or clinic contact intentions. 
The second objective of this aim was to investigate the relationships between the background 
variables and perceived risk (see Table 12). It was expected that age would be negatively related 
to perceived risk; no relationship was found. It was also expected that perceived risk would be 
positively related to objective risk, education, income, and healthcare communication. The only 
relationship found was between perceived risk and objective risk (r =  .23; p = .002).  Finally, 
perceived risk was investigated as a mediator of the relationship between age and outcomes, 
objective risk and outcomes, education and outcomes, and income and the outcomes. Based on 
the above bivariate results (e.g., Baron & Kenny, 1986), the only testable relationship was 
examining perceived risk as a mediator of objective risk and early detection behavior. To test the 
mediating hypothesis, partial correlations were done controlling for perceived risk and 
examining whether objective risk accounted for any residual variation in early detection 
behaviors; the resulting correlation was decreased (r =  .11; p = .14) suggesting mediation. 
However, when testing the statistical significance of the mediation with the Sobel test (outlined 
above in the Statistical Analyses section), the change in the relationship between objective risk 
and early detection behaviors when controlling for perceived risk was not significant (z = 1.52; p 
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 = .13). This suggests that objective risk and perceived risk influence early detection behavior 
along separate pathways.  
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Figure 8. Results for Aim 2. 
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Primary Aim 3 
 
The hypotheses and results for Aim 3 are represented in Figure 9. The first objective of this aim 
was to examine the relationship between attitudes and the outcome variables (see Table 13). 
Attitude Information was positively related to adherence intentions (r =  .23; p = .002) and clinic 
contact intentions (r =  .34; p < .001), but not to early detection behaviors. As expected, Attitude 
Worth was positively related to early detection behaviors (r =  .21; p = .005), adherence 
intentions (r =  .57; p < .001), and clinic contact intentions (r =  .18; p = .02).  
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Figure 9. Results for Aim 3. 
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 Next the relationship among the background variables and attitudes were examined. It was 
expected that attitudes would be positively related to age, education, and income, but not related 
to objective risk and healthcare communication (see Table 12). Attitude Information was 
positively related to age (r =  .19; p = .009), healthcare communication (see Table 14; r =  .19; p 
= .01), and negatively associated with income (r =  -.15; p = .05). Attitude Worth was not related 
to the background variables. It was expected that attitudes would at least partially mediate the 
relationship between age, education, and income, and the outcomes. Education could not be 
tested in mediational relationships because of the lack of necessary bivariate results (Baron & 
Kenny, 1986); the results of testable relationships are reported below.  
To examine whether or not Attitude Information mediated the relationship between age 
and adherence intentions, partial correlations were done controlling for Attitude Information; 
there was a decrease in the relationship (r =  .20; p = .009) between age and adherence 
intentions. However, when testing for statistical significance using the Sobel test (z = 1.88; p = 
.06) the change in the relationship between age and adherence intentions when controlling for 
Attitude Information was not statistically significant and did not indicate mediation. These 
results suggests that age and Attitude Information influence adherence along separate pathways. 
To examine Attitude Information as a mediator of the relationship between income and 
adherence intentions, partial correlations were done controlling for Attitude Information. 
Unexpectedly, Attitude Information was not a mediator of this relationship, rather it had a 
suppressor effect and by controlling this variable the degree of relationship between the income 
and adherence intentions increased (r =  .22; p = .004). Suppression occurs when a variable 
increases the predictive validity of another variable when controlled for in a statistical equation 
(Tzelgov & Henik, 1991). However, when testing for statistical significance of this change, 
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 Sobel tests revealed that the change was not significant (z = -1.76; p = .07). This suggests that 
Attitude Information and income influence adherence intentions along separate pathways.  
To examine Attitude Information as a mediator of the relationship between Attitude 
Information and clinic contact intentions, partial correlations were done controlling for Attitude 
Information. Again, Attitude Information was not a mediator of this relationship, but rather a 
suppressor, and the relationship between income and clinic contact intentions increased (r =  -
.24; p = .001); however, results of the Sobel test indicate that the change in relationship was not 
significant (z = -1.82; p = .07).  
 
Primary Aim 4 
 
 
The hypotheses and results of Aim 4 are summarized in Figure 10. There were several 
objectives, beginning with the relationships among Cancer Worry and Cancer Distress and each 
outcome behavior. Both Cancer Worry and Cancer Distress were predicted to be positively 
related to outcomes. However, the only relationships found were between clinic contact 
intentions and Cancer Worry (r =  .17; p = .02) and Cancer Distress (r =  .24; p = .001; see 
Table 13). The second objective of this aim was to test the relationship between perceived risk 
and Cancer Worry and Cancer Distress, and attitudes and Cancer Worry and Cancer Distress. 
Both Cancer Worry and Cancer Distress were positively related to perceived risk (see Table 14; r 
=  .42; p < .001 and r =  .21; p = .004, respectively). As predicted, Attitude Information was 
related to Cancer Worry (r =  .16; p = .03); contrary to expectations Attitude Worth was not 
related to either cancer specific distress variable.  
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Figure 10. Results for Aim 4. 
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 It was hypothesized that age, education, and income would all be positively related to cancer 
specific distress (see Table 12). Contrary to these hypotheses, in this sample, age was not related 
to either Cancer Worry or Cancer Distress. Also unexpectedly, education was negatively related 
to Cancer Worry (r =  -.27; p < .001) and Cancer Distress (r =  -.20; p = .008), as was income (r 
=  -.15; p = .05 and r =  -.22; p = .003, respectively). As hypothesized, neither objective risk nor 
communication was related to cancer specific distress (see Table 14).  
Cancer Worry and Cancer Distress were expected to at least partially mediate the 
relationships between perceived risk and the outcomes, and age and the outcomes. No direct 
relationships met criteria to test for these mediational relationships (e.g., Baron & Kenny, 1986). 
Cancer Distress also was expected to at least partially mediate the relationship between attitudes 
and outcome variables. The only testable relationship was that of Cancer Worry mediating the 
relationship between Attitude Information and clinic contact intentions. Partial correlations were 
done controlling for Cancer Worry and examining whether Attitude Information accounted for 
any residual variation in clinic contact intentions. The relationship between cancer worry and 
clinic contact intentions was decreased when controlling for attitude information (r =  .11; p = 
.15). However, the results of the Sobel test (z = 1.97; p = .05) suggest that the difference was not 
significant and that both Attitude Information and Cancer Worry influence clinic contact 
intentions along separate pathways.  
Cancer Worry and Cancer Distress were hypothesized to at least partially mediate the 
relationship between education and outcome variables. Two testable relationships were 
identified. Partial correlations were done controlling for Cancer Worry and examining whether 
education accounted for any residual variation in clinic contact intentions. Although the resulting 
correlation decreased (r =  .28; p < .001), results of the Sobel test were not significant (z = -1.35; 
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 p = .17). This suggests that both education and Cancer Worry influence clinic contact intentions 
along separate pathways. 
 Partial correlations were also done controlling for Cancer Distress and examining 
whether education accounted for any residual variation in clinic contact intentions. The resulting 
correlation was decreased (r =  -.28; p < .001) although the results of the Sobel test suggest that 
the difference was not significant (z = -1.91; p = .06). This suggests that Cancer Distress and 
education influence clinic contact intentions along separate pathways. 
Finally, Cancer Worry and Cancer Distress were expected to at least partially mediate the 
relationship between income and outcome variables. Partial correlations were done controlling 
for the influence of Cancer Worry and examining whether income accounted for any residual 
variation in clinic contact intentions. The resulting correlation was decreased (r =  -.26; p < 
.001), however Sobel tests suggest that the mediation was not statistically significant (z = 1.31; p 
= .19), suggesting that income and Cancer Worry impact clinic contact intentions along separate 
pathways. Partial correlations were done controlling for the influence of Cancer Distress and 
examining whether income accounted for any residual variation in clinic contact intentions. The 
resulting correlation was decreased (r =  -.24; p = .001) significantly (z = 1.96; p = .04). This 
suggests that Cancer Distress partially mediates the relationship between income and clinic 
contact intentions.  
 
Primary Aim 5 
 
The last primary aim of this study involved testing the hypotheses using SEM as to account for 
unique variance among the predictor variables and outcomes, and to better explain the 
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 relationships between these variables. Initially, SEM using EQS software was used to test the fit 
of the proposed model examining all hypothesized pathways (Figure 11). This model did not 
converge, thus results were not interpretable. The failure of the initial model to converge was due 
to parameter values with illogical values known as “Heywood cases” (e.g., negative error 
variances). Heywood cases are usually caused by misspecification of the model, a combination 
of small sample sizes and only two indicators per latent variable, and/or bad starting values in 
maximum likelihood estimation. Due to this, as well as the ratio of variables in the model and the 
number of participants, it was determined that the model should be respecified. To respecify the 
model and evaluate the fit of the revised model to the same data, the study hypotheses and the 
results of bivariate analyses were given close attention when determining initial pathways. The 
respecified model is represented in Figure 12. The respecified model data did converge making it 
possible to validate the measurement model and then examine the fit of the structural model.  
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Figure 11. Full hypothesized model tested with structural equation modeling. 
123 
  
 
Figure 12. Respecified. Model. 
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       Although the respecified model did converge, it was rejected, as it did not meet the minimum 
criteria of goodness of fit. Model modification indexes were used until an acceptable model was 
produced. The first modifications were made to parameters that were dropped based on non-
significant parameter estimates and Wald W indexes. Parameters that were dropped included 
adherence intentions predicted by age and early detection behavior predicted by objective risk 
and education. This new model is shown in Figure 13. The second model did not meet goodness 
of fit criteria, using the same modification criteria as above, the parameter of education 
predicting the factor Cancer Distress was dropped. The third model is shown in Figure 14. The 
third model did not meet goodness of fit criteria and again using the overlap between 
nonsignficant parameter estimates and Wald W indexes, two additional parameters were 
dropped: clinic contacted predicted by income and early detection behaviors predicted by 
perceived risk were excluded from the fourth model. Model 4 is shown in Figure 15. The fit 
again was not acceptable, and based on results of the Lagrange Multiplier index, a path was 
added predicting Attitudes Toward Information Seeking from healthcare communication (Figure 
16). Again, the model did not meet fit criteria, and modification indexes resulted in the addition 
of a path from perceived risk to the factor score of Cancer Distress. This model is shown in 
Figure 17, and the model fit was acceptable (Satorra-Bentler χ2 (52, N =  173) = 59.74; p = .22; 
CFI = .98, RMSEA =.029). Based on modification indexes, two additional models were tested. 
In the first model, perceived risk predicted by education was added and clinic contact intention 
predicted by the latent variable Cancer Distress was dropped (Figure 18). Again, although the 
model was significant, based on modification indexes, parameters were added that predicted 
clinic contact intention from the latent variable distress and early detection behaviors from 
perceived risk. The last tested model is displayed in Figure 19. Chi-square difference tests were 
125 
 used to determine the best model (See Table 17). The best model was the final model represented 
in Figure 19 (Satorra-Bentler χ2 (50, N =  173) = 51.95; p = .40; CFI = .99, RMSEA =.015).  
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Figure 13. Respecified Model 2.  
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Figure 14. Respecified Model 3.  
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Figure 15. Respecified Model 4.  
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Figure 16. Respecified model 5.  
130 
  
 
 
Figure 17. Respecified model 6.  
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Figure 18. Respecified model 7. 
132 
 Table 17. Goodness of fit difference tests summary for model with latent factor.  
 
Model Chi-
Square 
Santorra-
Bentler 
Chi-
Square 
 
df 
 
p 
 
CFI 
 
RMSEA 
 
∆X2 
 
∆df 
 
p 
1 86.29 76.75 48 .005 .908 .059    
2 90.61 79.77 51 <.001 .908 .057    
3 92.31 80.29 52 .006 .908 .920    
4 99.59 86.54 54 .003 .896 .059    
5 91.97 80.00 53 .010 .914 .054    
6 67.34 59.74 52 .215 .975 .029    
7 63.32 56.52 52 .309 .984 .022    
8 57.32 51.95 50 .398 .994 .015 5.8 2 .05 
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Figure 19. Respecified model 8. 
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 Because it has been suggested that latent factors should have at least three indicators 
(Comrey & Lee, 1992) and model modification indexes suggested that the latent variable 
indicators might be uniquely related to variables in the model, examining a model without the 
factor was indicated. Based on this, a new model was specified again using study hypotheses and 
bivariate relationships as a guide. The new model omitted the latent variable and used both 
indicators as observed variables only. This model is displayed in Figure 20. The model was 
acceptable based on χ2 statistics, however, modification indexes suggested parameters that could 
be added or deleted from the model. In the first modification all parameters that had 
nonsignficant parameter estimates and were indicated based on the Wald W test were dropped 
and the error terms between adherence intentions and early detection behaviors were allowed to 
correlate based on LeGrange Multiplier indices. The second model is displayed in Figure 21. 
Again the model fit was acceptable, but based on LaGrange Multiplier indices, paths were added 
that predicted worry from age and perceived risk from education, and Wald W test indicated 
dropping the correlation between the error terms of adherence intentions and early detection 
behavior (Figure 22). The model fit was acceptable, however, LaGrange Multiplier test 
suggested adding perceived risk as a predictor of early detection behaviors and letting the error 
terms between adherence intentions and early detection behaviors correlate. The fourth model is 
displayed in Figure 23. One more model was run, again dropping the correlation between the 
error terms of adherence intentions and early detection behaviors (Figure 24). Several χ2 
difference tests were done to determine which model best explained the relationships between 
the variables (See Table 18.). The best model with observed variables only is represented in 
Figure 23 (Satorra-Bentler χ2 (48, N =  173) = 36.54, p = .89, CFI = 1.0, RMSEA = .00). 
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Figure 20. Observed variables only model 1. 
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Figure 21. Observed variables only model 2.  
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Figure 22. Observed variables only model 3.  
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Figure 23. Observed variables only. Model 4.  
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Figure 24. Observed variables only model 5. 
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 Table 18. Goodness of fit summary for model with no latent factor.  
 
Model Chi-
Square 
Santorra-
Bentler 
Chi-
Square 
 
df 
 
p 
 
CFI 
 
RMSEA 
Difference 
Test 
Models 
 
∆X2 
 
∆df 
 
p 
01 44.72 40.27 42 .54 1.0 .000     
02 55.07 48.57 51 .57 1.0 .000 01 vs. 02 8.33 9 .501 
03 51.36 45.00 50 .08 1.0 .000 02 vs. 03 4.89 1 .027 
04 40.89 36.54 48 .89 1.0 .000 03 vs. 04 6.25 2 .044 
05 46.75 41.65 49 .11 1.0 .000 04 vs. 05 4.56 1 .033 
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 To determine if the model that included the latent variable or the model with observed 
variables only was best explaining the relationships in the data, AIC and CAIC were examined 
(see Table 19). Models with the lower AIC and CAIC values are thought to be the best fit to the 
data (Akaike, 1987; Bozdogan, 1987). Based on this, it was determined that the model with 
observed variables only was best explaining the data and this model was used to interpret the 
parameters of the model. Again, this model is shown in Figure 23 and parameter estimates for 
this model are shown in Table 20.   
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 Table 19. Summary of comparison of non-nested models.  
 
Model Model 
AIC 
Model 
CAIC 
    
04 -59.46 -258.82     
       
8 -48.05 -255.72     
Note. AIC = Akaike Informaiton Criterion. CAIC = Consistent AIC 
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 Table 20. Standardized parameters for the final structural equation model predicting risk 
reducing behaviors. 
 
 Effect z 
value 
Indirect 
effect 
z 
value
Education → Clinic Contact Intentions -.26*** -3.85   
Income → Adherence Intentions .17** 3.17   
Income → Early Detection Behaviors .30*** 4.83   
Healthcare Communication → Adherence Intentions .24*** 4.43   
Healthcare Communication → Early Detection Behavior .25*** 4.18   
Objective Risk → Perceived Risk .27*** 3.46   
Education → Perceived Risk -.17* -2.14   
Attitude Information → Adherence Intentions .19** 2.82   
Attitude Worth → Adherence Intentions .53*** 5.17   
Attitude Worth → Early Detection Behaviors .18* 2.08   
Attitude Information → Clinic Contact Intentions .27*** 3.81   
Attitude Worth → Clinic Contact Intentions .20** 2.67   
Age → Attitude Information .28*** 3.84   
Income → Attitude Information -.24*** -3.19   
Healthcare Communication → Attitude Information .20** 2.83   
Cancer Distress → Clinic Contact Intentions .16* 2.74   
Perceived Risk → Worry .39*** 6.40   
Perceived Risk → Cancer Distress .19** 2.60   
144 
 Age → Worry -.12** -2.38   
Education → Worry -19** -2.78   
Income → Cancer Distress -.19** -2.81   
Income → Healthcare communication .17** 2.23   
Objective Risk → Worry     .11** 2.72 
Education → Worry   -.07* -2.04 
Age → Adherence Intentions   .05* 2.47 
Age → Clinic Contact Intentions   .08** 2.66 
Income → Early Detection Behaviors   .04* 2.01 
Income → Clinic Contact Intentions   -.09** -2.74 
Healthcare Communication → Clinic Contact Intentions   .06** 2.36 
Note. Effects and indirect effects shown are standardized regression weights. * = p < .05, ** = p 
< .01, *** = p < .001. 
145 
 AIM 1 within SEM. The first aim of this study was to examine the relationship between the 
outcome variables of adherence intentions, early detection behaviors, and clinic contact 
intentions and the background variables of age, objective risk, education, income, and healthcare 
communication. It was hypothesized that both objective risk and age would be related to each 
outcome variable. Although bivariate results found that age was related to adherence intentions 
and lifetime risk was related to early detection behaviors, neither variable was a predictor in the 
context of the model. Education was expected to be positively related to each of the outcome 
variables and bivariate analyses found that education was positively related to early detection 
behaviors and unexpectedly negatively related to clinic contact intentions. Within the model, 
lower levels of education predicted higher intentions to contact the high risk clinic, β = -.26, z = -
3.85, p <.001. Education was not related to adherence intentions or early detection behaviors in 
the model.  
Initial analyses revealed that, as expected, income was positively related to adherence 
intentions and early detection behaviors. Contrary to hypotheses, income was negatively related 
to clinic contact intentions. Within the SEM model, income was not related to clinic contact 
intentions, but did predict adherence intentions and early detection behaviors, β = .17, z = 3.17, p 
< .001 and β =.30, z = 4.83, p <.001, respectively. Healthcare Communication performed 
similarly in the model as previously by positively predicting adherence intentions and early 
detection behaviors, β =.24, z = 4.43, p < .001 and β =.25, z = 4.18, p < .001, respectively. 
Although it was hypothesized that Healthcare Communication would also be related to clinic 
contact intentions, no relationship was found.  
In summary, corroborating bivariate findings, education accounted for unique variance 
when predicting clinic contact intentions, income uniquely predicted early detection behaviors, 
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 and Healthcare Communication predicted both adherence intentions and early detection 
behaviors. Contrary to bivariate analyses when shared variance among the model variables was 
accounted for by testing the hypotheses with SEM for Aim 1, age and objective risk were not 
related to the outcomes. Likewise, the relationships between education and early detection 
behaviors and between income and clinic contact intentions were no longer found.  
 
AIM 2 within SEM. Next, the parameter estimates were examined to better explain the 
hypotheses in Aim 2. First, it was hypothesized that perceived risk would be positively related to 
each outcome variable. Bivariate relationships found a weak significant relationship between 
perceived risk and early detection behaviors; however, within the model perceived risk was not 
related to any of the outcome variables. Next, it was hypothesized that both age and Healthcare 
Communication would positively predict perceived risk, however, consistent with the bivariate 
findings neither of these relationships was found. As expected, higher objective risk predicted 
higher perceived risk β = .27, z = 3.46, p < .001. Contrary to predictions, education was not 
related to perceived risk in bivariate analyses. However, when using SEM it was found that 
education negatively predicted perceived risk β = -.17, z = -2.14, p = .02.  
Both analyses methods supported the positive relationship between objective risk and 
perceived risk. When testing the model, as hypothesized education was a predictor of perceived 
risk even though bivariate analysis did not find a relationship between these two variables. The 
emergence of this relationship may be due to the ability of SEM to account for all variance in the 
model simultaneously and to also take into account any non-normal data that could influence the 
outcomes.  
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 AIM 3 within SEM. The first objective of Aim 3 was to examine the relationship between the 
attitude factors and the outcome variables. Consistent with the bivariate relationships, the attitude 
factors were related to all outcome measures. First, adherence intentions was positively predicted 
by both Attitudes Toward Information Seeking and Attitudes Toward the Worth of Prevention 
and Surveillance, β =.19, z = 2.82, p = .004 and β = .53, z = 5.17, p < .001, respectively. Next, 
Attitudes Toward the Worth of Prevention and Surveillance positively predicted early detection 
behaviors β =.18, z = 2.08, p = .04. Finally, both Attitudes Toward Information Seeking and 
Attitudes Toward the Worth of Prevention and Surveillance predicted clinic contact intentions β 
=.27, z = 3.81, p < .001 and β =.20, z = 2.67, p = .004, respectively.  The second objective of this 
aim was to examine the relationship between the background variables and the attitude factors. 
All relationships mirrored the bivariate findings. As expected, age positively predicted Attitudes 
Toward Information Seeking, β =.27, z = 3.85, p < .001, although it did not predict Attitudes 
Toward the Worth of Prevention and Surveillance. Contrary to expectations, education did not 
predict attitudes, although income negatively predicted Attitudes Toward Information Seeking, β 
=-.24, z = -3.19, p < .001. It was hypothesized that there would be not be a relationship between 
Healthcare Communication and the attitude factors, however it was found that Healthcare 
Communication positively predicted Attitudes Toward Information Seeking, β =.20, z = 2.84, p 
= .005. As expected, objective risk was not related to the attitude factors. 
In summary, when testing Aim 3 hypotheses within the model, all findings between the 
attitude factors and the model variables were consistent with initial analyses. Attitudes Toward 
Information Seeking predicted adherence intentions and clinic contact intentions, Attitudes  
Toward the Worth of Prevention and Surveillance predicted all three outcome variables, and age 
predicted Attitudes Toward Information Seeking. Consistent with the initial analyses where 
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 Attitudes Toward Information Seeking was suggested to mediate the relationship between age 
and adherence intentions, there was no relationship between age and adherence intentions. Also 
like the initial analyses, model results suggested that income did predict Attitudes Toward 
Information Seeking, and both of these variables uniquely influenced adherence intentions. The 
bivariate analyses suggested that Attitudes Toward Information Seeking suppressed the 
relationship between income and clinic contact intentions, and not surprisingly, in the final 
model there was not a relationship between income and clinic contact intentions. Last, 
supporting bivariate results, Healthcare Communication was related to Attitudes Toward 
Information Seeking.   
 
AIM 4 within SEM. It was hypothesized that Cancer Distress would be related to the outcomes in 
this model. The bivariate results found that Cancer Worry and Cancer Distress were associated 
with the outcome of clinic contact, however, within the model the only relationship found was 
that of clinic contact intentions being predicted by the Cancer Distress, β = .16, z = 2.74, p = 
.003. Cancer Distress was not related to other outcomes and Cancer Worry was not related to any 
outcomes. As expected and in sync with the bivariate results, Perceived Risk positively predicted 
Cancer Worry and Cancer Distress, β =.39, z = 6.4, p < .001 and β = .19, z = 2.60, p = .009, 
respectively. Attitudes Toward Information Seeking were also expected to be positively related 
to Cancer Distress, although no significant relationships were found.  
 Next, the relationships among Cancer Worry and Cancer Distress and the background 
variables were explored. Age was hypothesized to negatively predict Cancer Worry and distress. 
Although no bivariate relationship was found, within the model age did negatively predict 
Cancer Worry β = -.12, z = -2.38, p = .009, but it did not predict Cancer Distress. Education and 
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 income were hypothesized to be positively related to Cancer Worry and Cancer Distress, 
although bivariate results found negative associations. Within the model, education was found to 
negatively predict Cancer Worry β = -.19, z = -2.78, p = .003 but was not related to Cancer 
Distress. Interestingly, income negatively predicted Cancer Distress β = -.19, z = -2.81, p = .003, 
but was not related to worry. As hypothesized, neither objective risk nor Healthcare 
Communication was related to Cancer Worry or Cancer Distress.  
Summarizing the results of modeling for Aim 4, bivariate results suggested that both 
Cancer Distress and Cancer Worry were related to clinic contact intentions; however, when 
shared variance was accounted for within the model, only Cancer Distress predicted clinic 
contact intentions. Mirroring the bivariate results, Perceived Risk did predict both cancer specific 
distress variables. Interestingly, bivariate results did not find age to be related to Cancer Worry, 
but consistent with the hypothesis, age was negatively predictive of worry within the model. 
Further, in initial analyses, both education and income were related to both specific distress 
variables. Within the model, only education predicted worry and only income predicted Cancer 
Distress. In bivariate analyses, Cancer Distress was suggested as a potential mediator between 
income and clinic contact intentions and consistent with this finding, in the model, income was 
not related to clinic contact intentions but did predict Cancer Distress.  
 
Indirect Effects .In SEM, indirect effects are a test of change in direct effects after mediation has 
been entered into the model. In this model, significant indirect effects were evident for objective 
risk, education, age, income, and Healthcare Communication. Indirect effects are the product of 
the regression coefficients of the direct effects. For instance, in this model, objective risk and 
education had indirect effects on worry (β = .11; z = 2.72; p = .007 and β = .07; z = -2.04; p = 
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 .02, respectively) working through Perceived Risk.  Age had indirect effects on both adherence 
intentions and clinic contact intentions (β = .05; z = 2.47; p = .01 and β = .08; z = 2.66; p = .008, 
respectively) through its direct effect on Attitudes Toward Information Seeking. Income had an 
indirect effect on both early detection behaviors through its relationship with Healthcare 
Communication (β = .04; z = 2.01; p = .05), and income had an indirect effect on clinic contact 
intentions through its relationship with both Cancer Distress and Attitudes Toward Information 
Seeking (β = .09; z = -2.74; p = .003). Last, an indirect relationship was seen between Healthcare 
Communication and clinic contact intentions (β = .06; z = 2.36; p = .004) working through 
Attitudes Toward Information Seeking. Indirect effects are summarized in Table 20. 
 
Other Model Pathways. There was no hypothesis made about the relationship between 
Healthcare Communication and income. However, when building this model it was found that 
Healthcare Communication was positively predicted by income, β = .17, z = 2.23, p = .007. 
There were also several significant covariances in the data. Among the background variables, 
age was related to objective risk and income, β = -.18, z = -2.38, and p = .009 and β = .25, z = 
3.51, p < .001 respectively. Objective risk was also related to education and income, β = .19, z = 
2.30, p = .02 and β = .19, z = 2.49, p = .006, respectively. Also, education and income were 
related, β = .43, z = 5.68, p < .001. In SEM modeling, among variables that are dependent 
variables, the error terms are allowed to correlate. In this model there was a significant 
covariance among the error terms of IES scores and Cancer Worry, β = .48, z = 4.09, p < .001. 
There was also a significant relationship between the error terms of adherence intentions and 
early detection behaviors, β = .18, z = 2.01, p = .04.  
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 Model Summary. In summary, within the model, income accounted for 3% of the variance in 
Healthcare Communication. Model variables of objective risk and education accounted for 8% of 
the variance in Perceived Risk. Twenty-two percent of the variance in Cancer Worry was 
predicted by Perceived Risk, age, and education, while Perceived Risk and income accounted for 
7% of the variance in Cancer Distress. Healthcare Communication, age, and education accounted 
for 13% of the variance in Attitudes Toward Information Seeking. Finally, when considering the 
outcomes of interest in this study, income, Attitudes Toward Information Seeking, Healthcare 
Communication, and Attitudes Toward Worth of Prevention and Surveillance predicted 42% of 
the variance in adherence intentions. Early detection behaviors were predicted by Healthcare 
Communication, Perceived Risk, income, and Attitudes Toward Worth of Prevention and 
Surveillance accounting for 23% of the variance in this outcome, and the variables of Cancer 
Distress, Attitudes Toward Information Seeking, education, and Attitudes Toward the Worth of 
Prevention and Surveillance accounted for 23% of the variance in clinic contact intentions.  
 
Secondary Aim 
 
The secondary aim of this study was to explore whether or not the variables included in the 
proposed model were associated with actual clinic contact after women had been given risk 
information and a brochure about the high risk clinic at their study appointment. In addition to 
examining the model variables of age, objective risk, education, income, Healthcare 
Communication, Perceived Risk, Cancer Worry, Cancer Distress, Attitudes Toward Information 
Seeking, and Attitudes Toward the Worth of Prevention and Surveillance, the outcome variables 
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 of adherence intentions and clinic contact intentions were explored.  First, the univariate analyses 
were done to determine which variables to include in the logistic regression equation.  
As expected, results of univariate analyses found lifetime objective risk was positively 
related to clinic contact. This relationship was found at the two week follow-up F(1,185)=6.55; p 
= .011, with higher risk (M =  19.55; SD =4.5 vs. M =  17.04; SD =4.1) being related to clinic 
contact. As well, objective risk was related to overall clinic contact F(1, 179) = 6.00; p = .015, 
with higher lifetime risk being related to clinic contact (M =  18.65; SD =4.50 vs. M =  18.65; 
SD =4.50).  
Higher Perceived Risk was expected to be related to clinic contact, but a marginally 
statistically significant relationship at the six-week follow up found the opposite, F( 1, 136) = 
3.60; p = .06. Those with a lower Perceived Risk were more likely to contact the clinic at six 
weeks (M =  -1.43; SD =5.6 vs. M =  .75; SD =5.92). Clinic contact at six weeks and overall was 
also related to IES Cancer Distress, F(1,141)=4.00; p = .05 and F(1, 179) = 4.65; p = .03 with 
higher levels of distress were related to clinic contact (M =  10.65; SD =11.71 vs. M =  6.75; SD 
=7.85 and M =  9.65; SD =10.55 vs. M =  6.42; SD =7.86). Baseline clinic contact intentions 
were related to clinic contact at 2-weeks, F(1, 185) = 11.78; p = .001, 6-weeks, F(1, 141) = 6.42; 
p = .012, and overall, F(1.179) = 21.89; p < .001 (M =  3.34; SD =1.21 vs. M =  4.30; SD =.92, 
M =  3.37; SD =1.11 vs. 4.00; SD =1.04, M =  3.20; SD =1.20 vs. M =  4.14; SD =1.0, 
respectively). Further, higher 2-week clinic contact intentions were related to 6-week clinic 
contact, F(1,141) = 16.05; p < .001 and overall clinic contact F(1,159) = 21.78; p < .001 (M =  
3.33; SD =1.01 vs. M =  4.26; SD =.75 and M =  3.03; SD =1.23 vs. M =  4.26; SD =.75, 
respectively).   It was also expected that age, education, income, Healthcare Communication, and 
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 the attitude factors would share positive relationships with clinic contact, although no 
relationships were found. Race was not related to clinic contact.  
Based on these findings, objective risk, Perceived Risk, Cancer Distress as measured by 
the IES, and clinic contact intentions were included in the logistic regression equations 
predicting 2-week clinic contact, 6-week clinic contact, and overall clinic contact. At two weeks, 
the equation including objective risk, Perceived Risk, Cancer Distress, and baseline clinic 
contact intentions was significant in predicting clinic contact χ2 (4, N =  182) = 19.30; p = .001. 
Women at higher objective risk for breast cancer (OR =  1.17; p = .02) and higher baseline 
intentions (OR =  2.35; p = .002) were more likely to contact the clinic. Next, the same variables 
plus clinic contact intentions at two weeks were entered to predict clinic contact at six weeks. 
The equation was again significant χ2 (5, N =  138) = 30.12; p < .001, with higher lifetime risk 
(OR =  1.17; p = .03), lower Perceived Risk (OR =  .86; p = .007), higher Cancer Distress (OR 
=  1.06; p = .06), and higher two week clinic contact (OR =  2.67; p < .001) predicting clinic 
contact. 
Last, overall clinic contact was predicted using the variables of objective risk, Perceived 
Risk, Cancer Distress, and clinic contact intentions at baseline as predictors. The overall equation 
was significant χ2 (4, N =  176) = 33.58; p < .001, with objective risk (OR =  1.18; p = .004), 
baseline intentions (OR =  2.17; p < .001), Cancer Distress (OR =  1.04; p = .04), and Perceived 
Risk (OR =  .91; p = .03) all predicting clinic contact overall. These results suggest that 
objective risk and behavioral intentions are the most consistent predictors of high-risk clinic 
contact. Further, in this sample higher distress, but lower perceived risk appears to impact high-
risk clinic contact overall.   
154 
  
 
DISCUSSION 
 
 
After an extensive literature review examining predictors of risk-reducing behaviors, several 
hypotheses were made regarding predictors of adherence intentions, early detection behavior, 
clinic contact intentions, and clinic contact in a community sample of women with a family 
history of disease. Specifically, this study examined the role of distal background variables of 
age, objective risk, education, income, and healthcare communication on risk-reducing behaviors 
of adherence intentions, early detection behaviors, and high-risk clinic contact. This research 
also investigated the relationship between more proximal variables (perceived risk, cancer 
distress, attitudes toward risk reducing behavior) that were hypothesized to account for much of 
the influence of distal variables on these outcomes. These variables accounted for 42% of the 
variance in adherence intentions and 23% of the variance in both early detection behaviors and 
clinic contact intentions. Further, this study explored the relationships between the background 
variables and the proximal variables. Examining clinic contact prospectively, higher objective 
risk, lower perceived risk, higher cancer distress, and higher clinic contact intentions predicted 
risk-reducing behavior. Broadly, the proposed variables accounted for variance in the outcome 
measures of interests and some of the study hypotheses were supported while others were not 
supported.  
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 BACKGROUND VARIABLES AND OUTCOMES 
 
 
Socioeconomic Variables 
 
To help better understand the impact of socioeconomic status on health, this study was designed 
to examine difference in relation to other variables. The importance of examining these variables 
rather than simply controlling for them has been highlighted (Adler et al., 1994). There was also 
a clear relationship between socioeconomic resources (e.g., income and education) and risk-
reducing behaviors in this sample. Not surprisingly, higher income was directly related to higher 
adherence intentions and increased early detection behaviors. This finding is consistent with 
other research suggesting that socioeconomic resources influence the use of health behaviors 
(e.g., mammography; Hedegaard, Davidson, & Wright, 1996;  Lerman et al., 1991; Lerman, 
Daly, Masny, & Balshem, 1994; Rimer et al., 1996).  
A more intriguing finding was the inverse relationships between clinic contact intentions 
and socioeconomic resources. It was expected that more resources would be related to better 
clinic contact intentions, but instead it was found that fewer socioeconomic resources were 
related to greater intention to contact a high-risk clinic. Specifically, lower levels of education 
were directly related to clinic contact intentions and lower income was indirectly related to clinic 
contact intentions through attitudes toward information seeking. Past research investigating 
adoption of individual risk-reducing behaviors such as genetic testing, chemoprevention, and 
risk-reducing surgeries has found little influence of socioeconomic variables on these behaviors. 
This lack of relationship may be due to the methods of recruitment characterizing past studies 
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 (i.e., recruitment in high-risk clinics where women have either been referred by their own 
healthcare professional or have self-referred). One of the aims of this study was to examine the 
influence of socioeconomic variables on risk-reducing behaviors in a group of women recruited 
from the community. These findings are potentially important and have several implications. 
First the relationship between clinic contact intention and income is particularly 
interesting because presumably the same group of women (e.g., those with fewer socioeconomic 
resources) who are reporting fewer intentions to adhere and fewer early detection behavior 
appear to have more positive attitudes about seeking out information than their more advantaged 
counterparts. Women with greater resources may have less positive attitudes about seeking out 
information because they feel as though they already have the information that they need, 
reflected by their higher levels of adherence to recommended behaviors (e.g., early detection 
behaviors). However, women with fewer resources may feel as though they are not as 
knowledgeable about risk-reduction, are more motivated to seek information, and have higher 
intentions to contact a high-risk clinic. In fact, one study found that a primary motivation for 
contacting a high risk clinic was to find out more information about screening options (Julian-
Reynier et al., 1999).  
The relationship between information seeking and resources might be partially explained 
by the condition characterized as the “knowledge gap” which suggests that knowledge about 
health is unequally distributed and people with more socioeconomic resources have more 
information than those with fewer resources (e.g., Viswanath et al., 2006). It is encouraging that 
the results of this study suggest that women with fewer resources are eager for information, 
reflected through not only their attitudes toward information seeking but also their intentions to 
contact a high-risk clinic. These findings highlight the need to decrease the “knowledge gap” by 
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 providing less informed women with information, and suggest that by providing information 
women’s use of risk-reducing behaviors may be increased. 
 
Healthcare Communication 
 
The power and centrality of healthcare communication to reduce cancer risks and incidence is 
being given increasing attention (e.g., Kreps, 2003; Viswanath, 2005; Wallace et al., 2006) and 
its importance in health behaviors such as mammography use, chemoprevention use, and prostate 
screening has been documented (Aiken et al., 1994; Beaulieu, Beland, Foy, & Falardeau, 1996; 
Bober et al., 2004; Rutten et al., 2005). Despite this, to date, communication has received limited 
attention as a cause for disparities in use of health services (i.e., Ashton et al., 2003). The 
importance of communication is highlighted by the study results, with higher levels of healthcare 
communication related to the use of each risk-reducing outcome. Women who reported that they 
had better communication were more likely to report intention to adhere to recommendations and 
higher levels of early detection behaviors. Additionally, healthcare communication indirectly 
affected intentions to contact the high-risk clinic. Women who reported better communication 
had more positive attitudes toward information, and this directly affected clinic contact 
intentions. Also, as one might expect, higher income was related to higher reported levels of 
healthcare communication.  
 Healthcare communication in the context of the current model of risk-reducing behavior 
adds important understanding to current knowledge.  There has been limited work done aimed at 
understanding the role of healthcare communication on the use of risk-reducing behaviors. In this 
study communication was assessed with several items that measured the degree of 
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 communication. In past work, physician’s recommendations for a certain health behavior have 
been assessed and are often highly related to behavior (i.e., Aiken et al., 1994; Guerra, 
Dominguez, & Shea, 2005). However, results of this study suggest that there may be a gradient 
of effect for communication: the more communication one has with their healthcare provider, the 
more likely they are to act.  
Additionally, this study adds to knowledge about communication which has been stymied 
in past work due to recruitment strategies (e.g., women recruited from high-risk clinics and/or 
other healthcare settings). Since women in this study were not recruited into the study based on 
their immediate healthcare activity, the impact of healthcare communication was more purely 
evaluated. The strong results in this study highlight the importance of communication in 
promoting the use of risk-reducing behaviors. Importantly, these results also show that women 
who have higher levels of communication with healthcare professionals are more amenable to 
seeking out information about reducing their risks, which affects risk-reducing behaviors.  
 This study accentuates the importance of healthcare communication and suggests that this 
is a variable that can be used as a mechanism for change in risk-reducing behaviors. The most 
obvious way to increase communication is to target healthcare professional’s interactions with 
women who have a family history of breast cancer. However, interventions with women at 
increased risk may also be effective. Ashton et al. (2003) report the findings of four different 
randomized trials where coaching patients about communicating with their physicians has 
increased their communication behaviors and improved health outcomes. In women who are 
affected by healthcare communication deficits and do not adhere to risk-reducing 
recommendations, interventions with both patients and healthcare professions to increase 
communicate may increase participation in risk-reducing behaviors.  
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Age 
 
Based on past literature, it was expected that age would be directly related to all three outcome 
variables. Suprisingly, there were no direct relationships between age and adherence intentions, 
early detection behaviors, or clinic contact intentions, although two indirect relationships were 
found. Women who were older had more positive attitudes about information seeking, had 
higher adherence intentions, and higher intentions to contact the high risk clinic. It is important 
to note that when investigating bivariate results, age held a strong association with adherence 
intentions (r = .25). However, when controlling for the impact of other variables within the 
model, the importance of attitudes about information seeking within this relationship became 
apparent. This finding suggests that younger women have more reservations about information 
seeking and that this affects their intention for risk-reduction. Understanding why younger 
women are less receptive to seeking out information and in turn have lower intentions for action 
is necessary because many health behaviors that have been suggested as protective against breast 
cancer (e.g., avoiding birth control pills, having children before the age of 35, eating a healthy 
diet, avoiding hormone replacement therapy) are most useful if adopted by younger women and 
may have more benefit the earlier they are introduced. Further, the benefits of chemoprevention 
and risk-reducing oophorectomy are thought to provide the most benefit to younger women (i.e., 
Gail et al., 1999).  
One possible reason for less positive attitudes about information seeking among younger 
women may be the implications of risk-reducing behaviors. Chemoprevention and risk-reducing 
surgeries have harsh consequences, including chemically or surgically induced menopause, 
160 
 changes in childbearing and sexual functioning, and body disfigurement. Women may be less 
knowledgeable about risk-reducing options that are less invasive and have fewer side effects 
(e.g., increased screening routines and genetic testing). In fact, some research has found that 
benefits such as reassurance and decreased levels of distressed are associated with these risk-
reducing options (e.g., Claes et al., 2005; Lim et al., 2004). It is important that women with a 
family history of disease are amenable to recommendations about several health behaviors that 
appear to protect women against breast cancer and to decrease incidence and severity of disease.  
The absence of a relationship between age and early detection behaviors was not 
expected. Past work has indicated that age influences early detection behaviors (Bowen et al., 
2003; Diefenbach et al., 1999; Lerman et al., 2000). Failure to find this relationship may have 
been due to several factors. First, care was taken when designing this study to include women 
across the range of ages that could benefit from risk-reducing behaviors and to create an early 
detection variable that was relevant for all women. Relationships between age and early 
detection in other studies might be based on the outcome measurement and its applicability to 
certain ages. It is encouraging that these results suggest that women of all ages are adhering to 
early detection behaviors as recommended. However, based on the high levels of adherence in 
this study, it should be noted that women who responded to study advertisements may be 
particularly health conscious and adherent to early detection advice. Although other studies have 
found similarly high rates of adherence in community recruited samples (e.g., Lipkus, 
Biradovolu, Fenn, Keller, & Rimer, 2001), it is possible that the absence of a relationship 
between age and early detection may be due to limited variability in early detection behaviors. 
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Objective Risk 
 
It was expected that objective risk would be related to the outcome variables within the model; 
but no direct or indirect relationships were found. Objective risk is clearly an important factor in 
determining the use of risk-reducing behaviors for breast cancer, so it is important to explore 
possible reasons for this lack of relationships. One possible explanation is the restricted range of 
risk in this sample. In general population samples that include women with and without a family 
history of disease, risk is often associated with early detection behaviors (Aiken et al., 1994; 
McCaul et al., 1996). However, women in this study all had a family history of disease, thus 
restricting the range of risk.  
Another possibility for a lack of relationships within the model may be the outcomes 
measured. Early detection behaviors are readily accepted as commonplace for all women and 
particularly for women with a family history of disease. Further, the outcomes of intentions 
(adherence and clinic contact) may be easier to positively endorse, whereas actual behaviors 
might be more influenced by objective risk. Studies of women with family or personal histories 
have found objective risk to be related to risk-reducing behaviors such as genetic testing (Lee et 
al., 2002; Lerman et al., 1997) and risk-reducing surgeries (Hatcher et al., 2001; Schwartz et al., 
2003). These behaviors require more initiative than the outcomes measured within the context of 
the study model. In fact, in the current study, when examining the secondary aim in this study, 
high-risk clinic contact was predicted by objective risk. Taken together with past research, these 
results may suggest that objective risk is less important when examining commonly accepted 
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 behaviors such as early detection, but does affect behaviors that require more initiative such as 
high risk clinic contact, genetic testing, and risk-reducing surgeries.  
Two other possible reasons for null findings should be mentioned. Many of the studies 
that have found links between objective risk and behaviors have been sampled from high-risk 
clinics or other medical settings. It may be that these samples actually do have women at higher 
risk than the present sample, thus accounting for the impact of objective risk on behaviors. Next, 
in this study lifetime risk, as opposed to 5-year risk, was used to test the hypotheses. Lifetime 
risk was chosen as the predictor variable in this study because of the wide range of ages 
included. Other studies have used a more definite time period to examine risk. In fact, when 
examining the bivariate findings in this study there was a positive association between 5-year 
risk and adherence intentions (r = .23). Thus, when evaluating literature it is important to 
consider how objective risk has been operationalized in the study. 
 
  
PROXIMAL VARIABLES 
  
A primary goal of this study was to understand the independent variance that perceived risk, 
cancer specific distress, and attitudes toward risk –reducing behaviors had on the outcome 
variables after accounting for the relationship between the background variables and outcomes. 
Many of the hypothesized relationships between perceived risk and cancer specific distress and 
the outcome variables were not found in this study. However, attitudes toward risk-reducing 
behaviors were a strong direct and indirect predictor of the outcomes. Further, there were several 
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 relationships between the background variables and proximal variables that are important to 
explore.  
 
Perceived Risk 
 
Contrary to expectations, perceived risk was not related to adherence intentions or clinic contact 
intentions, and was only marginally related to early detection behaviors. In the bivariate findings, 
perceived risk was significantly associated with early detection behaviors (r = .15), but within 
the model, although the inclusion of a pathway from perceived risk to early detection made the 
overall model stronger, the direct relationship only approached significance. These findings are 
consistent with recent work in a large population based sample where no relationship was found 
between perceived risk and early detection behaviors (Bowen et al., 2004) and two other studies 
that found that perceived risk was not associated with interest in genetic testing (Braithwaite et 
al., 2002; Cameron and Reeve, 2006). However, despite these findings, the relationship between 
perceived risk and risk-reducing behaviors has been well established (i.e., Bober et al., 2004; 
Hatcher et al., 2001; Schwartz et al., 2003). There are several possibilities for the absence of this 
relationship in the present study. 
A dominant issue in this study was limited variability in early detection behaviors; 
women in this sample were very compliant with recommendations for early detection. It may be 
that greater variability in early detection behaviors would have produced a stronger relationship 
with perceived risk. Similar to objective risk, the recruitment strategies for this study may have 
influenced the relationship between the outcome variables and perceived risk. Many studies that 
investigate risk-reducing behaviors recruit through a high-risk or other medical setting or through 
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 a relative that had cancer (i.e., Schwartz et al., 1995; Isaacs et al., 2002). It is possible that 
women who have initiated contact with a high risk clinic or have a relative recently diagnosed 
with cancer have higher levels of perceived risk than the current community recruited sample 
and that these higher levels of perceived risk are more influential on intentions and behaviors.  
Interestingly, lower perceived risk was related to actual clinic contact. Again, this finding 
is inconsistent with a large body of literature that suggests that higher perceived risk predicts 
risk-reducing behaviors for breast cancer (e.g., McCaul, Branstetter, Schroeder, & Glasgow, 
1996). This finding is interesting and warrants further exploration. Consistent with other studies, 
women in this sample had high levels of perceived risks of developing breast cancer. One 
possible explanation for the finding between low perceived risk and behavior is that women in 
this sample who are contacting the high risk clinic have high enough risk perceptions, although 
relatively low within the sample, to motivate them to action, whereas women with the highest 
levels of perceived risk might be influenced by biased reasoning and avoidance of learning new 
information (e.g., Renner, 2004). Alternatively, Cameron et al. (2006) found that women with 
higher perceived risk were less inclined to believe that genetic testing would have positive 
benefits; a similar mechanism may have been at work in the current study in that women with the 
highest perceived risk did not contact the clinic because they did not believe it would be 
beneficial. These possibilities should be explored in future work. 
Further, risk appraisals are thought to be only weakly associated with an action when the 
effectiveness of the action is unknown (e.g., Cameron et al., 2006). This may help in 
understanding the inverse relationship between perceived risk and clinic contact. Women in this 
study could not know what the effectiveness of contacting the high-risk clinic prior to consulting 
with the clinic, thus possibly affecting the relationship between perceived risk and behavior.  
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 Also, as will be discussed below, cancer distress was positively related to clinic contact. Findings 
that distress was positively related to clinic contact while perceived risk was weakly negatively 
related  to clinic contact are congruent with other findings that suggest that emotional reactions 
(e.g., cancer distress) may promote action even when cognitions (e.g., perceived risk) do not 
support fully support the action (Cameron et al., 2003).  
 
Perceived Risk, Background Variables, and Cancer Specific Distress. As expected, women with 
a higher objective risk had higher perceived risk, and higher perceived risk was related to more 
cancer worry and cancer distress. Further, objective risk was indirectly related to worry through 
its direct relationship with perceived risk. Consistent with other work in community samples, 
lower levels of education were related to higher levels of perceived risk (e.g., Bosompra et al., 
2000; Han, Moser, & Klein, 2006).  
There are several reasons that these relationships are of interest. First, the relationship 
between perceived risk and cancer distress may reflect a personal overestimation of risk that is 
causing distress because the influence of objective risk has been controlled. In short, it may be 
the overestimation of risk that is causing distress and not actual risk. These findings are 
consistent with a recent study that found that family history of disease predicted perceived risk, 
which in turn predicted disease-specific worry (i.e., diabetes, heart disease, colon cancer, and 
breast cancer; DiLorenzo et al., 2006). Understanding the implications of overestimation of risk 
is important because of its impact on distress which has been related to risk-reducing behaviors 
in other studies (Bober et al., 2004; Lerman et al., 1997; Schwartz et al., 2003) and was related to 
high-risk clinic contact intentions and behaviors in this study.  
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 Further, although the perceived risk measure in this study included both absolute risk 
items (e.g., what do you think is your percentage risk of developing breast cancer in the future) 
and comparative risk items (e.g., compared to other women your age what do you believe is the 
likelihood you will develop breast cancer in the future), recent work has suggested that these two 
ways of measuring risk might have differential relationships with worry (Zajac, Klein, & 
McCaul, 2006). In the current study relationships were seen between perceived risk and cancer 
worry and distress, with distress predicting intentions for clinic contact and actual clinic contact. 
However, findings by Zajac et al. suggest that absolute risk is more strongly related to worry 
about breast cancer than comparative risk. This will be important to explore in future work due 
to demonstrated relationships between risk perceptions and cancer distress and worry and also 
between worry and health behaviors. Additionally, given the lack of relationship between 
perceived risk and the risk-reducing outcomes in this study, it would be of interest to examine 
the relationship between absolute risk measures and the study outcomes.  
These findings are also relevant for recent questions about the direction of the 
relationship between perceived risk and worry (e.g., Loescher, 2003). The results of the current 
study are consistent with those of DiLorenzo et al. (2006) and add strength to the suggestion that 
worry is a consequence of perceived risk and not a cause. The findings in the current study 
would suggest that the same relationships hold for perceived risk and distress, although cancer 
worry was more strongly related to perceived risk than was cancer distress (r = .39 vs. r = .19). 
In future work, it will be important to further delineate the relationships between perceived risk 
(e.g., absolute and comparative), cancer worry, cancer distress, and risk-reducing behaviors, 
particularly through the use of longitudinal investigation.   
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 Cancer Distress 
 
Contrary to expectations, cancer worry was not related to any of the measured risk reducing 
outcomes and cancer distress was related only to clinic contact intentions. When examining the 
bivariate results, both cancer worry and cancer distress were related to clinic contact intentions 
with cancer distress demonstrating the stronger relationship (r = .24 vs. r = .17). Within the 
model, when other variance was accounted for, the only relationship that remained was that 
higher levels of distress were related to higher clinic contact intentions. In a study examining the 
use of chemoprevention, Bober et al. (2004) also examined both cancer worry and cancer 
distress. In this study, both higher worry and distress were related to chemoprevention, although 
within their logistic regression equation, distress held the stronger relationship with 
chemoprevention use (p < .0001 vs. p < .03). Cancer worry reflects a measure of concern and 
thought about breast cancer risk; its content reflects less interference than does the cancer 
distress measure. On the other hand, the cancer distress measure (e.g., IES) was designed to 
capture symptoms consistent with post-traumatic stress disorder. These results suggest that 
distress rather than worry is more influential on risk-reducing intentions and behavior. 
 This possibility is further suggested by the results of the secondary aim in this study: 
cancer distress accounted for individual variance in the outcome of clinic contact behavior while 
worry was not related to clinic contact. Given the positive relationship between perceived risk 
and distress in this sample, it is of interest that women with lower perceived risk and higher 
cancer distress appear to be contacting the clinic most often. Perhaps there is an interaction 
between these two variables when examining their influence on high-risk clinic contact. This 
possibility should be explored in future work.  
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 As with other study variables, it is important to note that the absence of relationships 
between cancer specific distress and the outcome variables might be due to the method of 
recruitment in this study. Women in this study may have had lower levels of worry and distress 
than those in other studies. In fact, in a study that examined methods of recruitment, women who 
were recruited through a mass mailing had less worry than women who were self-referred or 
referred from their physician or affected relatives (Andersen et al., 2004).  
Consistent with other research, women who were younger and less educated reported 
more levels of cancer worry (Han et al., 2006). There were divergent relationships between 
education and income and cancer worry and distress. Women with less education reported 
greater cancer worry although no relationship was found between education and adherence 
intentions or early detection behaviors. However, women with less income reported greater 
cancer distress, with lower income being related to fewer adherence intentions and early 
detection behaviors. It may be that women with less economical resources may have less access 
to traditional healthcare where screening behaviors are often initiated. These women have a 
family history of breast cancer may realize their increased risk and know that they are not 
adhering to recommendations for risk-reduction (because of limited access to healthcare) which 
may cause cognitive dissonance thus increasing their levels of distress. These findings suggests 
the importance of considering individual socioeconomic factors when determining the impact of 
these factors on health behaviors.  
In summary, the methods of analyses used in this study are able to reveal some 
distinctions between cancer worry and cancer distress. Taken together with the findings of Bober 
et al., it appears that distress may be more strongly related to risk-reducing behaviors that are less 
common. For instance, although this work did not find a relationship between worry and risk-
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 reducing adherence intentions or early detection behaviors, several other investigators have 
found this relationship. However, in this study, when the variance between worry and distress 
was accounted for, only distress predicted clinic contact intentions. Further, only distress 
predicted high-risk clinic contact, and although Bober et al. (2004) found both worry and distress 
were related to chemoprevention use, the relationship with distress was stronger.  
 
Attitudes Toward Risk-Reducing Behavior 
 
The proximal variables of attitudes toward risk-reducing behaviors were most consistently 
related to the outcome variables. Attitudes toward information seeking was directly related to 
adherence intentions and clinic contact intentions, and attitudes toward worth of prevention and 
surveillance was directly related to all outcomes in this study. Further, the construct of attitudes 
toward information seeking was the conduit for several indirect relationships in the model. Age 
worked through attitudes toward information seeking to indirectly influence both adherence 
intentions and clinic contact intentions. Additionally, healthcare communication indirectly 
influenced clinic contact intentions through its relationship with attitudes toward information 
seeking.  
Attitudes toward risk-reducing behavior have not been widely investigated and are 
measured in different ways in the literature. In this study principal component analyses were 
used to extract factor scores of related items. The first factor used to test the hypothesis in this 
study was an attitudes toward information seeking scale that consisted of questions about 
women’s attitudes about the value and utility of seeking information at a high-risk clinic or of 
risk-reduction overall. These questions were adapted from questions used by Cameron and 
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 Reeve (2006) to assess attitudes toward prophylactic surgery and genetic testing. The second 
factor score was attitudes toward the worth of prevention and surveillance consisted of questions 
regarding women’s attitude about the value of following prevention with questions from the 
ADQ (see Table 7). Two subcomponents of the attitude concept have been suggested: an 
affective component (e.g., enjoyable, not enjoyable) and an instrumental component (e.g., 
beneficial, not beneficial; Ajzen, 2006). Attitudes toward risk-reducing behavior as measured in 
this study are best thought of as an instrumental attitude measurement.  
Overall, women in this study had high levels of positive attitudes about seeking out 
information from a high-risk clinic and positive attitudes about the worth of prevention and 
surveillance recommendations. Further, positive attitudes about risk reduction were related to all 
of the risk-reducing behaviors in this study. This is consistent with findings by Cameron and 
Reeve (2006) who used similar items to measure attitudes and found that attitudes were 
associated with interest in genetic testing. In a study that examined the influence of attitudes 
toward uncertainty investigators found that participants with more negative attitudes about 
uncertainty were much more likely to intend to use genetic testing than those with less negative 
attitudes about uncertainty (Braithwaite et al., 2002). The concept of attitudes toward uncertainty 
overlaps with the concept of attitudes toward information seeking in this study, and findings 
suggest that those who are more motivated to seek out information and understanding are more 
likely to use behaviors that can provide more information about disease status. These results 
suggest that women’s attitude about health behaviors, and more specifically risk-reducing 
behaviors, are important components underlying use of these behaviors. 
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 Attitudes Toward Risk-Reducing Behavior and Other Study Variables.  Due to the consistent 
associations of attitudes toward risk-reducing behavior and the outcomes in this study and others, 
it is important to understand what influences attitudes that women have about risk-reduction. 
First, as discussed above, older age is related to more positive attitudes about risk-reduction and 
it will be important to explore the reasons why younger women have less positive attitudes 
towards risk reduction. Others have also found that younger women have less positive attitudes 
toward risk-reducing surgeries (Cameron & Reeve, 2006; Meiser et al., 1999). Lower income 
was related to more positive attitudes about information seeking, which is consistent with 
Cameron et al. findings that lower income was related to more positive attitudes toward 
prophylactic surgeries. This relationship is important to understand particularly given the 
negative relationships between income and adherence intentions and early detection behaviors. 
Importantly, higher levels of healthcare communication were related to more positive attitudes 
about information seeking. This finding continues to highlight the importance of healthcare 
communication on the use of health behaviors. As mentioned previously, interventions to 
improve communication and affect attitudes could be applied to either healthcare workers or 
women with a family history of breast cancer.  
Somewhat perplexing was the finding that despite the relationship between attitudes 
toward the worth of prevention and surveillance with each outcome variable, none of the 
background variables were related to attitude worth. While there were no relationships between 
background variables and attitudes toward the worth of prevention and surveillance, attitudes 
toward information seeking was the conduit for several indirect relationships in the model. Age 
worked through attitudes toward information seeking to indirectly influence both adherence 
intentions and clinic contact intentions. Additionally, healthcare communication indirectly 
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 influenced clinic contact intentions through its relationship with attitudes toward information 
seeking.  
Finally, it is interesting that in the study by Cameron and Reeve (2006), perceived risk 
and worry were associated with attitudes toward genetic testing. In the present study, bivariate 
analyses showed that attitudes toward information seeking was related to cancer worry, although 
this relationship was not found when using SEM, and no relationship was seen between 
perceived risk and attitudes. One possible reason for this lack of finding is that the current study 
used attitude constructs that asked about high-risk clinic use and the use of prevention and 
surveillance, while Cameron and Reeve were specifically examining attitudes about genetic 
testing and prophylactic surgeries.  
 
Race 
 
Although race was not included as a predictor variable in the model predicting risk-reducing 
intentions and behaviors, the results of the preliminary analyses in this sample provide 
information about differences based on race that should be explored. This is particularly 
important because although as seen in this study, Caucasian women are at a higher objective risk 
for breast cancer, a higher percentage of African American women die as a result of breast 
cancer (Gwyn et al., 2004). African American women reported lower levels of early detection 
behavior, although higher intentions to contact a high-risk clinic at baseline and two- and six-
week following baseline. Other studies have found that African American women with a family 
history of breast or ovarian cancer are less likely to undergo genetic counseling and genetic 
testing than white women with a family history of these diseases (Armstrong, Micco, Carney, 
173 
 Stopfer, & Putt, 2005).  Despite differences in clinic contact intentions, there were no differences 
between African American and white women in contacting the clinic. In addition, black women 
reported less familiarity with prevention, although they reported more positive attitudes about 
prevention strategies than white women. African American women also reported less positive 
attitudes about the utility of prevention and surveillance strategies. It should also be noted, that 
there were differences between education and income by race with white women reporting more 
socioeconomic resources. Future work should examine whether socioeconomic variables or race 
account for more of the variance in these outcomes.  
 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 
The results of this study suggest that both distal background variables and proximal variables are 
important when examining the risk-reducing outcomes of adherence intentions, early detection 
behaviors, and clinic contact intentions. Further, the same results were found when examining 
high-risk clinic contact with both background variables (objective risk) and proximal variables 
(perceived risk, cancer distress) being related to the use of high risk services. These results 
suggest that there is work to be done in promoting risk-reducing behaviors at both a public health 
level (e.g., income affects risk-reducing behaviors) and on an individual level (e.g., attitudes 
affect risk-reducing behaviors).  
There are several areas of future work suggested by this study, many of which have been 
noted throughout the discussion. To our knowledge, this is the first study that examined the use 
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 of high-risk clinic contact in this context. Women in this study had no prior contact with a high-
risk clinic and were simply given written information about a high-risk clinic and followed-up by 
phone. No specific recommendations were made. Within six weeks time, 24% (n = 43) of this 
sample had contacted the high risk clinic. It is possible that this observed percentage may have 
been higher if women were followed up longer because intentions to contact the clinic at the 
final assessment were still high for many women. This suggests that women are willing to seek 
out sources of information if presented with the opportunity. Many women in this study 
indicated that they did not know that resources for women at increased risk existed. This, 
together with the number of women who did contact the clinic, suggests the importance of 
disseminating information about such clinics and/or information related to risk-reduction. It is 
important to note the somewhat disparate findings between clinic contact intentions and actual 
clinic contact behavior. Women with lower education and lower income had higher intentions to 
contact the clinic. However, these variables were not related to actual clinic contact. This 
suggests that women with lower socioeconomic resources, although reporting higher intentions 
for behavior, their intentions are not being realized. This is an important finding to examine in 
future research to better understand the mechanisms behind this disparity.     
Given the consistent relationships between the risk-reducing outcomes and attitudes 
toward risk-reducing behavior in this study and the relative dearth of information available on 
these relationships, one important area of work is improved understanding of attitudes in relation 
to risk-reduction. The construct that this study used to measure attitudes was similar to others 
(e.g., Cameron & Reeve, 2006), yet still unique. However, the strong relationships found 
between attitudes and risk-reducing intentions and behaviors suggest that this construct may be 
central in promoting our understanding. It will be important in future work to strengthen these 
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 findings by replication and also to better understand the relationships between attitudes and 
health behaviors. One way to strengthen this relationship might be to increase healthcare 
communication. Healthcare communication was related to attitudes toward information seeking, 
and as well, healthcare communication was related to risk-reducing behaviors. Healthcare 
communication for risk-reducing behaviors may be improved by intervening directly with 
women at increased risk or with healthcare professionals. Future work should evaluate effective 
ways of implementing such communication systems and also evaluate the efficacy of both 
systems to determine the best way to increase healthcare communication. 
The necessity to continue to understand the relationships between race, socioeconomic 
resources, and risk-reducing behaviors can not be overstated. Women who were African-
American and women with lower socioeconomic resources are reporting lower levels of standard 
care (e.g., mammography, clinical breast exam, breast self exam) and lower levels of healthcare 
communication. Additionally, women with lower resources are reporting higher levels of distress 
than women with more resources. The results of this study suggested that women with fewer 
resources are eager to acquire information, but for a host of possible reasons have not received it. 
Again, implementing and increasing access to healthcare systems that are reliable for all women 
is an important area of future work.  
Future work will need to examine the use of high-risk clinic contact and subsequently 
examine what predicts the adoption of recommendations given through the clinic. As stated 
earlier, the side effects of chemoprevention and prophylactic surgeries are not desirable. As 
others have suggested, it is critical to identify populations with an increased risk of serious 
cancer for which the benefits of risk-reduction outweigh the possible side effects (Lippman & 
Lee, 2006). When women at the highest levels of risk are identified through the high risk clinic, 
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 it will be important to understand what factors influence the utilization of chemoprevention or 
preventative surgeries. Further, it may be beneficial to examine the use genetic testing and 
decisions about treatment in women who have been newly diagnosed with breast cancer. Are 
women with a new diagnosis routinely informed about genetic testing and/or the protective 
benefits of chemoprevention and risk-reducing surgeries? If they were informed, what factors 
would impact treatment decisions? This will be an important question to examine in the future. 
 
   
LIMITATIONS 
 
 
This study has several limitations. Perhaps the most significant limitation in this study is the 
limited variability found in early detection behaviors. It is not likely that all women with a family 
history of breast cancer are following recommendations for early detection as closely as those in 
this study. Although efforts were made to recruit in a diverse way throughout the community, 
there was likely a bias toward risk-reducing behaviors in the women who responded to study 
advertisements. Other recent work in community samples has also reported high levels of 
adherence to early detection behavior (Lipkus, Green, & Marcus, 2003). To adequately 
understand what variables are most predictive of early detection behaviors it will be necessary to 
sample women who are less adherent to recommendations than this sample. Additionally, 
although there is a wide range of income represented in this study, this is a sample of well-
educated women with a large percentage of women in this sample having at least completed 
college and many having completed post-graduate work. These sample biases also suggest that 
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 results of this study must be interpreted cautiously and may not be applicable to the general 
population.  
Another limitation is the cross-sectional nature of the data for the main study hypotheses. 
Causal relationships can not be definitively discerned from the data used. A current project is 
underway to investigate these study variables over time and to better understand the impact of 
this project on behavior over time. It should also be noted that the original hypothesized 
structural equation model was not a good fit to the data; the model had to be respecified to test 
the hypotheses with SEM. Although it is not uncommon that hypothesized SEM models need to 
be respecified and it has been done in other research examining intentions for cancer screening 
(i.e., Manne et al., 2003), respecified models are based on post-hoc examination of the data. This 
suggests a strong need for findings to be replicated with future work.  
 
 
 
 
 
 
 
178 
  
 
BIBLIOGRAPHY 
 
Adams, E. K., Florence, C. S., Thorpe, K. E., Becker, E. R., & Joski, P. J. (2003). Preventive 
care: Female cancer screening, 1996-2000. American Journal of Preventative Medicine, 
25, 301-307. 
 
Adler, N.E., Boyce, T., Chesney, M.A., Cohen, S., Folkman, S., Kahn, R.L. et al. (1994). 
Socioeconomic status and health. American Psychologist, 49, 15-24. 
 
Aiken, L.S., West, S.G., Woodward, C.K., 7 Reno, R.R. (1994). Health beliefs and compliance 
with mammography-screening recommendations in asymptomatic women. Health 
Psychology, 13, 122-129. 
 
Ajzen, I. (1991). The theory of planned behavior. Organizational behavior and human decision 
processes, 50, 179-211. 
 
Ajzen, I. (2006). Constructing a TpB questionnaire: Conceptual and methodological 
considerations. http://www-unix.oit.umass.edu/~aizen/ [Retrieved July 4, 2006]. 
  
Akaike, H. (1987). Factor analysis and AIC. Psychometrika, 52, 317-332. 
 
American Cancer Society (2004). Breast Cancer Facts and Figures. Atlanta: American Cancer 
Society. 
 
Andersen, M.R., Peacock, S., Nelson, J., Wilson, S., McIntosh, M., Drescher, C., et al. (2002). 
Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for 
ovarian cancer. Gynecologic Oncology, 85, 3-8. 
 
Andersen, M.R., Nelson, J., Peacock, S., Giedzinska, A., Dresher, C., Bowen, D., & Urban N. 
(2004). Worry about ovarian cancer risk and use of screening by high-risk women: How 
you recruit affects what you find. American Journal of medical Genetics, 129A, 130-135. 
 
Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the 
use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. 
Journal of the American Medical Association, 293, 1729-1736. 
 
Ashton, C., Haidet, P., Paterniti, D.A., Collins, T.C., Gordon, H., O’Malley, K. et al. (2003). 
Racial and ethnic disparities in the use of healthcare services. Journal of General Internal 
Medicine, 18, 146-152. 
 
179 
 Baron, R. M. & Kenny, D. A. (1986). The moderator-mediator variable distinction in social 
psychological research: Conceptual, strategic, and statistical considerations. Journal of 
Personality and Social Psychology, 51, 1173-1182. 
 
Bastani, R., Marcus, A.C., & Hollatz-Brown, A. (1991). Screening mammography rates and 
carriers to use: a Los Angeles County survey. Preventive Medicine, 20, 350-363. 
 
Beaulieu, M.D., Beland, F., Foy, D., & Falardeau, M. (1996). Factors determining compliance 
with mammography screening. Canadian Medical Association Journal, 154, 1335-1343. 
 
Bentler, P.M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107, 
238-246. 
 
Bober, S.L., Hoke, L.A., Duda, R.B., Regan, M.M., & Tung, N.M. (2004). Decision-making 
about tamoxifen in women at high risk for breast cancer: Clinical and psychological 
factors. Journal of Clinical Oncology, 22, 4951-4957. 
 
Bosompra, K., Flynn, B.S., Ashikaga, T., Rairikar, C.J., Worden, J.K., & Solomon, L.J. (2000). 
Likelihood of undergoing genetic testing for cancer risk: A population-based study. 
Preventive Medicine, 30, 155-166. 
 
Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D. et al. (2003). 
Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in 
women 2 years post testing. American Journal of Medical Genetics, 118A, 201-209. 
 
Bowen, D. J., Alfano, C. M., McGregor, B. A., Anderson, M. R. (2004). The relationship 
between perceived risk, affect, and health behaviors. Cancer Detection and Prevention, 
28, 409-417. 
 
Bowen, D. J., Helms, A., Powers, D., Andersen, R., Burke, W., McTiernan, A. et al. (2003). 
Predicting breast cancer screening intentions and behavior with emotion and cognition. 
Journal of Social and Clinical Psychology, 22, 213-232. 
 
Bozdogan, H. (1987). Model selection and Akaike’s information criterion (AIC): The general 
theory and its analytical extensions. Psychometrika, 52, 345-370.  
 
Braithwaite, D., Sutton, S., & Steggles, N. (2002). Intention to participate in predictive genetic 
testing for hereditary cancer: The role of attitude toward uncertainty. Psychology and 
Health, 17, 761-772. 
 
Breen, N., Wagener, D. K., Brown, M. L., Davis, W. W., & Ballard-Barbash, R. (2001). Progress 
in cancer screening over a decade: result sof cancer screening from 1987, 1992, and 1998 
national health interview surveys. Journal of the National Cancer Institute, 93, 1704-13. 
 
180 
 Bunn, J.Y., Bosompra, K., Ashikaga, T., Flynn, B.S., & Worden, J.K. (2002). Factors 
influencing intention to obtain a genetic test for colon cancer risk: A population-based 
study. Preventive Medicine, 34, 567-577. 
 
Burke, W., Daly, M. Garber, J., Botkin, J., Kahn, M.J., Lynch, P. et al. (1997). 
Recommendations for follow-up care of individuals with an inherited predisposition to 
cancer. BRCA1 and BRCA2. Journal of the American Medical Association, 277, 997-
1003. 
 
Burnett, C., Steakley, C. S., Slack, R., Roth, J., & Lerman, C. (1999). Patterns of breast cancer 
screening among lesbians at increased risk for breast cancer. Women and Health, 29, 35-
55. 
 
Butow, P., Meiser, B., Price, M., Bennett, B., Tucker, K., Davenport, T., et al. (2005). 
Psychological morbidity in women at increased risk of developing breast cancer: A 
controlled study. Psycho-Oncology, 14, 196-203. 
 
Cameron, L.D. (2003). Anxiety, cognition, and responses to health threats. In L.D. Cameron & 
H. Leventhal (Eds.). The self-regulation of health and illness behavior. (pp. 157-183). 
New York, NY: Routledge. 
 
Cameron, L.D., & Reeve, J. (2006). Risk perceptions, worry, and attitudes about genetic testing 
for breast cancer susceptibility. Psychology and Health, 21, 211-230. 
 
Cappelli, M., Surh, L., Walker, M., Korneluk, Y., Humphreys, L., Verma, S. et al. (2001). 
Psychological and social predictors of decisions about genetic testing for breast cancer in 
high risk women. Psychology, Health, and Medicine, 6, 321-333. 
 
Cauley, J.A., Norton, L., Lippman, M.E., Eckert, S., Krueger, K.A., Purdie, D.W. et al. (2001). 
Continued brest cancer risk reductin in postmenopausal women treated with raloxifene: 4-
year results from the MORE trial. Multiple outcomes of raloxifen evaluation. Breast 
Cancer Research and Treatment, 65, 125-134. 
 
Chaffee, S.H., & Roser, C. (1986). Involvement and the consistency of knowledge, attitudes, and 
behaviors. Communication Research, 23, 373-399. 
 
Chou, C. P. & Bentler, P.M. (1990). Model modification in covariance structure modeling: A 
comparison among likelihood ratio, Language Multiplier, and Wald tests. Multivariate 
Behavior Research, 25, 115-136. 
 
Claes, E., Evers-Kiebooms, G., Denayer, L., Decruyenaere, M., Boogaerts, A., Philippe, K., & 
Legius, E. (2005). Predictive genetic testing for hereditary breast and ovarian cancer: 
psychological distress and illness representations 1 year following disclosure. Journal of 
Genetic Counseling, 14, 349-363.  
 
181 
 Clark, M.A., Rakowski, W., & Bonacore, L.B. (2003). Repeat mammography: Prevalence 
estimates and considerations for assessment. Annals of Behavioral Medicine, 26, 201-211.  
 
Claus, E.B., Schildkraut, J.M., Thompson, W.D., & Risch, N.J. (1996). The genetic attributable 
risk of breast and ovarian cancer. Cancer, 77, 2318-2324. 
 
Clemons, M. & Goss, P. (2001). Estrogen and the risk of breast cancer. New England Journal of 
Medicine, 344, 276-285. 
 
Collins, V., Halliday, J., Warren, R., & Williamson, R. (2000). Cancer worries, risk perceptions 
and associations with interest in DNA testing and clinic satisfication in a familial 
colorectal cancer clinic. Clinical Genetics, 58, 460-468. 
 
Coyne, C. J., Benazon, N. R., Gaba, C. G., Calzone, K., & Weber, B. L. (2000). Distress and 
psychiatric morbidity among women from high risk breast and ovarian cancer families. 
Journal of Consulting and Clinical Psychology, 68, 864-874. 
 
Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer 
susceptibility. Journal of the National Cancer Institute Monographs, No. 25, 59-66. 
 
Curran, P.J., West, S.G., & Finch, J.F. (1996). The robustness of test statistics to nonnormality 
and specification error in confirmatory analysis. Psychological Methods, 1, 16-29.  
 
Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S. et al. (2003). Overview 
of the main outcomes in breast-cancer prevention trials. Lancet, 361, 296-300. 
 
Dennerstein, L., Burrows, G.D., Wood, C., & Poynton, C. (1977). The development of a scale 
for the assessment of sexual behaviour in Australian women. Australian and New Zealand 
Journal of Psychiatry, 11, 233-240. 
 
DiLorenzo, T.A., Schnur, J., Montgomery, G.H., Erblich, J., Winkel, G., & Bovbjerg, D.H. 
(2006). A model of disease-specific worry in heritable disease: the influence of family 
history, perceived risk, and worry about other illnesses. Journal of Behavioral Medicine, 
29, 37-29. 
 
DiMatteo, M.R., Hays, R.D., Gritz, E.R., Bastani, R., Crane, L., Elashoff, R., Ganz, P., Heber, 
D., McCarthy, W., & Marcus, A. (1993). Patient adherence to cancer control regimens: 
Scale development and initial validation. Psychological Assessment, 5, 102-112. 
 
Diefenbach, M.A., Miller, S.M., & Daly, M.B. (1999). Specific worry about breast cancer 
predicts mammography use in women at risk for breast and ovarian cancer. Health 
Psychology, 18, 532-536. 
 
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993). Genetic linkage analysis in 
familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage 
Consortium. American Journal of Human Genetics, 52, 678-701. 
182 
  
Eisen, A., Rebbeck, T.R., Wood, W.C., & Weber, B. L. (2000). Prophylactic surgery in women 
with a hereditary predisposition to breast and ovarian cancer. Journal of Clinical 
Oncology, 18, 1980-1995. 
 
Erblich, J., Bovbjerg, D.H., & Valdimarsdottir, H.B. (2000). Psychological distress, health 
beliefs, and frequency of breast self-examination. Journal of Behavioral Medicine, 23, 
277-292. 
 
Euhus, D.M., Leitch, M., Huth, J.F., & Peters, G.N. (2002). Limitations of the Gail model in the 
specialized breast cancer risk assessment clinic. The Breast Journal, 8, 23-27. 
 
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Delvilee, P., et al. (1998). Genetic 
heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer 
families. The Breast Cancer Linkage Consortium. American Journal of Human Genetics, 
62, 676-689. 
 
Foster, R.S. & Costanza, M.C. (1984). Breast self-examination practices and breast cancer 
survival. Cancer, 53, 999-1005. 
 
Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., Green, S.B., Schairer, C et al. (1989). 
Projecting individualized probabilities of developing breast cancer for white females who 
are examined annually. Journal of the National Cancer Institute, 81, 1879-1886. 
 
Garofalo, J.P. & Baum, A. (2003). Psychosocial implications of prophylactic surgical 
intervention for ovarian cancer. Current Opinion in Psychiatry,16, 207-213. 
 
Gerend, M., Aiken, L.S., & West, S.G. (2004). Personality factors in older women’s perceived 
susceptibility to disease of aging. Journal of Personality, 72, 243-270. 
 
Green, J.S., Grant, M., Hill, K.L., Brizzolara, J., & Belmont, B. (2003). Heart disease risk 
perception in college men and women. Journal of American College Health, 51, 207-211. 
 
Guerra, C.E., Dominguez, F., & Shea, J.A. (2005). Literacy and knowledge, attitudes, and 
behavior about colorectal cancer screening. Journal of Health Communication, 10, 651-
663. 
 
Gurevich, M., Devins, G.M., Wilson, C., McCready, D., Marmar. C.R., & Rodin, G.M. (2004). 
Stress response syndromes in women undergoing mammography: a comparison of 
women with and without a history of breast cancer. Psychosomatic Medicine, 66, 104-12. 
 
Gwyn, K., Bondy, M.L., Cohen, D.S., Lund, M.J., Liff, J.M., Flagg, E.W., et al. (2004). Racial 
differences in diagnosis, treatment, and clinical delays in a population-based study of 
patients with newly diagnosed breast carcinoma. Cancer, 100, 1549-1769. 
 
183 
 Haber, D. (2002). Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in 
carriers of BRCA mutations. The New England Journal of Medicine, 21, 1660-1662. 
 
Hailey, B.J. (1991). Family history of breast cancer and screening behavior: An inverted U-
shaped curve? Medical Hypotheses, 36, 397-402. 
 
Han, P. K., Moser, R. P., & Klein, W. M. (2006). Perceived ambiguity about cancer prevention 
recommendations: Relationship to perceptions of cancer preventability, risk, and worry. 
Journal of Health Communication, 11, 51-69. 
 
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L. Sitta, D. L. et al. 
(2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene 
mutation carriers, Journal of the National Cancer Institutes, 93, 1633-1637. 
 
Hartmann, L.C., Schaid, D.J., Woods, J.E., Crotty, T.P., Meyers, J.L., Arnold, P.G. et al. (1999). 
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast 
cancer. The New England Journal of Medicine, 340, 77-84. 
 
Hatcher, M. B., Fallowfield, L., & A’Hern, R. (2001). The psychosocial imipact of bilaterial 
prophylactic mastectomy: Prospective study using questionnaires and semistructured 
interviews. BMJ, 322, 1-6. 
 
Helzlsouer, K.J. (1999). Bad news/good news: Information about breast cancer risk following 
prophylactic oophorectomy. Journal of the National Cancer Institutes, 91, 1442-1443. 
 
Hedegaard, H.B., Davidson, A.J., & Wright, R.A. (1996). Factors associated with screening 
mammography in low-income women. American Journal of Preventive Medicine, 12, 51-
56. 
 
Horowitz, M.J., Wilner, N., & Alvarez, W. (1979). Impact of Event Scale: A measure of 
subjective stress. Psychosomatic Medicine, 41, 209-218. 
 
Hu, L., & Bentler, P.M. (1998). Fit indices in covariance structure modeling: Sensitivity to 
underparameterized model misspecification. Psychological Methods, 3, 424-453. 
 
Hyman, R., Baker, S., Ephraim, R., Moadel, A., & Phillip, J. (1994). Health belief model 
variables as predictors of screening mammography utilization. Journal of Behavioral 
Medicine, 17, 391-406. 
 
Isaacs, C., Peshkin, B. N., Schwartz, M., DeMarco, T. A., Main, D., & Lerman, C. (2002). Breast 
and ovarian cancer screening practices in healthy women with a strong family history of 
breast or ovarian cancer. Breast Cancer Research and Treatment, 71, 103-112. 
 
Jacobsen, P. B., Valdimarsdottir, H.B., Brown, K.L., & Offit, K. (1997). Decision making about 
genetic testing among women at familial risk for breast cancer. Psychosomatic Medicine, 
59, 459-466. 
184 
  
Jose, P.E. (2004). Moderation/Mediation Help Centre. http://www.vuw.ac.nz/psyc/staff/paul-
jose/files/helpcentre/help1_intro.php. 
 
Julian-Reynier, C., Bouchard, L., Evans, D., Eisinger, F.A., Foulkes, W.D., Kerr, B. et al. 
(2001). Women’s attitudes toward preventative strategies for hereditary breast or ovarian 
carcinoma differ from one country to another. Cancer, 92, 959-000. 
 
Julian-Reynier, C., Eisinger, F., Chabal, F., Aurran, Y., Bignon, Y., Machelard-Roumagnac, M., 
et al. (1999). Cancer genetic consultation and anxiety in healthy consultees.Psychology & 
Health, 14, 379-390. 
 
Kash, K.M., Holland, J.C., Halper, M.S., & Miller, D.G. (1992). Psychological distress and 
surveillance behaviors of women with a family history of breast cancer. Journal of the 
National Cancer Institute, 84, 24-30. 
 
Kash, K. M., Holland, J. C., Osborne, M. P., & Miller, D. G. (1995). Psychological counseling 
strategies for women at risk for breast cancer. Journal of the National Cancer Institute 
Monographs, No. 17, 73-79. 
 
Katapodi, M.C., Lee, K.A., Facione, N.C., & Dodd, M.J. (2004). Predictors of perceived breast 
cancer risk and breast cancer screening: a meta-analytic review. Preventive Medicine, 38, 
388-402. 
 
Kelly, K., Leventhal, H., Andrykowski, M., Toppmeyer, D., Much, J., Dermody, J. et al. (2004). 
The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 
mutaitons. Journal of Genetic Counseling, 13, 237-257. 
 
King, E.S., Rimer, B.K., Trock, B., Balshem, A., & Engstrom, P. (1990). How valid are 
mammography self-reports? American Journal of Public Health, 80, 1386-1388. 
 
Kinney, A. Y., Croyle, R. T., Dudley, W. N., Bailey, C. A., Pelias, M. K., & Neuhausen, S. L. 
(2001). Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: A survey 
of a large African-American kindred with a  BRCA1  mutation. Preventive Medicine: An 
International Journal Devoted to Practice and Theory, 33, 543-551. 
 
Kinney, A., Richards, C., Vernon, S.W., & Vogel, V.G. (1998). The effect of physician 
recommendation on enrollment in the Breast Cancer Chemoprevention Trial. Preventive 
Medicine, 27, 713-719. 
 
Komenaka, I. K., Ditkoff, B., Joseph, K., Russo, D., Gorroochurn, D., Ward, M. et al. (2004). 
The development of interval breast malignancies in patients with BRCA mutations. 
Cancer, 100, 2079-2083. 
 
Kreps, G. (2003). The impact of communication on cancer risk, incidence, morbidity, mortality, 
and quality of life. Health Communication, 15, 161-169. 
185 
  
Lebo, M.A. & Nesselroade, J.R. (1978). Intraindivdual differences dimensions of mood change 
during pregnancy identified in five P-technique factor analyses. Journal of Research in 
Personality, 12, 205-224. 
 
Lee, S. C., Bernhardt, B. A., & Helzlsouer, K. J. (2002). Utilization of BRCA1/2 genetic testing 
in the clinical setting: report from a single institution. Cancer, 94, 1876-1885. 
 
Lerman, C., Daly, M., Masney, A., & Balshem, A. (1994). Attitudes about genetic testing for 
breast-ovarian cancer susceptibility. Journal of Clinical Oncology, 12, 843-850. 
 
Lerman, C., Daly, M., Sands, C., Balshem, A., Lustbader, E., Heggan, T., et al. (1993). 
Mammography adherence and psychological distress among women at risk for breast 
cancer. Jounral of the National Cancer Institute, 85, 1074-1080. 
 
Lerman, C., Hughes, C., Croyle, R.T., Main, D., Durham, C., Snyder, C. et al. (2000). 
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 
testing. Preventative Medicine, 31, 75-80. 
 
Lerman, C., Kash, K., & Stefanek, M. (1994). Younger women at increased risk for breast 
cancer: perceived risk, psychological well-being, and surveillance behavior. Monographs 
of the National Caner Institute, 16, 171-116. 
 
 
Lerman, C., Narod, S., Schluman, K., Hughes, C., Gomez-Caminero, A., Bonney, G. et al. 
(1996). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective 
study of patient decision making and outcomes. Journal of the American Medical 
Association, 275, 1885-1892. 
 
Lerman, C., Schwartz, M. D., Lin, T. H., Hughes, C., Narod, S., & Lynch, H. T. (1997). The 
influence of psychological distress on use of genetic testing for cancer risk. Journal of 
Consulting and Clinical Psychology, 65, 414-420. 
 
Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological 
side effects of breast cancer screening. Health Psychology, 10, 259-267.  
 
Lim, J., Macluran, M., Price, M., Bennett, B., Butow, B., & the kConFab Psychosocial Group 
(2004). Short- and long-term impact of receiving genetic mutation results in women at 
increased risk for hereditary breast cancer. Journal of Genetic Counseling, 13, 115-122. 
 
Lipkus, I.M., Biradavolu, M., Fenn, K., Keller, P., & Rimer, B.K. (2001). Informing women 
about their breast cancer risks: Truth and consequences. Health Communication, 13, 205-
226. 
 
186 
 Lipkus, I.M., Green, L.G., & Marcus, A. (2003). Manipulating perceptions of colorectal cancer 
threat: Implications for screening intentions and behaviors. Journal of Health 
Communication, 8, 213-228. 
 
Lippman, S.M. & Lee, J.J. (2006). Reducing the “risk” of chemoprevention: Defining and 
targeting high risk – 2005 AACR Cancer Research and Prevention Foundation Award 
Lecture. Cancer Research, 66, 2893-2903. 
 
Lodder, L,. Frets, P.G., Trijsburg, R.W., Klign, J.G., Seynaeve, C., Tilanus, M.M. et al. (2003). 
Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation 
who decline genetic testing. American Journal of Medical Genetics, 119A, 266-272. 
 
Loescher, L. (2003). Cancer worry in women with hereditary risk factors for breast cancer. 
Oncology Nursing Forum, 30, 767-772. 
 
Lovegrove, E., Rumsey, N., Harcourt, D., & Cawthorn, S.J. (2000). Factors implicated in the 
decision whether or not to join the tamoxifen trial in women at high familial risk of breast 
cancer. Psychooncology, 9, 193-202. 
 
Lowe, R., Bennett, P., Walker, I., Milne, S., & Bozionelos, G. (2003). A connectionist 
implementation of the theory of planned behavior: Association of beliefs with exercise 
intention. Health Psychology, 22, 464-470. 
 
Manne, S., Markowitz, A., Winawer, S., Guillem, J., Meropool, N.J., Haller, D., et al. (2003). 
Understanding intention to undergo colonoscopy among intermediate-risk siblings of 
colorectal cancer patients: a test of a mediational model. Preventive Medicine, 36, 71-84.  
 
McCaul, K.D., Branstetter, A.D., O’Donnell, S.M., Jacobson, K., & Quinlan, K.B. (1998). A 
descriptive study of breast cancer worry. Journal of Behavioral Medicine, 21, 565-579. 
 
McCaul, K.D., Branstetter, A. D., Schroeder, D. M., & Glasgow, R. E. (1996). What is the 
relationship between breast cancer risk and mammography screening? A meta-analytic 
review. Health Psychology, 15, 423-429. 
 
McCaul, K.D. & Mullens, A.B. (2003). Affect, thought, and self-protective health behavior: The 
case of worry and cancer screening. In J. Suls & K.A. Wallston (Eds.), Social 
psychological foundations of health and illness (pp. 137-168). Malden, MA: Blackwell. 
 
McCaul, K.D., Reid, P.A., Rathge, R.W., & Martinson, B. (1996). Does concern about breast 
cancer inhibit or promote breast cancer screening? Basic and Applied Social Psychology, 
18,183-194. 
 
McCaul, K.D., Sandgren, A.K., O’Neill, H.K., and Hinsz, V.B. (1993). The value of the theory 
of planned behavior, perceived control, and self-efficacy for predicting health-protective 
behaviors. Basic and Applied Social Psychology, 14, 231-252. 
 
187 
 McCaul, K.D., Schroeder, D.M., & Reid, P.A. (1996). Breast cancer worry and screening: Some 
perspective data. Health Psychology, 15, 430-433. 
 
McGregor, B.A., Bowen, D.J., Ankerst, D.P., Andersen, R., Yasui, Y., & McTiernan, A. (2004). 
Optimism, perceived risk of breast cancer, and cancer worry among a community based 
sample of women. Health Psychology, 23, 339-344. 
 
Meijers-Heijboer, H., van Geel B, van Putten, W.L., Henzen-Logmans, S. C., Seynaeve, C., 
Menke-Pluymers, M. B. et al. (2001). Breast cancer after prophylactic bilateral 
mastectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of 
Medicine, 345, 159-164. 
 
Meijers-Heijboer, E.J., Verhoog, L.C., Brekelmans, C.T.M., Seynaeve, C., Tilanus-Linthorst, 
M.M.A., Wagner, A., et al. (2000). Presymptomatic DNA testing and propohylactic 
surgery in families with a BRCA1 or BRCA2 mutation. Lancet, 355, 2015-2020. 
 
Meiser, B., Butow, P., Barratt, A., Gattas, M, Gaff, C., Haan, E. et al. (2001). Risk perceptions 
and knowledge of breast cancer genetics in women at increased risk of developing 
hereditary breast cancer. Psychology and Health, 16, 297-311. 
 
Meiser, B., Butow, P., Barratt, A. Friedlander, M., Gattas, M., Kirk, J. et al. (1999). Attitudes to 
proohylactic oophorectomy and screening utilization in women at incrased risk of 
developing hereditary breast/ovarian cancer. Gynecological  Oncology, 75, 122-129. 
 
 
Meiser, B., Butow, P., Friedlander, M., Schnieden, V., Gattas, M., Kirk, J. et al. (2000). Intention 
to undergo prophylactic bilateral mastectomy in women at increased risk of developing 
hereditary breast cancer. Journal of Clinical Oncology, 18, 2250-2257. 
 
Meiser, B., Butow, P., Price, M., Bennett, B., Berry, G., Tucker, K., et al. (2003). Attitudes to 
prophylactic surgery and chemoprevention in Australian women at increased risk for 
breast cancer. Journal of Women’s Health, 12, 769-778. 
 
Meiser, B. & Halliday, J.L. (2002). What is the impact of genetic counseling in women at 
increased risk of developing hereditary breast cancer? A meta-analytic review. Social 
Science & Medicine, 54, 1463-1470. 
 
Meissner, H. I., Breen, N., & Yabroff, R. (2003). Whatever happened to clinical breast 
examinations? American Journal of Preventive Medicine, 25, 259-263. 
 
Miki, Y., Swenson, J., Shattuck-Evans, D., Futreal, P.A., Harshman, K., Tavtigian, S., et al. 
(1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. 
Science, 266, 66-71. 
 
Morrison, L. (1994). Management of breast cancer. Self-referral service is unique. British 
Medical Journal, 308, 716. 
188 
  
Nathorst-Boos, J., von Schoultz, B., & Carlstrom, K. (1993). Elective ovarian removal and 
estrogen replacement therapy—effects on sexual life, psychological well-being and 
androgen status. Journal of Pscyhosomatics Obstetrics and Gynaecology, 14, 283-293.
 
Newman, B., Austin, M. A., Lee, M., & King, M. C. (1988). Inheritance of human breast cancer: 
evidence for autosomal dominant transmission in high risk families. Proceedings of the 
National Academy of Science U.S.A., 85, 3044-3048. 
 
Nkondjock, A., & Ghardirian, P. (2004). Epidemiology of breast cancer among BRCA mutation 
carriers: an overview. Cancer Letters, 205, 1-8. 
 
Norman, P., Conner, M., & Bell, R. (1999). The theory of planned behavior and smoking 
cessation. Health Psychology, 18, 89-94. 
 
Pakenham, K.I., Pruss, M., & Clutton, S. (2000). The utility of socio-demographics, knowledge, 
and health belief model variables in predicting reattendance for mammography screening: 
A brief report. Psychology and Health, 15, 585-591. 
 
Peto, R., Boreham, J., Clarke, M., Davies, C. & Beral, V. (2000). UK and USA breast cancer 
deaths down 25% in year 2000 at ages 20-69. Lancet, 355, 1822. 
 
Preacher, K.J., & Hayes, A.F. (2004). SPSS and SAS procedures of estimating indirect effects in 
simple mediation models. Behavior Research Methods, Instruments, & Computers, 36, 
717-731.  
 
Rebbeck, T. R. (2000). Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. 
Journal of Clinical Oncology, 18, 100S-103S. 
 
Rebbeck, T.R., Eisen, B.L., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L, et al. (1999). 
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. 
Journal of the National Cancer Institute, 91, 1475-1479. 
 
Rebbeck, T.R., Friebel, T., Lynch, H.T., Neuhausen, S.L., van’t Veer, L., Garber, J.E., et al. 
(2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and 
BRCA2 mutation carriers: The PROSE study group. Journal of Clinical Oncology, 22, 
1055-1062. 
 
Rebbeck, T. R., Lynch, S. L., Neuhausen, S. A., Narod, L., Van’t Veer, J.E., Garber et al. (2002). 
Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. New England 
Journal of Medicine, 346, 1616-1622. 
 
Renner, B. (2004). Biased reasoning: Adaptive response to health risk feedback. Personality and 
Social Psychology Bulletin, 30, 384-396. 
 
189 
 Rimer, B.K., Conaway, M.R., Lyna, P.R., Rakowski, W., et al. (1996). Cancer screening 
practices among women in a community health center population. American Journal of 
Preventive Medicine, 12, 351-357. 
 
Rimer, R.N. & Real, K. (2003). Perceived risk and efficacy beliefs as motivators of change use 
of the risk perception attitude framework to understand health behaviors. Human 
Communication Research, 29, 370-399. 
 
Rogers, R. W. (1983). Cognitive and physiological processes in fear appeals and attitude change: 
A revised theory of protection motivation. In J. T. Cacioppo & R.E. (Eds.), Social 
psychophysiology: A sourcebook (pp. 153-176). New York: Guilford Press. 
 
Rosenstock, I.M. (1990). The health belief model: Explaining health behavior through 
expectancies. In K. Glanz, F.M. Lewis, & B.K. Rimer (Eds.), Health behavior and health 
education (pp. 39-62). San Francisco: Jossey-Bass. 
 
Rothemund, Y., Paepke, S., & Flor, H. (2001). Perception of risk, anxiety, and health behaviors 
in women at high risk for breast cancer. International Journal of Behavioral Medicine, 8, 
230-239. 
 
Rutten, L.J.F., Meissner, H.I., Breen, N., Vernon, S.W., & Rimer, B. (2005). Factors associated 
with men’s use of prostate-specific antigen screening: Evidence from Health 
Informational National Trends Survey. Preventive Medicine, 40, 461-468. 
 
Sabatino, S.A., Burns, R.B., Davis, R.B., Phillips, R.S., Chen, Y., & McCarthy, E.P. (2004). 
Breast carcinoma screening and risk perception among women at increased risk for breast 
carcinoma. Cancer, 100, 2338-2346. 
 
Satorra, A., & Bentler, P. M. (2001). A scaled difference chi-square test 
statistic for moment structure analysis. Psychometrika, 66(4), 507-514. 
 
Satorra, A. & Bentler, P.M. (1994). Corrections to test statistics and standard errors in covariance 
structure analysis. In A. von Eye & C.C. Clogg (Eds.). Latent variables analysis: 
Applications for developmental research (pp. 399-419). Thousands Oaks, CA: Sage 
Publications, Inc.  
 
Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J. et al. (2002). Outcome 
of preventive surgery and screening for breast and ovarian cancer in BRCA mutation 
carriers. Journal of Clinical Oncology, 20, 1260-1268. 
 
Schwartz, M.D., Kaufman, E., Peshkin, B.N., Isaacs, C., Hughes, C., DeMarco, T. et al. (2003). 
Bilateral prophylactic oophorectomy and ovarian cancer screening following 
BRCA1/BRCA2 mutation testing. Journal of Clinical Oncology, 21, 4034-4041. 
 
190 
 Schwartz, M.D., Lerman, C., Miller, S.M., Daly, M., & Masny, A. (1995). Coping disposition, 
perceived risk, and psychological distress among women at increased risk for ovarian 
cancer. Health Psychology, 14, 232-235. 
 
Schwartz, M.D., Taylor, K.L., & Willard, K. (2003). Prospective association of distress and 
mammography among women with a family history of breast cancer. Journal of 
Behavioral Medicine, 26, 105-117.  
 
Schwartz, M.C, Taylor, K.L., Willard, K.S., Siegel, J.E., Lamdan, R.M., & Moran, K. (1999). 
Distress, personality, and mammography utilization among women with a family history 
of breast cancer. Health Psychology, 18, 327-332. 
 
Simon, A., Steptoe, A., & Wardle, J. (2005). Socioeconomic status differences in coping with a 
stressful medical procedure. Psychosomatic Medicine, 67, 270-276. 
 
Smith, B.N. & Stasson, M.F. (2000). A comparison of health behavior constructs: Social 
psychological predictors of AIDS-preventive behavioral intentions. Journal of Applied 
Social Psychology, 30, 443-462. 
 
Sobel, M.E. (1982). Asymptotic confidence intervals for indirect effects in structural equation 
models. In S. Leinhart (Ed.), Sociological methodology 1982 (pp. 290-312). San 
Francisco: Jossey-Bass. 
 
Stefanek, M., Hartmann, L., & Nelson, W. (2001). Risk reduction mastectomy: Clinical issues 
and research needs. Journal of the National Cancer Institute, 93, 1297-1306. 
 
Steiger, J.H. & Lind, J.C. (1980). Statistically based tests for the number of factors. Paper 
presented at the annual meeting of the Psychometric Society, Iowa City, IA. 
 
Tchou, J., Hou, N., Rademaker, A., Jordan, V.C., & Morrow, M. (2004). Acceptance of 
tamoxifen chemoprevention by physicians and women at risk. Cancer, 100, 1800-1806. 
 
Thompson, H.S., Valdimarsdottir, H.B., Duteau-Buck, C., Guevarra, J., Bovbjerg, D.H., 
Richmond-Avellaneda, C., et al. (2002). Psychosocial predictors of BRCA counseling and 
testing decisions among urban African-American women. Cancer Epidemiology, 
Biomarkers, & Prevention, 11, 1579-1585. 
 
Tzelgov, J. & Henik, A. (1991). Suppression situation sin psychological research: Definitions, 
implications, and applications. Psychological Bulletin, 109, 524-536. 
 
United States Preventative Services Task Force. (2002). Chemoprevention of breast cancer: 
Recommendations and Rationale. Annals of Internal Medicine, 137, 56-58. 
 
Valdimarsdottir, H.B., Bovbjerg, D.H., Kash, K.M., Holland, J.C., Osborne, M.P., & Miller, 
D.G. (1995). Psychological distress in women with a familial risk of breast cancer. 
Psycho-Oncology, 4,133-141. 
191 
  
Valdimarsdottir, H.B., Zadowski, S.G., Gerin, W., Mamakos, J., Pickering, T., & Bovberg, D.H. 
(2002).  Heightened psychobiological reactivity to laboratory stressors in healthy women 
at familial risk for breast cancer. Journal of Behavioral Medicine, 25, 51-65.. 
 
Viswanath, K. (2005). The communications revolution and cancer control. Nature Reviews 
Cancer, 5, 828-835. 
 
Viswanath, K., Breen, N., Meissner, H., Moser, R. P., Hesse, B., Steele, W. R. et al. (2006). 
Cancer knowledge and disparities in the information age. Journal of Health 
Communication, 11, 1-17. 
 
Wallace, A.E., MacKenzie, T.A., & Weeks, W.B. (2006). Women’s primary care providers and 
breast cancer screening: Who’s following the guidelines? American Journal of Obstetrics 
& Gynecology, 194, 744-748. 
 
Weinstein, N.D. (1988). The precaution adoption process. Health Psychology, 7, 355-386. 
 
Weinstein, N.D. (1982). Why it won’t happen to me: perceptions of risk factors and 
susceptibility. Health Psychology, 3, 431-457. 
 
Weinstein, N.D. & Klein, W.M. (1995). Resistance of personal risk perceptions to debiasing 
interventions. Health Psychology, 2, 132-140. 
 
Weiss, D., & Marmar, C. (1997). The Impact of Event Scale-Revised. In J. Wilson & T. Keane 
(Eds), Assessing Psychological Trauma and PTSD. New York: Guildford.  
 
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J. et al. (1995). Identification 
of the breast cancer susceptibility gene BRCA2.  Nature, 378, 789-792. 
 
Zajac, L. E., Klein, W. M., & McCaul, K. D. (2006). Absolute and comparative risk perceptions 
as predictors of cancer worry: Moderating effects of gender and psychological distress. 
Journal of Health Communication, 11, 37- 
 
192 
